000032033512/312025Q2FALSExbrli:sharesiso4217:USDiso4217:USDxbrli:sharesgl:segmentxbrli:puregl:Issuegl:issuergl:securitygl:loangl:guaranteegl:complainantgl:claimgl:extension_option00003203352025-01-012025-06-300000320335us-gaap:CommonStockMember2025-01-012025-06-300000320335gl:JuniorSubordinatedDebenturesMember2025-01-012025-06-3000003203352025-07-3100003203352025-06-3000003203352024-12-310000320335gl:PartnershipInterestFairValueOptionMember2025-06-300000320335gl:PartnershipInterestFairValueOptionMember2024-12-310000320335us-gaap:LifeInsuranceSegmentMember2025-04-012025-06-300000320335us-gaap:LifeInsuranceSegmentMember2024-04-012024-06-300000320335us-gaap:LifeInsuranceSegmentMember2025-01-012025-06-300000320335us-gaap:LifeInsuranceSegmentMember2024-01-012024-06-300000320335us-gaap:HealthInsuranceProductLineMember2025-04-012025-06-300000320335us-gaap:HealthInsuranceProductLineMember2024-04-012024-06-300000320335us-gaap:HealthInsuranceProductLineMember2025-01-012025-06-300000320335us-gaap:HealthInsuranceProductLineMember2024-01-012024-06-3000003203352025-04-012025-06-3000003203352024-04-012024-06-3000003203352024-01-012024-06-300000320335us-gaap:OtherInsuranceProductLineMember2025-04-012025-06-300000320335us-gaap:OtherInsuranceProductLineMember2024-04-012024-06-300000320335us-gaap:OtherInsuranceProductLineMember2025-01-012025-06-300000320335us-gaap:OtherInsuranceProductLineMember2024-01-012024-06-300000320335us-gaap:PreferredStockMember2024-12-310000320335us-gaap:CommonStockMember2024-12-310000320335us-gaap:AdditionalPaidInCapitalMember2024-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000320335us-gaap:RetainedEarningsMember2024-12-310000320335us-gaap:TreasuryStockCommonMember2024-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000320335us-gaap:RetainedEarningsMember2025-01-012025-03-3100003203352025-01-012025-03-310000320335us-gaap:TreasuryStockCommonMember2025-01-012025-03-310000320335us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000320335us-gaap:PreferredStockMember2025-03-310000320335us-gaap:CommonStockMember2025-03-310000320335us-gaap:AdditionalPaidInCapitalMember2025-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000320335us-gaap:RetainedEarningsMember2025-03-310000320335us-gaap:TreasuryStockCommonMember2025-03-3100003203352025-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000320335us-gaap:RetainedEarningsMember2025-04-012025-06-300000320335us-gaap:TreasuryStockCommonMember2025-04-012025-06-300000320335us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300000320335us-gaap:PreferredStockMember2025-06-300000320335us-gaap:CommonStockMember2025-06-300000320335us-gaap:AdditionalPaidInCapitalMember2025-06-300000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000320335us-gaap:RetainedEarningsMember2025-06-300000320335us-gaap:TreasuryStockCommonMember2025-06-300000320335us-gaap:PreferredStockMember2023-12-310000320335us-gaap:CommonStockMember2023-12-310000320335us-gaap:AdditionalPaidInCapitalMember2023-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000320335us-gaap:RetainedEarningsMember2023-12-310000320335us-gaap:TreasuryStockCommonMember2023-12-3100003203352023-12-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000320335us-gaap:RetainedEarningsMember2024-01-012024-03-3100003203352024-01-012024-03-310000320335us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000320335us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000320335us-gaap:PreferredStockMember2024-03-310000320335us-gaap:CommonStockMember2024-03-310000320335us-gaap:AdditionalPaidInCapitalMember2024-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000320335us-gaap:RetainedEarningsMember2024-03-310000320335us-gaap:TreasuryStockCommonMember2024-03-3100003203352024-03-310000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000320335us-gaap:RetainedEarningsMember2024-04-012024-06-300000320335us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000320335us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000320335us-gaap:PreferredStockMember2024-06-300000320335us-gaap:CommonStockMember2024-06-300000320335us-gaap:AdditionalPaidInCapitalMember2024-06-300000320335us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000320335us-gaap:RetainedEarningsMember2024-06-300000320335us-gaap:TreasuryStockCommonMember2024-06-3000003203352024-06-300000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-03-310000320335gl:FuturePolicyBenefitsMember2025-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2025-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-04-012025-06-300000320335gl:FuturePolicyBenefitsMember2025-04-012025-06-300000320335us-gaap:AccumulatedTranslationAdjustmentMember2025-04-012025-06-300000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-04-012025-06-300000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-06-300000320335gl:FuturePolicyBenefitsMember2025-06-300000320335us-gaap:AccumulatedTranslationAdjustmentMember2025-06-300000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-06-300000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-03-310000320335gl:FuturePolicyBenefitsMember2024-03-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-04-012024-06-300000320335gl:FuturePolicyBenefitsMember2024-04-012024-06-300000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-04-012024-06-300000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-300000320335gl:FuturePolicyBenefitsMember2024-06-300000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-12-310000320335gl:FuturePolicyBenefitsMember2024-12-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-01-012025-06-300000320335gl:FuturePolicyBenefitsMember2025-01-012025-06-300000320335us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-06-300000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-06-300000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310000320335gl:FuturePolicyBenefitsMember2023-12-310000320335us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000320335us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-06-300000320335gl:FuturePolicyBenefitsMember2024-01-012024-06-300000320335us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-06-300000320335us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-04-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-04-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-01-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-04-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2024-04-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-01-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2024-01-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-04-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-04-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-01-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-01-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-04-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-04-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300000320335us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2025-06-300000320335us-gaap:USStatesAndPoliticalSubdivisionsMember2025-06-300000320335us-gaap:ForeignGovernmentDebtSecuritiesMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMember2025-06-300000320335us-gaap:CollateralizedDebtObligationsMember2025-06-300000320335gl:OtherAssetBackedSecuritiesMember2025-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMember2024-12-310000320335us-gaap:USStatesAndPoliticalSubdivisionsMember2024-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMember2024-12-310000320335us-gaap:CollateralizedDebtObligationsMember2024-12-310000320335gl:OtherAssetBackedSecuritiesMember2024-12-310000320335us-gaap:FixedMaturitiesMember2025-06-300000320335us-gaap:FixedMaturitiesMember2024-12-310000320335us-gaap:FixedMaturitiesMember2025-04-012025-06-300000320335us-gaap:FixedMaturitiesMember2024-04-012024-06-300000320335us-gaap:FixedMaturitiesMember2025-01-012025-06-300000320335us-gaap:FixedMaturitiesMember2024-01-012024-06-300000320335us-gaap:PolicyLoansMember2025-04-012025-06-300000320335us-gaap:PolicyLoansMember2024-04-012024-06-300000320335us-gaap:PolicyLoansMember2025-01-012025-06-300000320335us-gaap:PolicyLoansMember2024-01-012024-06-300000320335gl:MortgageLoansMember2025-04-012025-06-300000320335gl:MortgageLoansMember2024-04-012024-06-300000320335gl:MortgageLoansMember2025-01-012025-06-300000320335gl:MortgageLoansMember2024-01-012024-06-300000320335us-gaap:OtherLongTermInvestmentsMember2025-04-012025-06-300000320335us-gaap:OtherLongTermInvestmentsMember2024-04-012024-06-300000320335us-gaap:OtherLongTermInvestmentsMember2025-01-012025-06-300000320335us-gaap:OtherLongTermInvestmentsMember2024-01-012024-06-300000320335us-gaap:ShortTermInvestmentsMember2025-04-012025-06-300000320335us-gaap:ShortTermInvestmentsMember2024-04-012024-06-300000320335us-gaap:ShortTermInvestmentsMember2025-01-012025-06-300000320335us-gaap:ShortTermInvestmentsMember2024-01-012024-06-300000320335us-gaap:FairValueOptionOtherEligibleItemsMember2024-04-012024-06-300000320335us-gaap:FairValueOptionOtherEligibleItemsMember2025-04-012025-06-300000320335us-gaap:FairValueOptionOtherEligibleItemsMember2025-01-012025-06-300000320335us-gaap:FairValueOptionOtherEligibleItemsMember2024-01-012024-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-06-300000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-06-300000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:FairValueInputsLevel1Member2025-06-300000320335us-gaap:FairValueInputsLevel2Member2025-06-300000320335us-gaap:FairValueInputsLevel3Member2025-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:FairValueInputsLevel1Member2024-12-310000320335us-gaap:FairValueInputsLevel2Member2024-12-310000320335us-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000320335us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-01-012025-06-300000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel3Member2025-01-012025-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-01-012025-06-300000320335us-gaap:FairValueInputsLevel3Member2025-01-012025-06-300000320335us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel3Member2023-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310000320335us-gaap:FairValueInputsLevel3Member2023-12-310000320335us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-06-300000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-06-300000320335us-gaap:FairValueInputsLevel3Member2024-01-012024-06-300000320335us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-06-300000320335us-gaap:CollateralizedDebtObligationsMemberus-gaap:FairValueInputsLevel3Member2024-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-06-300000320335us-gaap:FairValueInputsLevel3Member2024-06-300000320335us-gaap:AssetBackedSecuritiesMember2025-01-012025-06-300000320335us-gaap:CollateralizedDebtObligationsMember2025-01-012025-06-300000320335us-gaap:CorporateDebtSecuritiesMember2025-01-012025-06-300000320335us-gaap:AssetBackedSecuritiesMember2024-01-012024-06-300000320335us-gaap:CollateralizedDebtObligationsMember2024-01-012024-06-300000320335us-gaap:CorporateDebtSecuritiesMember2024-01-012024-06-300000320335gl:PrivatePlacementNotesMemberus-gaap:FairValueInputsLevel3Member2025-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:ExternalCreditRatingInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2025-06-300000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2025-06-300000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2025-06-300000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMember2025-06-300000320335gl:USGovernmentDirectGuaranteedAndGovernmentSponsoredEnterprisesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:ExternalCreditRatingInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:IndustrialsMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:FinancialMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMembergl:UtilitiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2024-12-310000320335us-gaap:CorporateDebtSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2024-12-310000320335gl:OtherAssetBackedSecuritiesMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMember2024-12-310000320335us-gaap:ExternalCreditRatingNonInvestmentGradeMember2024-12-310000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2025-01-012025-06-300000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2024-01-012024-12-310000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2025-06-300000320335gl:SeniorLoansInDefaultAndOnNonAccrualStatusMember2024-12-310000320335srt:IndustrialPropertyMember2025-06-300000320335srt:IndustrialPropertyMember2024-12-310000320335srt:MultifamilyMember2025-06-300000320335srt:MultifamilyMember2024-12-310000320335gl:HospitalityMember2025-06-300000320335gl:HospitalityMember2024-12-310000320335gl:RetailPropertyMember2025-06-300000320335gl:RetailPropertyMember2024-12-310000320335gl:MixedUseMember2025-06-300000320335gl:MixedUseMember2024-12-310000320335srt:OfficeBuildingMember2025-06-300000320335srt:OfficeBuildingMember2024-12-310000320335stpr:TX2025-06-300000320335stpr:TX2024-12-310000320335stpr:FL2025-06-300000320335stpr:FL2024-12-310000320335stpr:NJ2025-06-300000320335stpr:NJ2024-12-310000320335stpr:CA2025-06-300000320335stpr:CA2024-12-310000320335stpr:NC2025-06-300000320335stpr:NC2024-12-310000320335stpr:AL2025-06-300000320335stpr:AL2024-12-310000320335gl:OtherGeographicalLocationMember2025-06-300000320335gl:OtherGeographicalLocationMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVLessThan70PercentMember2025-06-300000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVLessThan70PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVLessThan70PercentMember2025-06-300000320335gl:LTVLessThan70PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV70PercentTo80PercentMember2025-06-300000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV70PercentTo80PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV70PercentTo80PercentMember2025-06-300000320335gl:LTV70PercentTo80PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV81PercentTo90PercentMember2025-06-300000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV81PercentTo90PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV81PercentTo90PercentMember2025-06-300000320335gl:LTV81PercentTo90PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVGreaterThan90PercentMember2025-06-300000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVGreaterThan90PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVGreaterThan90PercentMember2025-06-300000320335gl:LTVGreaterThan90PercentMember2025-06-300000320335gl:DebtServiceCoverageRatioLessThan1.00xMember2025-06-300000320335gl:DebtServiceCoverageRatio1.00x1.20xMember2025-06-300000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMember2025-06-300000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVLessThan70PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVLessThan70PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVLessThan70PercentMember2024-12-310000320335gl:LTVLessThan70PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV70PercentTo80PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV70PercentTo80PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV70PercentTo80PercentMember2024-12-310000320335gl:LTV70PercentTo80PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTV81PercentTo90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTV81PercentTo90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTV81PercentTo90PercentMember2024-12-310000320335gl:LTV81PercentTo90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMembergl:LTVGreaterThan90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMembergl:LTVGreaterThan90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMembergl:LTVGreaterThan90PercentMember2024-12-310000320335gl:LTVGreaterThan90PercentMember2024-12-310000320335gl:DebtServiceCoverageRatioLessThan1.00xMember2024-12-310000320335gl:DebtServiceCoverageRatio1.00x1.20xMember2024-12-310000320335gl:DebtServiceCoverageRatioGreaterThan1.20xMember2024-12-310000320335gl:CollaterallyDependentLoansMemberus-gaap:CommercialPortfolioSegmentMember2025-06-300000320335gl:CollaterallyDependentLoansMemberus-gaap:CommercialPortfolioSegmentMember2025-01-012025-06-300000320335us-gaap:CommercialPortfolioSegmentMember2025-04-012025-06-300000320335us-gaap:CommercialPortfolioSegmentMember2025-01-012025-06-300000320335us-gaap:CommercialPortfolioSegmentMembergl:LoansInProcessOfForeclosureMember2025-06-300000320335gl:NonaccrualLoansMemberus-gaap:CommercialPortfolioSegmentMember2025-06-300000320335gl:NonaccrualLoansMemberus-gaap:CommercialPortfolioSegmentMember2024-12-310000320335us-gaap:CommercialPortfolioSegmentMemberus-gaap:UnfundedLoanCommitmentMember2025-06-300000320335gl:CompanyOwnedLifeInsuranceMember2025-06-300000320335gl:CompanyOwnedLifeInsuranceMember2024-12-310000320335us-gaap:OtherInvestmentsMember2025-06-300000320335us-gaap:OtherInvestmentsMember2024-12-310000320335us-gaap:CommercialMortgageBackedSecuritiesMember2025-06-300000320335us-gaap:CommercialMortgageBackedSecuritiesMember2024-12-310000320335gl:OpportunisticAndPrivateCreditMember2025-06-300000320335gl:OpportunisticAndPrivateCreditMember2024-12-310000320335gl:InfrastructureMember2025-06-300000320335gl:InfrastructureMember2024-12-310000320335srt:PartnershipInterestMember2025-06-300000320335srt:PartnershipInterestMember2024-12-310000320335srt:MinimumMember2025-01-012025-06-300000320335srt:MaximumMember2025-01-012025-06-300000320335srt:PartnershipInterestMember2025-01-012025-06-300000320335us-gaap:LetterOfCreditMember2025-06-3000003203352024-04-302024-04-3000003203352024-11-1400003203352024-11-252024-11-2500003203352024-09-262024-09-260000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2023-12-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2023-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2023-12-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2023-12-310000320335gl:LifeSegmentMember2023-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-01-012024-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:LifeSegmentMember2024-01-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-06-300000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-06-300000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-06-300000320335gl:LifeSegmentMember2024-06-300000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-12-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-12-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-12-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-12-310000320335gl:LifeSegmentMember2024-12-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:DirectToConsumerMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-01-012025-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:LifeSegmentMember2025-01-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-06-300000320335gl:DirectToConsumerMembergl:LifeSegmentMember2025-06-300000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-06-300000320335gl:LifeSegmentMember2025-06-300000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-03-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-03-310000320335gl:LifeSegmentMember2024-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:DirectToConsumerMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2024-04-012024-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:LifeSegmentMember2024-04-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-03-310000320335gl:DirectToConsumerMembergl:LifeSegmentMember2025-03-310000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-03-310000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-03-310000320335gl:LifeSegmentMember2025-03-310000320335gl:AmericanIncomeExclusiveMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:DirectToConsumerMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:LifeSegmentMember2025-04-012025-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:LifeSegmentMember2025-04-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2023-12-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2023-12-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2023-12-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2023-12-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2023-12-310000320335gl:HealthSegmentMember2023-12-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:HealthSegmentMember2024-01-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-06-300000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-06-300000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-06-300000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-06-300000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-06-300000320335gl:HealthSegmentMember2024-06-300000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-12-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-12-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-12-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-12-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-12-310000320335gl:HealthSegmentMember2024-12-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:FamilyHeritageMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:DirectToConsumerMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:HealthSegmentMember2025-01-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-06-300000320335gl:FamilyHeritageMembergl:HealthSegmentMember2025-06-300000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-06-300000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-06-300000320335gl:DirectToConsumerMembergl:HealthSegmentMember2025-06-300000320335gl:HealthSegmentMember2025-06-300000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-03-310000320335gl:HealthSegmentMember2024-03-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:FamilyHeritageMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:DirectToConsumerMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:HealthSegmentMember2024-04-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-03-310000320335gl:FamilyHeritageMembergl:HealthSegmentMember2025-03-310000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-03-310000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-03-310000320335gl:DirectToConsumerMembergl:HealthSegmentMember2025-03-310000320335gl:HealthSegmentMember2025-03-310000320335gl:UnitedAmericanIndependentMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:FamilyHeritageMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:DirectToConsumerMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:HealthSegmentMember2025-04-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-01-012024-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-04-012025-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-04-012024-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2025-01-012025-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromExperienceMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:GainLossFromExperienceMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:GainLossFromExperienceMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:GainLossFromExperienceMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:GainLossFromExperienceMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-01-012024-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-04-012025-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-04-012024-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-01-012025-06-300000320335us-gaap:OtherInsuranceProductLineMembergl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:FamilyHeritageMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:FamilyHeritageMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:FamilyHeritageMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:FamilyHeritageMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromExperienceMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:GainLossFromExperienceMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:GainLossFromExperienceMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:GainLossFromExperienceMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:GainLossFromExperienceMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:FamilyHeritageMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:FamilyHeritageMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:FamilyHeritageMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:FamilyHeritageMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:LibertyNationalExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:AmericanIncomeExclusiveMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:DirectToConsumerMembergl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:GainLossFromUnlockingAssumptionsMembergl:HealthSegmentMember2024-01-012024-06-300000320335us-gaap:InterestSensitiveLifeMember2024-12-310000320335us-gaap:DeferredFixedAnnuityMember2024-12-310000320335us-gaap:OtherInsuranceProductLineMember2024-12-310000320335us-gaap:InterestSensitiveLifeMember2023-12-310000320335us-gaap:DeferredFixedAnnuityMember2023-12-310000320335us-gaap:OtherInsuranceProductLineMember2023-12-310000320335us-gaap:InterestSensitiveLifeMember2025-01-012025-06-300000320335us-gaap:DeferredFixedAnnuityMember2025-01-012025-06-300000320335us-gaap:InterestSensitiveLifeMember2024-01-012024-06-300000320335us-gaap:DeferredFixedAnnuityMember2024-01-012024-06-300000320335us-gaap:InterestSensitiveLifeMember2025-06-300000320335us-gaap:DeferredFixedAnnuityMember2025-06-300000320335us-gaap:OtherInsuranceProductLineMember2025-06-300000320335us-gaap:InterestSensitiveLifeMember2024-06-300000320335us-gaap:DeferredFixedAnnuityMember2024-06-300000320335us-gaap:OtherInsuranceProductLineMember2024-06-300000320335us-gaap:InterestSensitiveLifeMember2025-03-310000320335us-gaap:DeferredFixedAnnuityMember2025-03-310000320335us-gaap:OtherInsuranceProductLineMember2025-03-310000320335us-gaap:InterestSensitiveLifeMember2024-03-310000320335us-gaap:DeferredFixedAnnuityMember2024-03-310000320335us-gaap:OtherInsuranceProductLineMember2024-03-310000320335us-gaap:InterestSensitiveLifeMember2025-04-012025-06-300000320335us-gaap:DeferredFixedAnnuityMember2025-04-012025-06-300000320335us-gaap:InterestSensitiveLifeMember2024-04-012024-06-300000320335us-gaap:DeferredFixedAnnuityMember2024-04-012024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MinimumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MaximumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2025-06-300000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MinimumMember2025-06-300000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MaximumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MinimumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MaximumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MinimumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MaximumMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember2025-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember2025-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember2025-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MinimumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MaximumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAtGuaranteedMinimumCreditingRateMember2024-06-300000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MinimumMember2024-06-300000320335us-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membersrt:MaximumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Memberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MinimumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MaximumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Membergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0051To0150Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0200To0299Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MinimumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Membersrt:MaximumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMemberus-gaap:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0300To0399Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MinimumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Membersrt:MaximumMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0400To0499Member2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMembergl:PolicyholderAccountBalanceGuaranteedMinimumCreditingRateRangeFrom0500AndGreaterMember2024-06-300000320335us-gaap:InterestSensitiveLifeMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember2024-06-300000320335us-gaap:DeferredFixedAnnuityMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember2024-06-300000320335us-gaap:OtherInsuranceProductLineMemberus-gaap:PolicyholderAccountBalanceAboveGuaranteedMinimumCreditingRateRangeFrom0151AndGreaterMember2024-06-300000320335gl:AnnuitySegmentMember2025-06-300000320335gl:AnnuitySegmentMember2024-06-300000320335us-gaap:HealthInsuranceProductLineMember2024-12-310000320335us-gaap:HealthInsuranceProductLineMember2023-12-310000320335us-gaap:HealthInsuranceProductLineMember2024-01-012024-12-310000320335us-gaap:HealthInsuranceProductLineMember2025-06-300000320335us-gaap:LifeInsuranceSegmentMember2025-06-300000320335us-gaap:LifeInsuranceSegmentMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2025-06-300000320335us-gaap:ExchangeTradedFundsMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2025-06-300000320335gl:EquityExchangeTradedFundMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2025-06-300000320335us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2025-06-300000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2025-06-300000320335gl:GuaranteedAnnuityContractMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2025-06-300000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2025-06-300000320335gl:OtherMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ExchangeTradedFundsMember2024-12-310000320335us-gaap:ExchangeTradedFundsMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:EquityExchangeTradedFundMember2024-12-310000320335gl:EquityExchangeTradedFundMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember2024-12-310000320335us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherBondsMember2024-12-310000320335gl:OtherBondsMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:GuaranteedAnnuityContractMember2024-12-310000320335gl:GuaranteedAnnuityContractMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:ShortTermInvestmentsMember2024-12-310000320335us-gaap:ShortTermInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembergl:OtherMember2024-12-310000320335gl:OtherMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:QualifiedPlanMemberus-gaap:PensionPlansDefinedBenefitMember2025-06-300000320335us-gaap:QualifiedPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-12-310000320335us-gaap:NonqualifiedPlanMemberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2025-06-300000320335us-gaap:NonqualifiedPlanMemberus-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2024-12-310000320335gl:SeniorNotesDue2028Member2025-06-300000320335gl:SeniorNotesDue2028Member2024-12-310000320335gl:SeniorNotesDue2030Member2025-06-300000320335gl:SeniorNotesDue2030Member2024-12-310000320335gl:SeniorNotesDue2032Member2025-06-300000320335gl:SeniorNotesDue2032Member2024-12-310000320335gl:SeniorNotesDue2034Member2025-06-300000320335gl:SeniorNotesDue2034Member2024-12-310000320335gl:JuniorSubordinatedDebenturesDue2057Member2025-06-300000320335gl:JuniorSubordinatedDebenturesDue2057Member2024-12-310000320335gl:JuniorSubordinatedDebenturesDue2061Member2025-06-300000320335gl:JuniorSubordinatedDebenturesDue2061Member2024-12-310000320335gl:TermLoanDue2027Member2025-06-300000320335gl:TermLoanDue2027Member2024-12-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2025-06-300000320335us-gaap:FederalHomeLoanBankBorrowingsMember2024-12-310000320335us-gaap:CommercialPaperMember2025-06-300000320335us-gaap:CommercialPaperMember2024-12-310000320335srt:ConsolidationEliminationsMembersrt:SubsidiariesMembergl:SeniorNotesDue2032Member2025-06-300000320335gl:JuniorSubordinatedDebenturesDue2057Member2025-01-012025-06-300000320335us-gaap:SeniorNotesMember2025-01-012025-06-300000320335gl:JuniorSubordinatedDebenturesDue2056Member2025-06-300000320335us-gaap:LineOfCreditMember2025-06-300000320335us-gaap:LineOfCreditMember2024-03-290000320335us-gaap:LineOfCreditMember2024-03-292024-03-290000320335us-gaap:ShortTermDebtMember2025-06-300000320335us-gaap:ShortTermDebtMember2024-12-310000320335us-gaap:ShortTermDebtMember2024-06-300000320335us-gaap:CommercialPaperMember2025-01-012025-06-300000320335us-gaap:CommercialPaperMember2024-01-012024-06-300000320335us-gaap:FederalHomeLoanBankBorrowingsMember2025-06-300000320335us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetPledgedAsCollateralMember2025-06-300000320335us-gaap:FederalHomeLoanBankBorrowingsMember2024-12-310000320335us-gaap:FederalHomeLoanBankBorrowingsMember2024-06-3000003203352024-01-012024-09-3000003203352024-10-012024-12-310000320335gl:AmericanIncomeExclusiveMember2025-04-012025-06-300000320335gl:DirectResponseMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:DirectResponseMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:DirectResponseMember2025-04-012025-06-300000320335gl:LibertyNationalExclusiveMember2025-04-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:UnitedAmericanIndependentMember2025-04-012025-06-300000320335gl:FamilyHeritageMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:FamilyHeritageMember2025-04-012025-06-300000320335gl:DistributionChannelOtherMembergl:LifeSegmentMember2025-04-012025-06-300000320335gl:DistributionChannelOtherMembergl:HealthSegmentMember2025-04-012025-06-300000320335gl:DistributionChannelOtherMember2025-04-012025-06-300000320335gl:AmericanIncomeExclusiveMember2024-04-012024-06-300000320335gl:DirectResponseMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:DirectResponseMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:DirectResponseMember2024-04-012024-06-300000320335gl:LibertyNationalExclusiveMember2024-04-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:UnitedAmericanIndependentMember2024-04-012024-06-300000320335gl:FamilyHeritageMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:FamilyHeritageMember2024-04-012024-06-300000320335gl:DistributionChannelOtherMembergl:LifeSegmentMember2024-04-012024-06-300000320335gl:DistributionChannelOtherMembergl:HealthSegmentMember2024-04-012024-06-300000320335gl:DistributionChannelOtherMember2024-04-012024-06-300000320335gl:AmericanIncomeExclusiveMember2025-01-012025-06-300000320335gl:DirectResponseMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:DirectResponseMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:DirectResponseMember2025-01-012025-06-300000320335gl:LibertyNationalExclusiveMember2025-01-012025-06-300000320335gl:UnitedAmericanIndependentMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:UnitedAmericanIndependentMember2025-01-012025-06-300000320335gl:FamilyHeritageMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:FamilyHeritageMember2025-01-012025-06-300000320335gl:DistributionChannelOtherMembergl:LifeSegmentMember2025-01-012025-06-300000320335gl:DistributionChannelOtherMembergl:HealthSegmentMember2025-01-012025-06-300000320335gl:DistributionChannelOtherMember2025-01-012025-06-300000320335gl:AmericanIncomeExclusiveMember2024-01-012024-06-300000320335gl:DirectResponseMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:DirectResponseMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:DirectResponseMember2024-01-012024-06-300000320335gl:LibertyNationalExclusiveMember2024-01-012024-06-300000320335gl:UnitedAmericanIndependentMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:UnitedAmericanIndependentMember2024-01-012024-06-300000320335gl:FamilyHeritageMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:FamilyHeritageMember2024-01-012024-06-300000320335gl:DistributionChannelOtherMembergl:LifeSegmentMember2024-01-012024-06-300000320335gl:DistributionChannelOtherMembergl:HealthSegmentMember2024-01-012024-06-300000320335gl:DistributionChannelOtherMember2024-01-012024-06-300000320335gl:InvestmentSegmentMember2025-04-012025-06-300000320335gl:InvestmentSegmentMember2024-04-012024-06-300000320335gl:InvestmentSegmentMember2025-01-012025-06-300000320335gl:InvestmentSegmentMember2024-01-012024-06-300000320335us-gaap:OperatingSegmentsMembergl:LifeSegmentMember2025-06-300000320335us-gaap:OperatingSegmentsMembergl:HealthSegmentMember2025-06-300000320335us-gaap:OperatingSegmentsMembergl:InvestmentSegmentMember2025-06-300000320335us-gaap:OperatingSegmentsMember2025-06-300000320335us-gaap:CorporateNonSegmentMember2025-06-300000320335us-gaap:OperatingSegmentsMembergl:LifeSegmentMember2024-12-310000320335us-gaap:OperatingSegmentsMembergl:HealthSegmentMember2024-12-310000320335us-gaap:OperatingSegmentsMembergl:InvestmentSegmentMember2024-12-310000320335us-gaap:OperatingSegmentsMember2024-12-310000320335us-gaap:CorporateNonSegmentMember2024-12-310000320335gl:SeniorNotesDue2055Memberus-gaap:SeniorNotesMemberus-gaap:SubsequentEventMember2025-07-012025-07-010000320335us-gaap:PrivatePlacementMemberus-gaap:SubsequentEventMember2025-07-012025-07-010000320335gl:SeniorNotesDue2055Memberus-gaap:SeniorNotesMemberus-gaap:SubsequentEventMember2025-07-010000320335gl:RealEstateInMcKinneyTexasMemberus-gaap:SubsequentEventMember2025-07-032025-07-030000320335gl:RealEstateInMcKinneyTexasMemberus-gaap:BuildingMemberus-gaap:SubsequentEventMember2025-07-03
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark one)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2025
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ________
Commission File Number: 001-08052
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware 63-0780404
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
3700 South Stonebridge Drive, McKinney, Texas 75070
(Address of principal executive offices) (Zip Code)

(972569-4000
(Registrant’s telephone number, including area code)

NONE
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par value per shareGLNew York Stock Exchange
4.250% Junior Subordinated DebenturesGL PRDNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                 Yes       No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).                                             Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes     No  

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class Outstanding at July 31, 2025
Common Stock, $1.00 Par Value 81,003,536
GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Table of Contents
Page
PART I. FINANCIAL INFORMATION
Item 1.
Item 2.
Item 3.
Item 4.
PART II. OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 5.
Item 6.



As used in this Form 10-Q, “Globe Life,” the “Company,” “we,” “our” and “us” refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
GL Q2 2025 FORM 10-Q

Table of Contents
PART I—FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements

Globe Life Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
(Dollar amounts in thousands, except per share data)
June 30,
2025
December 31, 2024
Assets:
Investments:
Fixed maturities—available for sale, at fair value (amortized cost: 2025—$18,959,797;
2024—$18,835,809, allowance for credit losses: 2025— $10,355; 2024— $10,395)
$17,365,354 $17,155,012 
Mortgage loans455,767 396,088 
Policy loans718,621 699,669 
Other long-term investments (includes: 2025—$1,022,425; 2024—$986,766 under the fair value option)
1,268,624 1,235,759 
Short-term investments116,724 85,035 
Total investments19,925,090 19,571,563 
Cash239,122 165,325 
Accrued investment income271,670 269,791 
Other receivables690,705 691,907 
Deferred acquisition costs6,754,821 6,495,589 
Goodwill490,446 490,446 
Other assets1,437,494 1,391,560 
Total assets$29,809,348 $29,076,181 
Liabilities:
Future policy benefits at current discount rates: (at original discount rates: 2025—$17,901,979; 2024—$17,552,564)
$18,846,755 $18,457,263 
Unearned and advance premium273,195 257,631 
Policy claims and other benefits payable532,179 532,832 
Other policyholders' funds492,146 468,604 
Total policy liabilities20,144,275 19,716,330 
Current and deferred income taxes816,135 731,255 
Short-term debt464,540 415,401 
Long-term debt (estimated fair value: 2025—$2,172,267; 2024—$2,122,772)
2,325,642 2,324,251 
Other liabilities639,726 583,424 
Total liabilities24,390,318 23,770,661 
Commitments and Contingencies (Note 5)
Shareholders' equity:
Preferred stock, par value $1 per share—5,000,000 shares authorized; outstanding: 0 in 2025 and 2024
  
Common stock, par value $1 per share—320,000,000 shares authorized; outstanding: (2025—97,218,183 issued; 2024—97,218,183 issued)
97,218 97,218 
Additional paid-in-capital538,050 527,795 
Accumulated other comprehensive income (loss)(1,983,868)(2,029,720)
Retained earnings8,453,893 8,002,521 
Treasury stock, at cost: (2025—16,206,643 shares; 2024—13,240,616 shares)
(1,686,263)(1,292,294)
Total shareholders' equity5,419,030 5,305,520 
Total liabilities and shareholders' equity$29,809,348 $29,076,181 
See accompanying Notes to Condensed Consolidated Financial Statements.
1
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(Dollar amounts in thousands, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Revenue:
Life premium$839,544 $815,482 $1,669,407 $1,619,747 
Health premium378,099 351,643 747,890 692,662 
Total premium1,217,643 1,167,125 2,417,297 2,312,409 
Net investment income282,169 285,636 562,783 568,214 
Realized gains (losses)(18,574)(12,589)(18,489)(24,388)
Other income49 74 118 150 
Total revenue1,481,287 1,440,246 2,961,709 2,856,385 
Benefits and expenses:
Life policyholder benefits(1)
519,355 518,792 1,029,111 1,038,663 
Health policyholder benefits(2)
229,924 205,423 463,853 407,750 
Other policyholder benefits6,719 11,479 13,799 21,074 
Total policyholder benefits755,998 735,694 1,506,763 1,467,487 
Amortization of deferred acquisition costs111,401 101,915 216,916 201,393 
Commissions, premium taxes, and non-deferred acquisition costs157,411 149,802 321,734 297,912 
Other operating expense108,293 99,108 217,039 192,322 
Interest expense34,885 31,404 69,877 60,025 
Total benefits and expenses1,167,988 1,117,923 2,332,329 2,219,139 
Income before income taxes313,299 322,323 629,380 637,246 
Income tax benefit (expense)(60,550)(63,968)(122,068)(124,674)
Net income
$252,749 $258,355 $507,312 $512,572 
Basic net income per common share
$3.09 $2.83 $6.13 $5.53 
Diluted net income per common share
$3.05 $2.83 $6.07 $5.51 
(1)Net of a remeasurement gain of $16.7 million for the three months ended June 30, 2025 and a remeasurement gain of $12.4 million for the same period in 2024. Net of a remeasurement gain of $25.3 million for the six months ended June 30, 2025 and a remeasurement gain of $17.3 million for the same period in 2024.
(2)Net of a remeasurement gain of $3.9 million for the three months ended June 30, 2025 and a remeasurement gain of $3.2 million for the same period in 2024. Net of a remeasurement gain of $4.3 million for the six months ended June 30, 2025 and a remeasurement gain of $6.5 million for the same period in 2024.








See accompanying Notes to Condensed Consolidated Financial Statements.
2
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)
(Dollar amounts in thousands)
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Net income
$252,749 $258,355 $507,312 $512,572 
Other comprehensive income (loss):
Investments:
Unrealized gains (losses) on fixed maturities:
Unrealized holding gains (losses) arising during period(134,318)(263,012)80,810 (568,028)
Other reclassification adjustments included in net income10,603 7,400 7,262 4,988 
Foreign exchange adjustment on fixed maturities recorded at fair value(1,328)(117)(1,758)1,500 
Total unrealized investment gains (losses)(125,043)(255,729)86,314 (561,540)
Less applicable tax (expense) benefit26,264 53,701 (18,123)117,923 
Unrealized gains (losses) on investments, net of tax(98,779)(202,028)68,191 (443,617)
Future Policy Benefits:
Change in discount rate on future policy benefits92,229 606,384 (47,123)1,310,980 
Less applicable tax (expense) benefit(19,367)(127,342)9,896 (275,306)
Future policy benefit adjustments, net of tax72,862 479,042 (37,227)1,035,674 
Foreign exchange translation:
Foreign exchange translation adjustments, other than securities16,300 641 18,721 (11,956)
Less applicable tax (expense) benefit(3,425)(135)(3,933)2,511 
Foreign exchange translation adjustments, other than securities, net of tax12,875 506 14,788 (9,445)
Pension:
Pension adjustments59 118 127 236 
Less applicable tax (expense) benefit(12)(22)(27)(49)
Pension adjustments, net of tax47 96 100 187 
Other comprehensive income (loss)(12,995)277,616 45,852 582,799 
Comprehensive income (loss)
$239,754 $535,971 $553,164 $1,095,371 











See accompanying Notes to Condensed Consolidated Financial Statements.
3
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Shareholders' Equity
(Unaudited)
(Dollar amounts in thousands, except per share data)


Preferred StockCommon StockAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Retained EarningsTreasury StockTotal Shareholders' Equity
Balance at December 31, 2024
$ $97,218 $527,795 $(2,029,720)$8,002,521 $(1,292,294)$5,305,520 
Comprehensive income (loss)— — — 58,847 254,563 — 313,410 
Common dividends declared
($0.2700 per share)
— — — — (22,383)— (22,383)
Acquisition of treasury stock— — — — — (264,544)(264,544)
Stock-based compensation— — (3,754)— — 15,773 12,019 
Exercise of stock options— — — — (9,753)91,147 81,394 
Balance at March 31, 2025
 97,218 524,041 (1,970,873)8,224,948 (1,449,918)5,425,416 
Comprehensive income (loss)— — — (12,995)252,749 — 239,754 
Common dividends declared
($0.2700 per share)
— — — — (21,869)— (21,869)
Acquisition of treasury stock— — — — — (250,311)(250,311)
Stock-based compensation— — 14,009 — — 34 14,043 
Exercise of stock options— — — — (1,935)13,932 11,997 
Balance at June 30, 2025
$ $97,218 $538,050 $(1,983,868)$8,453,893 $(1,686,263)$5,419,030 


Preferred StockCommon StockAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Retained EarningsTreasury StockTotal Shareholders' Equity
Balance at December 31, 2023
$ $102,218 $532,474 $(2,772,419)$7,478,813 $(854,283)$4,486,803 
Comprehensive income (loss)— — — 305,183 254,217 — 559,400 
Common dividends declared
($0.2400 per share)
— — — — (22,603)— (22,603)
Acquisition of treasury stock— — — — — (23,469)(23,469)
Stock-based compensation— — (5,612)— (438)15,317 9,267 
Exercise of stock options— — — — (3,334)33,097 29,763 
Balance at March 31, 2024
 102,218 526,862 (2,467,236)7,706,655 (829,338)5,039,161 
Comprehensive income (loss)— — — 277,616 258,355 — 535,971 
Common dividends declared
($0.2400 per share)
— — — — (21,595)— (21,595)
Acquisition of treasury stock— — — — — (335,873)(335,873)
Stock-based compensation— — 7,166 — — 2,924 10,090 
Exercise of stock options— — — — — — — 
Balance at June 30, 2024
$ $102,218 $534,028 $(2,189,620)$7,943,415 $(1,162,287)$5,227,754 







See accompanying Notes to Condensed Consolidated Financial Statements.
4
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(Dollar amounts in thousands)
Six Months Ended
June 30,
20252024
Cash provided from (used for) operating activities
$739,813 $724,923 
Cash provided from (used for) investing activities:
Investments sold or matured:
Fixed maturities available for sale—sold272,067 510,904 
Fixed maturities available for sale—matured or other redemptions132,253 85,385 
Mortgage loans3,437 26,071 
Other long-term investments25,939 14,125 
Total investments sold or matured433,696 636,485 
Acquisition of investments:
Fixed maturities—available for sale(511,297)(923,096)
Mortgage loans(66,686)(92,167)
Other long-term investments(53,799)(165,322)
Total investments acquired(631,782)(1,180,585)
Net (increase) decrease in policy loans(18,952)(19,057)
Net (increase) decrease in short-term investments(31,689)(18,820)
Additions to property and equipment(24,687)(26,738)
Investments in low-income housing interests(30,569)(17,870)
Cash provided from (used for) investing activities
(303,983)(626,585)
Cash provided from (used for) financing activities:
Issuance of common stock93,391 29,763 
Cash dividends paid to shareholders(42,524)(43,681)
Net borrowing from Federal Home Loan Bank (FHLB)
70,000 180,000 
Net borrowing (repayment) of commercial paper26,983 (114,494)
Proceeds from commercial paper with original maturities greater than 90 days361,118 339,518 
Repayment of commercial paper with original maturities greater than 90 days(408,962)(236,786)
Acquisition of treasury stock(514,855)(359,342)
Net receipts (payments) from deposit-type products59,600 85,236 
Cash provided from (used for) financing activities
(355,249)(119,786)
Effect of foreign exchange rate changes on cash(6,784)6,206 
Net increase (decrease) in cash73,797 (15,242)
Cash at beginning of year165,325 103,156 
Cash at end of period $239,122 $87,914 






See accompanying Notes to Condensed Consolidated Financial Statements.
5
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

Note 1—Significant Accounting Policies

Business: (Globe Life), (the Company), refers to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and Globe Life Inc. subsidiaries and affiliates. Globe Life Inc.'s direct or indirect primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The underwriting companies are owned by their ultimate corporate parent, Globe Life Inc. (Parent Company).

Globe Life provides a variety of life and supplemental health insurance products to a broad base of customers. The Company is organized into three reportable segments: life insurance, supplemental health insurance, and investments.

Globe Life markets its insurance products through a number of distribution channels, each of which sells the products of one or more of Globe Life's insurance segments. Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (DTC).

Basis of Presentation: The accompanying condensed consolidated financial statements of Globe Life have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all of the disclosures required by accounting principles generally accepted in the United States of America (GAAP) for annual financial statements. However, in the opinion of management, these statements include all adjustments, consisting of normal recurring adjustments, which are necessary for a fair presentation of the condensed consolidated financial position at June 30, 2025, and the condensed consolidated results of operations, comprehensive income, and cash flows for the periods ended June 30, 2025 and 2024. The interim period condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements that were included in the Form 10-K filed with the Securities Exchange Commission (SEC) on February 26, 2025.

Use of Estimates: The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes.

Reinsurance and Recapture: In the normal course of business, Globe Life insurance subsidiaries will enter into reinsurance agreements to limit their exposure to the risk of loss as well as enhance their capital position. The Company entered into a coinsurance transaction with funds withheld agreement with a third-party reinsurer on March 6, 2025, with an agreement effective date of January 1, 2025. Under the terms of the agreement Globe Life ceded 100% of the liabilities, net of existing reinsurance, associated with certain term and whole life insurance policies. The contract is accounted for under deposit accounting as it did not pass the risk transfer requirements for reinsurance treatment on a GAAP basis. Since the agreement is subject to deposit accounting and meets the right of offset conditions outlined in the accounting policy the Company recorded the initial coinsurance, ceding commission and funds withheld balance on a net basis. At inception, no cash was exchanged between the parties and subsequently, a risk charge was recorded as a component of net investment income in the Condensed Consolidated Statement of Operations, with net cash settlements occurring quarterly between the parties.

On March 31, 2025, the Company entered into a recapture and termination agreement with a third-party reinsurer to recapture certain policies that had previously been ceded under a reinsurance agreement dated November 12, 2001. The recapture was executed to accomplish common objectives between the Company and the reinsurer. As a result of the transaction, the Company received net proceeds of $39 million, which are reflected as operating cash flows in the Condensed Consolidated Statement of Cash Flows. The Company also recognized a gain of approximately $14 million in policyholder benefits in the Condensed Consolidated Statement of Operations.
6
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 2—New Accounting Standards

Accounting Pronouncements Yet to be Adopted: ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, adds disclosure requirements to disaggregate information related to the effective tax rate reconciliation and information on income taxes paid. The disclosures will enhance the assessment of an entity’s operations and related tax risks.

This standard is effective for the Company for annual periods beginning on January 1, 2025, and will be implemented on a prospective basis. The Company does not expect the standard will have a material impact on the condensed consolidated financial statements. The guidance requires only additional disclosure, as a result there will be no effects on our financial position, results of operations or cash flows.

ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, adds disclosure requirements to disaggregate information related to an entity's income statement. The disclosures will allow for enhanced transparency of an entity's expenses.

This standard is effective for the Company for annual periods beginning on January 1, 2027. The Company is evaluating the standard.


7
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 3—Supplemental Information about Changes to Accumulated Other Comprehensive Income

Components of Accumulated Other Comprehensive Income: An analysis of the change in balance by component of Accumulated Other Comprehensive Income is as follows for the three and six month periods ended June 30, 2025 and 2024:
 Three Months Ended June 30, 2025
 Available
for Sale
Assets
Future Policy BenefitsForeign
Exchange
Pension
Adjustments
Total
Balance at April 1, 2025
$(1,152,648)$(819,131)$(19,844)$20,750 $(1,970,873)
Other comprehensive income (loss) before reclassifications, net of tax(107,155)72,862 12,875  (21,418)
Reclassifications, net of tax8,376   47 8,423 
Other comprehensive income (loss)(98,779)72,862 12,875 47 (12,995)
Balance at June 30, 2025
$(1,251,427)$(746,269)$(6,969)$20,797 $(1,983,868)

 Three Months Ended June 30, 2024
 Available
for Sale
Assets
Future Policy BenefitsForeign
Exchange
Pension
Adjustments
Total
Balance at April 1, 2024
$(1,069,185)$(1,390,759)$(5,232)$(2,060)$(2,467,236)
Other comprehensive income (loss) before reclassifications, net of tax(207,874)479,042 506  271,674 
Reclassifications, net of tax5,846   96 5,942 
Other comprehensive income (loss)(202,028)479,042 506 96 277,616 
Balance at June 30, 2024
$(1,271,213)$(911,717)$(4,726)$(1,964)$(2,189,620)

 Six Months Ended June 30, 2025
 Available
for Sale
Assets
Future Policy BenefitsForeign
Exchange
Pension
Adjustments
Total
Balance at January 1, 2025
$(1,319,618)$(709,042)$(21,757)$20,697 $(2,029,720)
Other comprehensive income (loss) before reclassifications, net of tax62,454 (37,227)14,788  40,015 
Reclassifications, net of tax5,737   100 5,837 
Other comprehensive income (loss)68,191 (37,227)14,788 100 45,852 
Balance at June 30, 2025
$(1,251,427)$(746,269)$(6,969)$20,797 $(1,983,868)

 Six Months Ended June 30, 2024
 Available
for Sale
Assets
Future Policy BenefitsForeign
Exchange
Pension
Adjustments
Total
Balance at January 1, 2024
$(827,596)$(1,947,391)$4,719 $(2,151)$(2,772,419)
Other comprehensive income (loss) before reclassifications, net of tax(447,558)1,035,674 (9,445) 578,671 
Reclassifications, net of tax3,941   187 4,128 
Other comprehensive income (loss)(443,617)1,035,674 (9,445)187 582,799 
Balance at June 30, 2024
$(1,271,213)$(911,717)$(4,726)$(1,964)$(2,189,620)

8
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Reclassification Adjustments: Reclassification adjustments out of accumulated other comprehensive income are presented below for the three and six month periods ended June 30, 2025 and 2024.
  Three Months Ended
June 30,
Six Months Ended June 30,Affected line items in the Statements of Operations
Component Line Item2025202420252024
Unrealized investment (gains) losses on available for sale assets:
Realized (gains) losses$12,837 $10,217 $12,009 $9,989 Realized (gains) losses
Amortization of (discount) premium(2,234)(2,817)(4,747)(5,001)Net investment income
Total before tax10,603 7,400 7,262 4,988 
Tax(2,227)(1,554)(1,525)(1,047)Income taxes
Total after-tax8,376 5,846 5,737 3,941 
Pension adjustments:
Amortization of prior service cost292 269 584 538 Other operating expense
Amortization of actuarial (gain) loss(233)(151)(457)(302)Other operating expense
Total before tax59 118 127 236 
Tax(12)(22)(27)(49)Income taxes
Total after-tax47 96 100 187 
Total reclassification (after-tax)
$8,423 $5,942 $5,837 $4,128 
9
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 4—Investments

Portfolio Composition: Summaries of fixed maturities available for sale by amortized cost, fair value, and allowance for credit losses at June 30, 2025 and December 31, 2024, and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income (loss) are as follows. Redeemable preferred stock is included within "Corporates, by sector."
At June 30, 2025

Amortized
Cost
Allowance for Credit LossesGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
 Value(1)
% of Total
Fixed
Maturities(2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises$411,371 $ $131 $(31,467)$380,035 2 
States, municipalities, and political subdivisions3,303,151  23,550 (633,924)2,692,777 16 
Foreign governments39,427  21 (9,842)29,606  
Corporates, by sector:
Industrials8,007,486 (7,058)138,507 (737,473)7,401,462 43 
Financial5,004,947  107,285 (386,613)4,725,619 27 
Utilities2,113,952  55,957 (109,524)2,060,385 12 
Total corporates15,126,385 (7,058)301,749 (1,233,610)14,187,466 82 
Collateralized debt obligations      
Other asset-backed securities79,463 (3,297)114 (810)75,470  
Total fixed maturities
$18,959,797 $(10,355)$325,565 $(1,909,653)$17,365,354 100 
(1)Amount reported in the balance sheet.
(2)At fair value.

At December 31, 2024
Amortized
Cost
Allowance for Credit LossesGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
 Value(1)
% of Total
Fixed
Maturities(2)
Fixed maturities available for sale:
U.S. Government direct, guaranteed, and government-sponsored enterprises$401,753 $ $1 $(42,794)$358,960 2 
States, municipalities, and political subdivisions3,300,901  20,662 (534,759)2,786,804 16 
Foreign governments36,883  18 (8,870)28,031  
Corporates, by sector:
Industrials
7,889,074 (7,098)105,610 (805,330)7,182,256 42 
Financial5,006,375  82,598 (413,043)4,675,930 27 
Utilities2,081,366  39,716 (118,007)2,003,075 12 
Total corporates14,976,815 (7,098)227,924 (1,336,380)13,861,261 81 
Collateralized debt obligations36,923  5,943  42,866  
Other asset-backed securities82,534 (3,297)39 (2,186)77,090 1 
Total fixed maturities
$18,835,809 $(10,395)$254,587 $(1,924,989)$17,155,012 100 
(1)Amount reported in the balance sheet.
(2)At fair value.

The Company had unfunded commitments of $146 million and $167 million in fixed maturities at June 30, 2025 and December 31, 2024, respectively.
10
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
A schedule of fixed maturities available for sale by contractual maturity date at June 30, 2025, is shown below on an amortized cost basis, net of allowance for credit losses, and on a fair value basis. Actual disposition dates could differ from contractual maturities due to call or prepayment provisions.
At June 30, 2025
Amortized
Cost, net
Fair
Value
Fixed maturities available for sale:
Due in one year or less$96,098 $96,423 
Due after one year through five years809,469 833,243 
Due after five years through ten years1,916,943 1,958,923 
Due after ten years through twenty years9,007,319 8,411,758 
Due after twenty years7,043,430 5,989,520 
Mortgage-backed and asset-backed securities76,183 75,487 
$18,949,442 $17,365,354 

Analysis of Investment Operations: "Net investment income" for the three and six month periods ended June 30, 2025 and 2024 is summarized as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
20252024% Change20252024% Change
Fixed maturities available for sale$245,205 $247,215 (1)$487,415 $493,313 (1)
Policy loans13,850 13,084 6 27,508 25,900 6 
Mortgage loans5,350 6,909 (23)12,018 13,669 (12)
Other long-term investments(1)
21,438 18,953 13 44,517 38,616 15 
Short-term investments3,059 3,625 4,535 5,313 
288,902 289,786  575,993 576,811  
Less investment expense(6,733)(4,150)62 (13,210)(8,597)54 
Net investment income
$282,169 $285,636 (1)$562,783 $568,214 (1)
(1)For the three months ended June 30, 2025 and June 30, 2024 the investment funds, accounted for under the fair value option method, recorded $18 million in net investment income for both periods. For the six months ended June 30, 2025 and 2024, the investment funds, accounted for under the fair value option method, recorded $37.3 million and $37.0 million, respectively, in net investment income. Refer to Other Long-Term Investments below for further discussion on the investment funds.

Selected information about sales of fixed maturities available for sale is as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Fixed maturities available for sale:
Proceeds from sales(1)
$218,156 $483,051 $272,067 $510,904 
Gross realized gains1,617 3,869 3,095 4,044 
Gross realized losses(7,026)(13,933)(8,490)(13,968)
(1)During the three and six months ended June 30, 2025 and 2024, the Company had $0 unsettled trades.
11
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
An analysis of "realized gains (losses)" is as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Realized investment gains (losses):
Fixed maturities available for sale:
Sales and other(1)
$(12,837)$(10,113)$(12,049)$(9,973)
Provision for credit losses (104)40 (16)
Fair value option—change in fair value(8,476)(3,691)(6,105)(19,094)
Mortgage loans
(126)(1,280)307 (2,154)
Other investments(264)837 (1,342)1,151 
Realized gains (losses) from investments
(21,703)(14,351)(19,149)(30,086)
Other gains (losses)3,129 1,762 660 5,698 
Total realized gains (losses)
(18,574)(12,589)(18,489)(24,388)
Applicable tax3,900 2,644 3,882 5,122 
Realized gains (losses), net of tax
$(14,674)$(9,945)$(14,607)$(19,266)
(1)During the three months ended June 30, 2025 and 2024, the Company recorded $72.6 million and $12.0 million of issuer-initiated exchanges of fixed maturities (noncash transactions) that resulted in $(3.2) million and $0 realized gains (losses) respectively. During the six months ended June 30, 2025 and 2024, the Company recorded $128.3 million and $78.9 million of issuer-initiated exchanges of fixed maturities (noncash transactions) that resulted in $(3.1) million and $0 realized gains (losses) respectively.
12
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fair Value Measurements: The following tables represent the fair value of fixed maturities measured on a recurring basis at June 30, 2025 and December 31, 2024:
Fair Value Measurement at June 30, 2025:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant Other
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises$ $380,035 $ $380,035 
States, municipalities, and political subdivisions 2,692,777  2,692,777 
Foreign governments 29,606  29,606 
Corporates, by sector:
Industrials
 7,222,920 178,542 7,401,462 
Financial 4,603,643 121,976 4,725,619 
Utilities
 1,942,506 117,879 2,060,385 
Total corporates 13,769,069 418,397 14,187,466 
Collateralized debt obligations    
Other asset-backed securities 42,877 32,593 75,470 
Total fixed maturities
$ $16,914,364 $450,990 $17,365,354 
Percentage of total %97 %3 %100 %

Fair Value Measurement at December 31, 2024:
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant Other
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total Fair
Value
Fixed maturities available for sale
U.S. Government direct, guaranteed, and government-sponsored enterprises$ $358,960 $ $358,960 
States, municipalities, and political subdivisions 2,786,804  2,786,804 
Foreign governments 28,031  28,031 
Corporates, by sector:
Industrials
 6,998,900 183,356 7,182,256 
Financial 4,551,737 124,193 4,675,930 
Utilities 1,890,559 112,516 2,003,075 
Total corporates 13,441,196 420,065 13,861,261 
Collateralized debt obligations  42,866 42,866 
Other asset-backed securities 65,907 11,183 77,090 
Total fixed maturities
$ $16,680,898 $474,114 $17,155,012 
Percentage of total %97 %3 %100 %

13
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables represent changes in fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
Collateralized
Debt
Obligations
CorporatesTotal
Balance at January 1, 2025
$11,183 $42,866 $420,065 $474,114 
Included in realized gains / losses (588)(4)(592)
Included in other comprehensive income71  (3,328)(3,257)
Acquisitions21,339  17,515 38,854 
Sales (36,398) (36,398)
Amortization 1,893 13 1,906 
Other(1)
 (7,773)(15,864)(23,637)
Transfers into Level 3(2)
    
Transfers out of Level 3(2)
    
Balance at June 30, 2025
$32,593 $ $418,397 $450,990 
Percent of total fixed maturities % %3 %3 %
(1)Includes capitalized interest, foreign exchange adjustments, and principal repayments. 
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Asset-
backed Securities
Collateralized
Debt
Obligations
CorporatesTotal
Balance at January 1, 2024
$ $42,146 $454,733 $496,879 
Included in realized gains / losses    
Included in other comprehensive income 742 (9,905)(9,163)
Acquisitions  14,800 14,800 
Sales    
Amortization 2,277 (33)2,244 
Other(1)
 (2,441)(21,564)(24,005)
Transfers into Level 3(2)
    
Transfers out of Level 3(2)
    
Balance at June 30, 2024
$ $42,724 $438,031 $480,755 
Percent of total fixed maturities % %3 %3 %
(1)Includes capitalized interest, foreign exchange adjustments, and principal repayments. 
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.

14
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents changes in unrealized gains and losses for the period included in accumulated other comprehensive income for assets held at the end of the reporting period for Level 3 classification:
Changes in Unrealized Gains (Losses) included in Accumulated Other Comprehensive Income for Assets Held at the End of the Period
Asset-
backed Securities
Collateralized
Debt
Obligations
CorporatesTotal
At June 30, 2025
$71 $ $(3,328)$(3,257)
At June 30, 2024
 742 (9,905)(9,163)

Transfers between levels within the hierarchy occur when there are changes in the observability of the inputs and market data. Transfers into Level 3 occur when there is little unobservable market activity for the asset/liability as of the measurement date and the Company is required to rely upon internally-developed assumptions or third parties. Transfers out of Level 3 occur when quoted prices in active markets becomes available for identical assets/ liabilities or the ability to corroborate by observable market data.

The following table represents quantitative information about Level 3 fair value measurements:
Quantitative Information about Level 3 Fair Value Measurements
June 30, 2025
Fair ValueValuation
Techniques
Significant Unobservable
Input
Range
Weighted-
Average(1)
Private placement fixed maturities$418,397 Determination of credit spreadCredit rating
B to AAA
BBB+
Asset-backed securities32,593 Determination of credit spreadCredit rating
CC to BBB
BB+
$450,990 
(1)Unobservable inputs were weighted by the relative fair value of the instruments.

Private placement fixed maturities and asset-backed securities are valued based on the contractual cash flows discounted by a yield determined as a treasury benchmark rate adjusted for a credit spread. The credit spread is developed from observable indices for similar securities and unobservable indices for private securities or private comparable securities for corresponding credit ratings. The credit ratings for the securities may be considered unobservable inputs, as they are private letter ratings issued by a nationally recognized statistical rating organization or are assigned by the third-party investment manager based on a quantitative and qualitative assessment of the credit underwritten. A higher (lower) credit rating would result in a higher (lower) valuation. For more information regarding valuation procedures, please refer to Note 1—Significant Accounting Policies under the caption Fair Value Measurements, Investments in Securities disclosed in the Form 10-K.
 
Unrealized Loss Analysis: The following table discloses information about fixed maturities available for sale in an unrealized loss position.
Less than Twelve MonthsTwelve Months or LongerTotal
Number of issues (CUSIPs) held:
As of June 30, 2025644 1,486 2,130 
As of December 31, 2024705 1,498 2,203 
 
Globe Life's entire fixed maturity portfolio consisted of 2,577 issues by 1,016 different issuers at June 30, 2025 and 2,552 issues by 1,014 different issuers at December 31, 2024. The weighted-average quality rating of all unrealized loss positions at amortized cost was A as of June 30, 2025 and A- as of December 31, 2024.

15
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables disclose unrealized investment losses by class and major sector of fixed maturities available for sale at June 30, 2025 and December 31, 2024.

Analysis of Gross Unrealized Investment Losses
At June 30, 2025
Less than Twelve MonthsTwelve Months or LongerTotal
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises$4,658 $(497)$365,241 $(30,970)$369,899 $(31,467)
States, municipalities, and political subdivisions788,376 (47,539)1,449,974 (586,385)2,238,350 (633,924)
Foreign governments  25,084 (9,842)25,084 (9,842)
Corporates, by sector:
Industrials
1,295,455 (63,946)3,437,449 (638,215)4,732,904 (702,161)
Financial749,725 (23,304)1,846,917 (346,568)2,596,642 (369,872)
Utilities
365,180 (9,905)564,596 (93,048)929,776 (102,953)
Total corporates2,410,360 (97,155)5,848,962 (1,077,831)8,259,322 (1,174,986)
Other asset-backed securities6,535 (66)19,430 (744)25,965 (810)
Total investment grade securities3,209,929 (145,257)7,708,691 (1,705,772)10,918,620 (1,851,029)
Below investment grade securities:
Corporates, by sector:
Industrials15,750 (697)185,564 (34,615)201,314 (35,312)
Financial6,185 (32)96,165 (16,709)102,350 (16,741)
Utilities15,778 (794)35,846 (5,777)51,624 (6,571)
Total corporates37,713 (1,523)317,575 (57,101)355,288 (58,624)
Other asset-backed securities      
Total below investment grade securities37,713 (1,523)317,575 (57,101)355,288 (58,624)
Total fixed maturities
$3,247,642 $(146,780)$8,026,266 $(1,762,873)$11,273,908 $(1,909,653)


16
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
At December 31, 2024
Less than Twelve MonthsTwelve Months or LongerTotal
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fair
Value
Unrealized
Loss
Fixed maturities available for sale:
Investment grade securities:
U.S. Government direct, guaranteed, and government-sponsored enterprises$11,268 $(290)$347,527 $(42,504)$358,795 $(42,794)
States, municipalities, and political subdivisions778,244 (32,894)1,532,264 (501,865)2,310,508 (534,759)
Foreign governments  24,925 (8,870)24,925 (8,870)
Corporates, by sector:
Industrials1,487,940 (73,404)3,433,034 (690,920)4,920,974 (764,324)
Financial961,932 (52,946)1,785,130 (333,873)2,747,062 (386,819)
Utilities546,965 (20,214)540,077 (90,996)1,087,042 (111,210)
Total corporates2,996,837 (146,564)5,758,241 (1,115,789)8,755,078 (1,262,353)
Other asset-backed securities23,231 (95)42,639 (2,091)65,870 (2,186)
Total investment grade securities3,809,580 (179,843)7,705,596 (1,671,119)11,515,176 (1,850,962)
Below investment grade securities:
Corporates, by sector:
Industrials54,199 (2,656)142,638 (38,350)196,837 (41,006)
Financial2,990 (53)126,811 (26,171)129,801 (26,224)
Utilities19,263 (1,113)24,003 (5,684)43,266 (6,797)
Total corporates76,452 (3,822)293,452 (70,205)369,904 (74,027)
Other asset-backed securities  2,198  2,198  
Total below investment grade securities76,452 (3,822)295,650 (70,205)372,102 (74,027)
Total fixed maturities
$3,886,032 $(183,665)$8,001,246 $(1,741,324)$11,887,278 $(1,924,989)

Gross unrealized losses may fluctuate quarter over quarter due to factors in the market that affect our holdings, such as changes in interest rates or credit spreads. The Company considers many factors when determining whether an allowance for a credit loss should be recorded. While the Company holds securities that may be in an unrealized loss position from time to time, Globe Life does not generally intend to sell and it is unlikely that the Company will be required to sell the fixed maturities prior to their anticipated recovery or maturity due to the strong cash flows generated by its insurance operations.

17
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fixed Maturities, Allowance for Credit Losses: A summary of the activity in the allowance for credit losses is as follows.
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Allowance for credit losses beginning balance
$10,355 $7,027 $10,395 $7,115 
Additions to allowance for which credit losses were not previously recorded    
Additions (reductions) to allowance for fixed maturities that previously had an allowance 105 (40)17 
Reduction of allowance for which the Company intends to sell or more likely than not will be required to sell or sold during the period    
Allowance for credit losses ending balance
$10,355 $7,132 $10,355 $7,132 

As of June 30, 2025 and December 31, 2024, the Company had one fixed maturity security in non-accrual status with an amortized cost of $5 million and an allowance of $3 million.

Mortgage Loans (commercial mortgage loans): Summaries of commercial mortgage loans by property type and geographical location at June 30, 2025 and December 31, 2024 are as follows:
June 30, 2025December 31, 2024
Carrying Value% of TotalCarrying Value% of Total
Property type:
Industrial$148,190 32 $110,456 28 
Multi-family112,680 25 111,234 28 
Hospitality86,250 19 73,931 19 
Retail75,848 16 65,612 16 
Mixed use36,367 8 35,960 9 
Office3,061 1 6,539 2 
Total recorded investment462,396 101 403,732 102 
Less allowance for credit losses(6,629)(1)(7,644)(2)
Carrying value, net of allowance for credit losses
$455,767 100 $396,088 100 

June 30, 2025December 31, 2024
Carrying Value% of TotalCarrying Value% of Total
Geographic location:
Texas$82,236 18 $75,131 19 
Florida81,203 18 63,308 16 
New Jersey55,941 12 51,744 13 
California47,708 10 48,371 12 
North Carolina41,992 9 23,253 6 
Alabama36,577 8 35,850 9 
Other116,739 26 106,075 27 
Total recorded investment462,396 101 403,732 102 
Less allowance for credit losses(6,629)(1)(7,644)(2)
Carrying value, net of allowance for credit losses
$455,767 100 $396,088 100 
18
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables are reflective of the key factors, debt service coverage ratios, and loan-to-value (LTV) ratios that are utilized by management to monitor the performance of the portfolios. The Company only makes new investments in commercial mortgage loans that have a LTV ratio less than 80%. LTV ratios that exceed 80% are generally a result of decreases in the valuation of the underlying property. Generally, a higher LTV ratio and a lower debt service coverage ratio equates to higher risk of loss.
June 30, 2025
Recorded Investment
Debt Service Coverage Ratios(1)
<1.00x1.00x—1.20x>1.20xTotal% of Gross Total
Loan-to-value ratio(2):
Less than 70%$114,189 $56,783 $242,599 $413,571 89 
70% to 80%     
81% to 90%     
Greater than 90%12,458 36,367  48,825 11 
Total$126,647 $93,150 $242,599 462,396 100 
Less allowance for credit losses(6,629)
Total, net of allowance for credit losses
$455,767 
(1)Annual net operating income divided by annual mortgage debt service (principal and interest).
(2)Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming.
December 31, 2024
Recorded Investment
Debt Service Coverage Ratios(1)
<1.00x1.00x—1.20x>1.20xTotal% of Gross Total
Loan-to-value ratio(2):
Less than 70%$88,507 $64,494 $196,867 $349,868 87 
70% to 80%     
81% to 90%     
Greater than 90%16,136 37,728  53,864 13 
Total$104,643 $102,222 $196,867 403,732 100 
Less allowance for credit losses(7,644)
Total, net of allowance for credit losses
$396,088 
(1)Annual net operating income divided by annual mortgage debt service (principal and interest).
(2)Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming.

As of June 30, 2025, the Company had 37 loans in the portfolio. During the quarter, the Company evaluated the commercial mortgage loan portfolio on both an individual and pooling basis to determine the allowance for credit losses and determined four loans were collateral dependent or likely to foreclose. The allowance for credit losses on these loans was determined using the practical expedient which was based on an estimate of fair value of the underlying collateral plus costs to sell the asset. The total principal balance of the four loans was $49 million and the allowance, determined using the practical expedient, was $3 million as of June 30, 2025. For the three months ended June 30, 2025, one loan with an outstanding principal value of $2 million was removed from the evaluation as a result of foreclosure. For the six months ended June 30, 2025, two loans with an outstanding principal value of $5 million were removed from the evaluation as a result of foreclosure and were transferred into limited partnerships, held under the fair value option, in other long-term investments. As of June 30, 2025, there were two commercial mortgage loans in the process of foreclosure, with an outstanding par value of $41 million and outstanding interest due of $0. For the six months ended June 30, 2025, the allowance for credit losses decreased by $1 million to $6.6
19
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
million. The provision for credit losses is included in "Realized gains (losses)" in the Condensed Consolidated Statements of Operations.
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Allowance for credit losses beginning balance
$6,731 $4,546 $7,644 $3,672 
Provision (reversal) for credit losses110 1,280 (138)2,154 
Reduction in allowance due to dispositions
(212) (877) 
Allowance for credit losses ending balance
$6,629 $5,826 $6,629 $5,826 

As of June 30, 2025, the Company had three commercial mortgage loans in non-accrual status with a principal balance of $48 million. As of December 31, 2024, the Company had five commercial mortgage loans in non-accrual status with a principal balance of $53 million. The Company's unfunded commitment balance to commercial loan borrowers was $19 million as of June 30, 2025.

Other Long-Term Investments: Other long-term investments consist of the following assets:
June 30,
June 30,
2025
December 31, 2024
Investment funds$1,022,425 $986,766 
Company-owned life insurance(1)
202,854 202,734 
Other43,345 46,259 
Total
$1,268,624 $1,235,759 
(1) Company-owned life insurance (COLI) is reported at cash surrender value.

The following table presents additional information about the Company's investment funds as of June 30, 2025 and December 31, 2024 at fair value:
Fair Value
Unfunded Commitments(2)
Investment CategoryJune 30,
2025
December 31, 2024June 30,
2025
Redemption Term/Notice(1)
Commercial mortgage loans$577,472 $566,142 $170,251 Fully redeemable and non-redeemable with varying terms.
Opportunistic and private credit
219,031 202,008 171,756 Fully redeemable and non-redeemable with varying terms.
Infrastructure183,102 179,627 25,000 Fully redeemable and non-redeemable with varying terms.
Other42,820 38,989 57,419 Non-redeemable with varying terms
Total investment funds $1,022,425 $986,766 $424,426 
(1) Non-redeemable funds generally have an expected life of 7 to 12 years from fund closing with extension options of 1 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. Redeemable funds can generally be redeemed over 6 to 36 months upon request from limited partners.
(2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of June 30, 2025, unfunded commitments totaled $567 million, including funds past the investment period.

The Company had $57 million of capital called during the period from existing investment funds. The Company's unfunded commitments were $424 million as of June 30, 2025.


20
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 5—Commitments and Contingencies

Guarantees: At June 30, 2025, Globe Life had no guarantee agreements which were either Parent Company guarantees of subsidiary obligations to a third party or Parent Company guarantees of obligations between wholly-owned subsidiaries.

Letters of credit—The Parent Company has guaranteed letters of credit with a group of banks in connection with its credit facility. The letters of credit were issued by TMK Re, Ltd., a wholly-owned subsidiary, to secure TMK Re, Ltd.’s obligation for claims on certain policies reinsured by TMK Re, Ltd. that were sold by other Globe Life insurance subsidiaries. These letters of credit facilitate TMK Re, Ltd.’s ability to reinsure the business of Globe Life's insurance carriers. The credit facility was amended on March 29, 2024 and now expires in 2029. The maximum amount of letters of credit available is $250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. The amount of letters of credit outstanding at June 30, 2025 was $115 million.

Litigation: Globe Life Inc. and its subsidiaries, in common with the insurance industry in general, are subject to litigation, including: putative class action litigation; alleged breaches of contract; torts, including bad faith and fraud claims based on alleged wrongful or fraudulent acts of agents of the Parent Company's insurance subsidiaries; alleged employment discrimination; alleged worker misclassification; and miscellaneous other causes of action. Based upon information presently available, and in light of legal and other factual defenses available to the Parent Company and its subsidiaries, management does not believe that it is reasonably possible that such litigation will have a material adverse effect on Globe Life Inc.'s financial condition, future operating results or liquidity; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future. This bespeaks caution, particularly in states with reputations for high punitive damage verdicts.

On November 30, 2023, Globe Life Inc. and its subsidiary, American Income Life Insurance Company, received subpoenas from the U.S. Attorney’s Office for the Western District of Pennsylvania, seeking documents relating to sales practices by certain independent sales agents contracted to sell American Income Life Insurance Company policies. Globe Life Inc. and American Income Life Insurance Company cooperated fully in responding to the Department of Justice’s requests. On July 28, 2025, the Department of Justice informed the companies that it had closed its investigation. The closing of the investigation means the Department of Justice will not be taking enforcement action against Globe Life Inc. or American Income Life Insurance Company.

In April 2024, Globe Life Inc. received an inquiry from the SEC's Fort Worth Regional Office requesting information related to recent short seller reports making allegations about Globe Life Inc. Globe Life Inc. provided information in response to the SEC’s requests and cooperated fully with the SEC. On July 24, 2025, SEC staff notified Globe Life Inc. that they had concluded their investigation and, based on the information gathered, did not intend to recommend an SEC enforcement action against Globe Life Inc.

On April 30, 2024, a putative securities class action was filed against Globe Life Inc. and six of its current/former executives and directors in the United States District Court for the Eastern District of Texas (City of Miami Gen. Emp. & Sanitation Emp. Ret. Trust, et al. v. Globe Life Inc., et al., Case No. 4:24-cv-00376). On July 24, 2024, the Court appointed Lead Plaintiffs and Lead Counsel for the putative class of shareholders. The Lead Plaintiffs filed a Consolidated Complaint on October 4, 2024 that asserts claims under §§ 10(b), 20(a), and 20(A) of the Securities Exchange Act of 1934 and SEC Rules 10b-5(a), 10b-5(b), and 10b-5(c) promulgated thereunder, on behalf of a putative class of purchasers of Globe Life Inc.'s securities from May 8, 2019 through April 10, 2024. The Consolidated Complaint adds four additional executives as defendants and alleges that certain of Globe Life Inc.'s disclosures about financial performance and certain other public statements during the putative class period were materially false or misleading. Defendants filed a motion to dismiss the litigation on December 3, 2024. Globe Life Inc. plans to vigorously defend against the lawsuit. Pursuant to Globe Life Inc.'s Restated Certificate of Incorporation and indemnification agreements with the named defendants, Globe Life Inc. has agreed to indemnify those defendants for all expenses and losses related to the litigation, subject to the terms of those indemnification agreements. The outcome of litigation of this type is inherently uncertain, and there is always the possibility that a Court rules in a manner that is adverse to the interests of Globe Life Inc. and the individual defendants. However,
21
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
the amount of any such loss in that outcome cannot be reasonably estimated at this time. Further, management cannot reasonably estimate whether an outcome on the putative class action will be resolved in the near term.

Also pending in the Eastern District of Texas is a consolidated shareholder derivative suit that is closely related to the putative securities class action disclosed above (the “City of Miami Matter”). On November 7, 2024, Globe Life Inc. shareholder Jui Cheng Hsiao filed a shareholder derivative complaint against Globe Life Inc. as a nominal defendant, as well as certain current and former Globe Life Inc. executives and members of its Board of Directors. On November 14, 2024, Globe Life Inc. shareholder Gautam Jadhav filed a shareholder derivative complaint against the same set of defendants. Each shareholder derivative complaint asserts one claim for breach of fiduciary duty against the individual defendants and alleges that the individual defendants breached their fiduciary duties to Globe Life Inc. by causing or permitting Globe Life Inc. to make misleading statements about its performance and financial results. The allegations are substantially similar to the allegations made in the City of Miami Matter and derive from a short seller report. On November 25, 2024, the two shareholder plaintiffs moved to consolidate the two actions into one action and the Court granted the motion on January 3, 2025 (In re Globe Life Inc. Stockholder Derivative Litigation, Lead Case No. 4:24-cv-00993-ALM (E.D. Tex.)). The case is before the same Court as the City of Miami Matter. On January 16, 2025, the parties filed a joint motion to stay such proceedings pending the Court’s resolution of the motion to dismiss filed by Globe Life Inc. in the City of Miami Matter. The Court granted such joint motion to stay the proceedings on January 25, 2025.

On September 26, 2024, Globe Life Inc. and its subsidiary, American Income Life Insurance Company, were notified by the Equal Employment Opportunity Commission (EEOC) that the EEOC conducted an investigation of charges filed against Globe Life Inc. and/or American Income Life Insurance Company by five former sales agents and one then-current sales agent. The EEOC asserts that there is reasonable cause to believe the six complainants were employees, not independent contractors, of Globe Life Inc. and/or American Income Life Insurance Company and were discriminated against on the basis of sex, and that one complainant was also discriminated against on the basis of race. In addition, the EEOC asserts that there is reasonable cause to believe that a class of female workers were employees, not independent contractors, and were subject to unlawful conduct which also constitutes a pattern-or-practice of discrimination. The EEOC’s investigative findings are not binding on Globe Life Inc. The EEOC’s procedures provide for a conciliation process that has concluded without achieving a resolution. The EEOC may elect to file a lawsuit in federal court on behalf of the workers based on the alleged statutory violations. The EEOC has not filed any legal proceedings at this time. In the event the EEOC elects to pursue any claims in court, Globe Life Inc. intends to defend against any such lawsuit vigorously. The outcome of litigation of this type would be inherently uncertain and cannot be reasonably estimated or determined at this time. There is always the possibility that a Court rules in a manner that is adverse to the interests of Globe Life Inc.
22
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 6—Policy Liabilities

The liability for future policy benefits is determined based on the net level premium method, which requires the liability be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders.

The following tables summarize balances and changes in the net liability for future policy benefits, before reinsurance, for traditional life long-duration contracts for the three and six month periods ended June 30, 2025 and 2024:
Life
Present value of expected future net premiums
American IncomeDTCLiberty NationalOtherTotal
Balance at January 1, 2024
$4,681,888 $6,052,651 $1,129,716 $478,052 $12,342,307 
Beginning balance at original discount rates4,523,329 5,664,259 1,077,831 443,949 11,709,368 
Effect of changes in assumptions on future cash flows
     
Effect of actual variances from expected experience(113,699)(122,971)(17,268)(7,321)(261,259)
Adjusted balance at January 1, 2024
4,409,630 5,541,288 1,060,563 436,628 11,448,109 
Issuances(1)
412,701 287,040 60,219 12,156 772,116 
Interest accrual(2)
109,168 147,351 27,775 11,505 295,799 
Net premiums collected(3)
(274,166)(305,391)(67,915)(22,738)(670,210)
Effect of changes in the foreign exchange rate(9,222)   (9,222)
Ending balance at original discount rates4,648,111 5,670,288 1,080,642 437,551 11,836,592 
Effect of change from original to current discount rates(12,208)140,230 4,591 12,332 144,945 
Balance at June 30, 2024
$4,635,903 $5,810,518 $1,085,233 $449,883 $11,981,537 
Balance at January 1, 2025
$4,645,917 $5,622,906 $1,048,447 $440,047 $11,757,317 
Beginning balance at original discount rates4,656,710 5,504,912 1,047,020 430,276 11,638,918 
Effect of changes in assumptions on future cash flows
     
Effect of actual variances from expected experience(112,710)(112,667)(13,776)(8,888)(248,041)
Adjusted balance at January 1, 2025
4,544,000 5,392,245 1,033,244 421,388 11,390,877 
Issuances(1)
380,213 257,099 54,393 12,114 703,819 
Interest accrual(2)
113,641 144,532 27,056 11,211 296,440 
Net premiums collected(3)
(281,023)(295,271)(66,699)(21,904)(664,897)
Effect of changes in the foreign exchange rate14,630    14,630 
Ending balance at original discount rates4,771,461 5,498,605 1,047,994 422,809 11,740,869 
Effect of change from original to current discount rates46,620 183,765 15,168 13,975 259,528 
Balance at June 30, 2025
$4,818,081 $5,682,370 $1,063,162 $436,784 $12,000,397 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in force business.

23
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future net premiums
American IncomeDTCLiberty NationalOtherTotal
Balance at April 1, 2024
$4,652,671 $5,945,259 $1,102,209 $464,169 $12,164,308 
Beginning balance at original discount rates4,596,138 5,698,050 1,073,485 442,392 11,810,065 
Effect of changes in assumptions on future cash flows
     
Effect of actual variances from expected experience(65,450)(86,743)(6,820)(5,471)(164,484)
Adjusted balance at April 1, 2024
4,530,688 5,611,307 1,066,665 436,921 11,645,581 
Issuances(1)
200,853 137,809 34,056 6,227 378,945 
Interest accrual(2)
55,345 73,931 13,936 5,741 148,953 
Net premiums collected(3)
(138,480)(152,759)(34,015)(11,338)(336,592)
Effect of changes in the foreign exchange rate(295)   (295)
Ending balance at original discount rates4,648,111 5,670,288 1,080,642 437,551 11,836,592 
Effect of change from original to current discount rates(12,208)140,230 4,591 12,332 144,945 
Balance at June 30, 2024
$4,635,903 $5,810,518 $1,085,233 $449,883 $11,981,537 
Balance at April 1, 2025
$4,757,044 $5,686,115 $1,058,696 $440,270 $11,942,125 
Beginning balance at original discount rates4,719,733 5,512,271 1,045,143 426,436 11,703,583 
Effect of changes in assumptions on future cash flows
     
Effect of actual variances from expected experience(61,093)(73,750)(5,858)(5,199)(145,900)
Adjusted balance at April 1, 2025
4,658,640 5,438,521 1,039,285 421,237 11,557,683 
Issuances(1)
184,580 135,319 28,611 6,902 355,412 
Interest accrual(2)
57,175 72,325 13,535 5,586 148,621 
Net premiums collected(3)
(141,459)(147,560)(33,437)(10,916)(333,372)
Effect of changes in the foreign exchange rate12,525    12,525 
Ending balance at original discount rates4,771,461 5,498,605 1,047,994 422,809 11,740,869 
Effect of change from original to current discount rates46,620 183,765 15,168 13,975 259,528 
Balance at June 30, 2025
$4,818,081 $5,682,370 $1,063,162 $436,784 $12,000,397 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in force business.
24
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future policy benefits
American IncomeDTCLiberty NationalOtherTotal
Balance at January 1, 2024
$10,163,627 $9,714,516 $3,605,392 $4,239,623 $27,723,158 
Beginning balance at original discount rates9,061,833 8,656,752 3,338,252 3,506,859 24,563,696 
Effect of changes in assumptions on future cash flows     
Effect of actual variances from expected experience(121,945)(129,976)(19,337)(10,212)(281,470)
Adjusted balance at January 1, 2024
8,939,888 8,526,776 3,318,915 3,496,647 24,282,226 
Issuances(1)
412,703 287,041 60,221 12,156 772,121 
Interest accrual(2)
243,096 236,977 89,276 104,571 673,920 
Benefit payments(3)
(220,560)(301,894)(111,881)(68,051)(702,386)
Effect of changes in the foreign exchange rate(21,601)   (21,601)
Ending balance at original discount rates9,353,526 8,748,900 3,356,531 3,545,323 25,004,280 
Effect of change from original to current discount rates457,881 540,934 68,237 436,575 1,503,627 
Balance at June 30, 2024
$9,811,407 $9,289,834 $3,424,768 $3,981,898 $26,507,907 
Balance at January 1, 2025
$9,870,692 $9,125,112 $3,377,517 $3,960,963 $26,334,284 
Beginning balance at original discount rates9,508,588 8,660,948 3,340,219 3,582,068 25,091,823 
Effect of changes in assumptions on future cash flows     
Effect of actual variances from expected experience(123,908)(122,494)(17,717)(12,945)(277,064)
Adjusted balance at January 1, 2025
9,384,680 8,538,454 3,322,502 3,569,123 24,814,759 
Issuances(1)
380,214 257,097 54,393 12,115 703,819 
Interest accrual(2)
256,757 239,097 89,565 107,021 692,440 
Benefit payments(3)
(226,848)(291,899)(107,656)(70,952)(697,355)
Effect of changes in the foreign exchange rate34,732    34,732 
Ending balance at original discount rates9,829,535 8,742,749 3,358,804 3,617,307 25,548,395 
Effect of change from original to current discount rates404,619 535,396 63,014 391,078 1,394,107 
Balance at June 30, 2025
$10,234,154 $9,278,145 $3,421,818 $4,008,385 $26,942,502 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, surrender, and maturity benefit payments based on the revised expected assumptions.
25
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Present value of expected future policy benefits
American IncomeDTCLiberty NationalOtherTotal
Balance at April 1, 2024
$9,958,093 $9,500,215 $3,499,742 $4,103,892 $27,061,942 
Beginning balance at original discount rates9,216,265 8,728,403 3,340,412 3,527,882 24,812,962 
Effect of changes in assumptions on future cash flows     
Effect of actual variances from expected experience(69,724)(93,532)(8,889)(7,345)(179,490)
Adjusted balance at April 1, 2024
9,146,541 8,634,871 3,331,523 3,520,537 24,633,472 
Issuances(1)
200,858 137,810 34,057 6,224 378,949 
Interest accrual(2)
122,894 119,052 44,723 52,436 339,105 
Benefit payments(3)
(115,802)(142,833)(53,772)(33,874)(346,281)
Effect of changes in the foreign exchange rate(965)   (965)
Ending balance at original discount rates9,353,526 8,748,900 3,356,531 3,545,323 25,004,280 
Effect of change from original to current discount rates457,881 540,934 68,237 436,575 1,503,627 
Balance at June 30, 2024
$9,811,407 $9,289,834 $3,424,768 $3,981,898 $26,507,907 
Balance at April 1, 2025
$10,112,896 $9,253,740 $3,415,857 $4,009,979 $26,792,472 
Beginning balance at original discount rates9,671,087 8,709,934 3,347,430 3,600,322 25,328,773 
Effect of changes in assumptions on future cash flows     
Effect of actual variances from expected experience(68,094)(80,546)(9,006)(7,498)(165,144)
Adjusted balance at April 1, 2025
9,602,993 8,629,388 3,338,424 3,592,824 25,163,629 
Issuances(1)
184,580 135,318 28,612 6,905 355,415 
Interest accrual(2)
129,298 119,903 44,830 53,634 347,665 
Benefit payments(3)
(117,722)(141,860)(53,062)(36,056)(348,700)
Effect of changes in the foreign exchange rate30,386    30,386 
Ending balance at original discount rates9,829,535 8,742,749 3,358,804 3,617,307 25,548,395 
Effect of change from original to current discount rates404,619 535,396 63,014 391,078 1,394,107 
Balance at June 30, 2025
$10,234,154 $9,278,145 $3,421,818 $4,008,385 $26,942,502 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, surrender, and maturity benefit payments based on the expected assumptions.



26
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Life
Net liability for future policy benefits as of June 30, 2024
American IncomeDTCLiberty NationalOtherTotal
Net liability for future policy benefits at original discount rates
$4,705,415 $3,078,612 $2,275,889 $3,107,772 $13,167,688 
Effect of changes in discount rate assumptions470,089 400,704 63,646 424,243 1,358,682 
Other adjustments(1)
194   34 228 
Net liability for future policy benefits, after other adjustments, at current discount rates
5,175,698 3,479,316 2,339,535 3,532,049 14,526,598 
Reinsurance recoverable
(170) (7,830)(35,403)(43,403)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$5,175,528 $3,479,316 $2,331,705 $3,496,646 $14,483,195 
(1)Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).



Life
Net liability for future policy benefits as of June 30, 2025
American IncomeDTCLiberty NationalOtherTotal
Net liability for future policy benefits at original discount rates
$5,058,074 $3,244,144 $2,310,810 $3,194,498 $13,807,526 
Effect of changes in discount rate assumptions357,999 351,631 47,846 377,103 1,134,579 
Other adjustments(1)
75   35 110 
Net liability for future policy benefits, after other adjustments, at current discount rates
5,416,148 3,595,775 2,358,656 3,571,636 14,942,215 
Reinsurance recoverable
(177) (7,984)(14)(8,175)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$5,415,971 $3,595,775 $2,350,672 $3,571,622 $14,934,040 
(1)Other adjustments include the effects of flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).



27
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables summarize balances and changes in the net liability for future policy benefits for long-duration health contracts for the three and six month periods ended June 30, 2025 and 2024:
Health
Present value of expected future net premiums
United AmericanFamily HeritageLiberty NationalAmerican IncomeDTCTotal
Balance at January 1, 2024
$3,697,771 $1,711,741 $358,472 $206,381 $115,363 $6,089,728 
Beginning balance at original discount rates3,625,803 1,783,173 348,570 201,869 109,880 6,069,295 
Effect of changes in assumptions on future cash flows
      
Effect of actual variances from expected experience(37,074)(31,290)(21,165)(7,058)(2,462)(99,049)
Adjusted balance at January 1, 2024
3,588,729 1,751,883 327,405 194,811 107,418 5,970,246 
Issuances(1)
191,794 128,874 29,015 22,124 8,503 380,310 
Interest accrual(2)
84,630 36,717 8,347 4,642 2,760 137,096 
Net premiums collected(3)
(145,045)(93,746)(25,833)(11,871)(5,434)(281,929)
Effect of changes in the foreign exchange rate   (839) (839)
Ending balance at original discount rates3,720,108 1,823,728 338,934 208,867 113,247 6,204,884 
Effect of change from original to current discount rates(61,617)(132,931)(1,193)(2,978)1,629 (197,090)
Balance at June 30, 2024
$3,658,491 $1,690,797 $337,741 $205,889 $114,876 $6,007,794 
Balance at January 1, 2025
$3,885,530 $1,734,875 $337,119 $223,247 $133,377 $6,314,148 
Beginning balance at original discount rates3,948,856 1,867,873 338,275 225,141 131,919 6,512,064 
Effect of changes in assumptions on future cash flows
      
Effect of actual variances from expected experience(3,085)(27,223)(17,307)(9,744)(299)(57,658)
Adjusted balance at January 1, 2025
3,945,771 1,840,650 320,968 215,397 131,620 6,454,406 
Issuances(1)
228,892 135,477 26,889 20,650 11,434 423,342 
Interest accrual(2)
95,079 39,696 8,053 5,305 3,403 151,536 
Net premiums collected(3)
(163,600)(100,206)(26,730)(13,457)(6,971)(310,964)
Effect of changes in the foreign exchange rate   1,274  1,274 
Ending balance at original discount rates4,106,142 1,915,617 329,180 229,169 139,486 6,719,594 
Effect of change from original to current discount rates5,981 (104,771)2,671 661 3,582 (91,876)
Balance at June 30, 2025
$4,112,123 $1,810,846 $331,851 $229,830 $143,068 $6,627,718 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in force business.
28
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future net premiums
United AmericanFamily HeritageLiberty NationalAmerican IncomeDTCTotal
Balance at April 1, 2024
$3,653,395 $1,694,026 $345,441 $203,795 $113,879 $6,010,536 
Beginning balance at original discount rates3,661,448 1,801,792 342,165 203,850 110,863 6,120,118 
Effect of changes in assumptions on future cash flows
      
Effect of actual variances from expected experience3,458 (14,197)(9,755)(3,508)(144)(24,146)
Adjusted balance at April 1, 2024
3,664,906 1,787,595 332,410 200,342 110,719 6,095,972 
Issuances(1)
87,190 64,865 15,457 12,174 3,893 183,579 
Interest accrual(2)
42,808 18,614 4,119 2,360 1,392 69,293 
Net premiums collected(3)
(74,796)(47,346)(13,052)(6,032)(2,757)(143,983)
Effect of changes in the foreign exchange rate   23  23 
Ending balance at original discount rates3,720,108 1,823,728 338,934 208,867 113,247 6,204,884 
Effect of change from original to current discount rates(61,617)(132,931)(1,193)(2,978)1,629 (197,090)
Balance at June 30, 2024
$3,658,491 $1,690,797 $337,741 $205,889 $114,876 $6,007,794 
Balance at April 1, 2025
$3,993,693 $1,777,351 $332,931 $227,273 $138,383 $6,469,631 
Beginning balance at original discount rates4,005,620 1,888,954 331,182 226,852 135,412 6,588,020 
Effect of changes in assumptions on future cash flows
      
Effect of actual variances from expected experience25,129 (13,323)(6,587)(4,863)1,116 1,472 
Adjusted balance at April 1, 2025
4,030,749 1,875,631 324,595 221,989 136,528 6,589,492 
Issuances(1)
111,268 70,716 14,233 10,209 4,770 211,196 
Interest accrual(2)
48,210 20,056 3,962 2,662 1,723 76,613 
Net premiums collected(3)
(84,085)(50,786)(13,610)(6,743)(3,535)(158,759)
Effect of changes in the foreign exchange rate   1,052  1,052 
Ending balance at original discount rates4,106,142 1,915,617 329,180 229,169 139,486 6,719,594 
Effect of change from original to current discount rates5,981 (104,771)2,671 661 3,582 (91,876)
Balance at June 30, 2025
$4,112,123 $1,810,846 $331,851 $229,830 $143,068 $6,627,718 
(1)Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate.
(3)Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in force business.





29
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future policy benefits
United AmericanFamily HeritageLiberty NationalAmerican IncomeDTCTotal
Balance at January 1, 2024
$3,814,328 $3,315,880 $865,808 $335,504 $109,482 $8,441,002 
Beginning balance at original discount rates3,741,530 3,506,689 816,819 315,431 104,501 8,484,970 
Effect of changes in assumptions on future cash flows      
Effect of actual variances from expected experience(36,684)(35,000)(21,424)(8,179)(2,326)(103,613)
Adjusted balance at January 1, 2024
3,704,846 3,471,689 795,395 307,252 102,175 8,381,357 
Issuances(1)
191,231 128,875 28,604 22,126 8,485 379,321 
Interest accrual(2)
87,778 72,179 21,549 7,956 2,760 192,222 
Benefit payments(3)
(160,345)(67,428)(46,232)(13,072)(6,277)(293,354)
Effect of changes in the foreign exchange rate   (1,556) (1,556)
Ending balance at original discount rates3,823,510 3,605,315 799,316 322,706 107,143 8,657,990 
Effect of change from original to current discount rates(65,023)(355,849)16,462 5,730 1,474 (397,206)
Balance at June 30, 2024
$3,758,487 $3,249,466 $815,778 $328,436 $108,617 $8,260,784 
Balance at January 1, 2025
$3,960,432 $3,336,546 $804,695 $355,303 $129,277 $8,586,253 
Beginning balance at original discount rates4,026,860 3,712,044 791,141 348,711 127,975 9,006,731 
Effect of changes in assumptions on future cash flows      
Effect of actual variances from expected experience(6,629)(30,870)(15,255)(12,205)(124)(65,083)
Adjusted balance at January 1, 2025
4,020,231 3,681,174 775,886 336,506 127,851 8,941,648 
Issuances(1)
228,111 135,476 26,531 20,650 11,392 422,160 
Interest accrual(2)
97,069 78,270 20,796 8,951 3,403 208,489 
Benefit payments(3)
(192,355)(79,732)(50,278)(11,126)(8,370)(341,861)
Effect of changes in the foreign exchange rate   2,431  2,431 
Ending balance at original discount rates4,153,056 3,815,188 772,935 357,412 134,276 9,232,867 
Effect of change from original to current discount rates1,250 (324,147)22,309 9,954 3,256 (287,378)
Balance at June 30, 2025
$4,154,306 $3,491,041 $795,244 $367,366 $137,532 $8,945,489 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period based on the revised expected assumptions.
30
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Present value of expected future policy benefits
United AmericanFamily HeritageLiberty NationalAmerican IncomeDTCTotal
Balance at April 1, 2024
$3,756,534 $3,271,604 $834,006 $328,783 $107,775 $8,298,702 
Beginning balance at original discount rates3,766,995 3,554,274 804,316 317,365 105,050 8,548,000 
Effect of changes in assumptions on future cash flows      
Effect of actual variances from expected experience3,641 (15,951)(8,603)(4,177)(5)(25,095)
Adjusted balance at April 1, 2024
3,770,636 3,538,323 795,713 313,188 105,045 8,522,905 
Issuances(1)
86,801 64,866 15,255 12,177 3,887 182,986 
Interest accrual(2)
44,334 36,517 10,716 4,019 1,392 96,978 
Benefit payments(3)
(78,261)(34,391)(22,368)(6,670)(3,181)(144,871)
Effect of changes in the foreign exchange rate   (8) (8)
Ending balance at original discount rates3,823,510 3,605,315 799,316 322,706 107,143 8,657,990 
Effect of change from original to current discount rates(65,023)(355,849)16,462 5,730 1,474 (397,206)
Balance at June 30, 2024
$3,758,487 $3,249,466 $815,778 $328,436 $108,617 $8,260,784 
Balance at April 1, 2025
$4,051,322 $3,430,602 $799,440 $362,540 $133,563 $8,777,467 
Beginning balance at original discount rates4,066,655 3,761,470 778,662 352,443 130,822 9,090,052 
Effect of changes in assumptions on future cash flows      
Effect of actual variances from expected experience18,426 (15,115)(4,250)(6,009)1,067 (5,881)
Adjusted balance at April 1, 2025
4,085,081 3,746,355 774,412 346,434 131,889 9,084,171 
Issuances(1)
110,710 70,717 14,054 10,209 4,762 210,452 
Interest accrual(2)
49,086 39,514 10,326 4,496 1,722 105,144 
Benefit payments(3)
(91,821)(41,398)(25,857)(5,806)(4,097)(168,979)
Effect of changes in the foreign exchange rate   2,079  2,079 
Ending balance at original discount rates4,153,056 3,815,188 772,935 357,412 134,276 9,232,867 
Effect of change from original to current discount rates1,250 (324,147)22,309 9,954 3,256 (287,378)
Balance at June 30, 2025
$4,154,306 $3,491,041 $795,244 $367,366 $137,532 $8,945,489 
(1)Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period.
(2)The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate.
(3)Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period based on the expected assumptions.

31
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
Net liability for future policy benefits as of June 30, 2024
United AmericanFamily HeritageLiberty NationalAmerican IncomeDirect to ConsumerTotal
Net liability for future policy benefits at original discount rates
$103,402 $1,781,587 $460,382 $113,839 $(6,104)$2,453,106 
Effect of changes in discount rate assumptions(3,406)(222,918)17,655 8,708 (155)(200,116)
Other adjustments(1)
14,032 52 9,169 933 6,952 31,138 
Net liability for future policy benefits, after other adjustments, at current discount rates
114,028 1,558,721 487,206 123,480 693 2,284,128 
Reinsurance recoverable
(2,905)(10,470)(1,114)  (14,489)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$111,123 $1,548,251 $486,092 $123,480 $693 $2,269,639 
(1)Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).

Health
Net liability for future policy benefits as of June 30, 2025
United AmericanFamily HeritageLiberty NationalAmerican IncomeDirect to ConsumerTotal
Net liability for future policy benefits at original discount rates
46,914 1,899,571 443,755 128,243 (5,210)2,513,273 
Effect of changes in discount rate assumptions(4,731)(219,376)19,638 9,293 (326)(195,502)
Other adjustments(1)
45,814 16 10,861 702 6,259 63,652 
Net liability for future policy benefits, after other adjustments, at current discount rates
87,997 1,680,211 474,254 138,238 723 2,381,423 
Reinsurance recoverable
(2,376) (890)  (3,266)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates
$85,621 $1,680,211 $473,364 $138,238 $723 $2,378,157 
(1)Other adjustments include the effects of flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).

32
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables include the total remeasurement gain or loss, bifurcated between the gain or loss due to differences between actual and expected experience and the amount due to assumption updates, for the three and six month periods ended June 30, 2025 and 2024:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Life Remeasurement Gain (Loss)—Experience:
American Income$6,672 $3,876 $10,851 $7,848 
Direct to Consumer6,609 6,561 9,589 6,727 
Liberty National1,432 538 1,614 650 
Other2,032 1,419 3,216 2,025 
Total Life Remeasurement Gain (Loss)—Experience
16,745 12,394 25,270 17,250 
Life Remeasurement Gain (Loss)—Assumption Updates(1):
American Income    
Direct to Consumer    
Liberty National    
Other    
Total Life Remeasurement Gain (Loss)—Assumption Updates
    
Total Life Remeasurement Gain (Loss)
16,745 12,394 25,270 17,250 
Health Remeasurement Gain (Loss)—Experience:
United American1,938 1,013 (1,882)677 
Family Heritage1,640 1,669 3,476 3,552 
Liberty National(821)(70)362 1,141 
American Income1,089 610 2,338 1,040 
Direct to Consumer32 26 28 46 
Total Health Remeasurement Gain (Loss)—Experience
3,878 3,248 4,322 6,456 
Health Remeasurement Gain (Loss)—Assumption Updates(1):
United American    
Family Heritage    
Liberty National    
American Income    
Direct to Consumer    
Health Remeasurement Gain (Loss)—Assumption Updates
    
Total Health Remeasurement Gain (Loss)
$3,878 $3,248 $4,322 $6,456 
(1)Changes to the judgments, assumptions, and methods used in measuring the liability for future policy benefits occur annually, unless otherwise necessary. There were no changes to the judgments, assumptions, and methods used in measuring the liability for future policy benefits during the six months ended June 30, 2025 and 2024.

33
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table reconciles the liability for future policy benefits to the Condensed Consolidated Balance Sheets as of June 30, 2025 and 2024:

At Original Discount RatesAt Current Discount Rates
As of June 30,As of June 30,
2025202420252024
Life(1):
American Income$5,058,139 $4,705,606 $5,416,148 $5,175,698 
Direct to Consumer3,244,145 3,078,612 3,595,775 3,479,316 
Liberty National2,310,810 2,275,889 2,358,656 2,339,535 
Other3,194,531 3,107,805 3,571,636 3,532,049 
Net liability for future policy benefits—long duration life13,807,625 13,167,912 14,942,215 14,526,598 
Health(1):
United American88,003 115,771 87,997 114,028 
Family Heritage1,899,578 1,781,632 1,680,211 1,558,721 
Liberty National454,025 469,145 474,254 487,206 
American Income128,924 114,716 138,238 123,480 
Direct to Consumer708 673 723 693 
Net liability for future policy benefits—long duration health2,571,238 2,481,937 2,381,423 2,284,128 
Deferred profit liability181,140 176,123 181,140 176,123 
Deferred annuity615,897 706,022 615,897 706,022 
Interest sensitive life717,140 728,097 717,140 728,097 
Other8,939 9,702 8,940 9,704 
Total future policy benefits
$17,901,979 $17,269,793 $18,846,755 $18,430,672 
(1)Balances are presented net of the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits).



34
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables provide the weighted-average original and current discount rates for the liability for future policy benefits and the additional insurance liabilities as of June 30, 2025 and 2024:
As of June 30,
20252024
Original discount rateCurrent discount rateOriginal discount rateCurrent discount rate
Life
American Income5.7 %5.4 %5.7 %5.3 %
Direct to Consumer6.0 %5.5 %6.0 %5.4 %
Liberty National5.6 %5.5 %5.6 %5.4 %
Other6.2 %5.5 %6.2 %5.4 %
Health
United American5.1 %5.1 %5.1 %5.2 %
Family Heritage4.2 %5.3 %4.2 %5.3 %
Liberty National5.8 %5.3 %5.8 %5.4 %
American Income5.8 %5.2 %5.8 %5.2 %
Direct to Consumer5.1 %5.1 %5.1 %5.2 %

The following table provides the weighted-average durations of the liability for future policy benefits and the additional insurance liabilities as of June 30, 2025 and 2024:
As of June 30,
20252024
At original discount ratesAt current discount ratesAt original discount ratesAt current discount rates
Life
American Income22.6022.4223.0323.17
Direct to Consumer19.0719.8619.4420.66
Liberty National15.3515.1815.2215.40
Other15.8316.5316.1017.23
Health
United American11.6810.4911.5910.64
Family Heritage15.2814.0015.1614.21
Liberty National9.419.229.269.26
American Income12.4512.3712.3512.55
Direct to Consumer11.6810.4911.5910.64
35
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables summarize the amount of gross premiums and interest related to long duration life and health contracts that are recognized in the Condensed Consolidated Statements of Operations for the three and six month periods ended June 30, 2025 and 2024:
Life
Six Months Ended
June 30, 2025
Six Months Ended
June 30, 2024
Gross
Premiums
Required Interest
Expense
Gross
Premiums
Required Interest
Expense
American Income$882,738 $143,116 $836,931 $133,928 
Direct to Consumer486,442 94,526 491,235 89,541 
Liberty National191,631 62,224 181,110 61,153 
Other100,108 95,333 101,652 92,151 
Total$1,660,919 $395,199 $1,610,928 $376,773 
Life
Three Months Ended
June 30, 2025
Three Months Ended
June 30, 2024
Gross
Premiums
Interest
Expense
Gross
Premiums
Interest
Expense
American Income$445,289 $72,123 $423,172 $67,549 
Direct to Consumer243,572 47,559 246,041 45,081 
Liberty National96,331 31,175 91,239 30,611 
Other50,194 48,048 50,583 46,233 
Total$835,386 $198,905 $811,035 $189,474 
Health
Six Months Ended
June 30, 2025
Six Months Ended
June 30, 2024
Gross
Premiums
Required Interest
Expense
Gross
Premiums
Required Interest
Expense
United American$239,422 $1,867 $214,850 $3,041 
Family Heritage228,210 38,574 209,246 35,204 
Liberty National95,221 12,690 94,952 13,155 
American Income59,543 3,646 58,389 3,314 
Direct to Consumer8,350  7,390  
Total$630,746 $56,777 $584,827 $54,714 
Health
Three Months Ended
June 30, 2025
Three Months Ended
June 30, 2024
Gross
Premiums
Interest
Expense
Gross
Premiums
Interest
Expense
United American$123,026 $818 $110,753 $1,474 
Family Heritage115,856 19,458 105,855 17,773 
Liberty National47,468 6,335 47,518 6,572 
American Income29,789 1,834 29,470 1,659 
Direct to Consumer4,214  3,733  
Total$320,353 $28,445 $297,329 $27,478 
Gross premiums are included within life and health premium on the Condensed Consolidated Statements of Operations, while the related interest expense is included in life and health policyholder benefits.
36
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables provide the undiscounted and discounted expected future net premiums, expected future gross premiums, and expected future policy benefits, at both original and current discount rates, for life and health contracts as of June 30, 2025 and 2024:
Life
As of June 30, 2025As of June 30, 2024
Not discountedAt original discount ratesAt current discount ratesNot discountedAt original discount ratesAt current discount rates
American Income
PV of expected future gross premiums$26,323,656 $14,880,435 $15,115,288 $25,077,717 $14,130,383 $14,177,334 
PV of expected future net premiums8,440,381 4,771,461 4,818,081 8,240,194 4,648,111 4,635,903 
PV of expected future policy benefits32,858,954 9,829,535 10,234,154 31,638,799 9,353,526 9,811,407 
DTC
PV of expected future gross premiums$17,465,145 $9,138,361 $9,430,064 $17,605,488 $9,202,366 $9,418,076 
PV of expected future net premiums10,454,351 5,498,605 5,682,370 10,784,908 5,670,288 5,810,518 
PV of expected future policy benefits26,022,344 8,742,749 9,278,145 25,978,972 8,748,900 9,289,834 
Liberty National
PV of expected future gross premiums$4,928,564 $2,871,400 $2,869,264 $4,760,222 $2,777,507 $2,744,508 
PV of expected future net premiums1,848,910 1,047,994 1,063,162 1,900,361 1,080,642 1,085,233 
PV of expected future policy benefits9,159,106 3,358,804 3,421,818 8,997,194 3,356,531 3,424,768 
Other
PV of expected future gross premiums$3,571,030 $1,820,383 $1,938,264 $3,671,193 $1,866,118 $1,974,726 
PV of expected future net premiums869,582 422,809 436,784 897,326 437,551 449,883 
PV of expected future policy benefits12,451,064 3,617,307 4,008,385 12,433,005 3,545,323 3,981,898 
Total
PV of expected future gross premiums$52,288,395 $28,710,579 $29,352,880 $51,114,620 $27,976,374 $28,314,644 
PV of expected future net premiums21,613,224 11,740,869 12,000,397 21,822,789 11,836,592 11,981,537 
PV of expected future policy benefits80,491,468 25,548,395 26,942,502 79,047,970 25,004,280 26,507,907 

As of June 30, 2025, for the life segment using current discount rates, the Company anticipates $29.4 billion of expected future gross premiums and $12.0 billion of expected future net premiums. As of June 30, 2024, using current discount rates, the Company anticipated $28.3 billion of expected future gross premiums and $12.0 billion in expected future net premiums. The determination of the liability for future policy benefits on the balance sheet does not include the difference between the expected future gross premiums and the expected future net premiums of $17.4 billion and $16.3 billion, as of June 30, 2025 and 2024, respectively, and rather only includes the expected future net premiums.

37
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
As of June 30, 2025As of June 30, 2024
Not discountedAt original discount ratesAt current discount ratesNot discountedAt original discount ratesAt current discount rates
United American
PV of expected future gross premiums$9,701,771 $5,974,711 $5,982,760 $8,930,346 $5,449,708 $5,359,418 
PV of expected future net premiums6,674,188 4,106,142 4,112,123 6,100,831 3,720,108 3,658,491 
PV of expected future policy benefits6,782,252 4,153,056 4,154,306 6,287,625 3,823,510 3,758,487 
Family Heritage
PV of expected future gross premiums$7,545,828 $4,365,220 $4,145,063 $6,998,187 $4,103,577 $3,823,106 
PV of expected future net premiums3,293,461 1,915,617 1,810,846 3,092,463 1,823,728 1,690,797 
PV of expected future policy benefits7,465,105 3,815,188 3,491,041 6,909,758 3,605,315 3,249,466 
Liberty National
PV of expected future gross premiums$2,006,456 $1,276,610 $1,309,873 $2,061,622 $1,307,386 $1,326,826 
PV of expected future net premiums489,624 329,180 331,851 505,985 338,934 337,741 
PV of expected future policy benefits1,353,104 772,935 795,244 1,391,768 799,316 815,778 
American Income
PV of expected future gross premiums$1,795,279 $1,005,844 $1,036,573 $1,792,241 $1,003,909 $1,021,346 
PV of expected future net premiums408,732 229,169 229,830 373,186 208,867 205,889 
PV of expected future policy benefits728,196 357,412 367,366 656,571 322,706 328,436 
Direct to Consumer
PV of expected future gross premiums$256,043 $163,050 $167,656 $242,288 $151,969 $154,318 
PV of expected future net premiums220,022 139,486 143,068 180,882 113,247 114,876 
PV of expected future policy benefits214,895 134,276 137,532 168,428 107,143 108,617 
Total
PV of expected future gross premiums$21,305,377 $12,785,435 $12,641,925 $20,024,684 $12,016,549 $11,685,014 
PV of expected future net premiums11,086,027 6,719,594 6,627,718 10,253,347 6,204,884 6,007,794 
PV of expected future policy benefits16,543,552 9,232,867 8,945,489 15,414,150 8,657,990 8,260,784 

As of June 30, 2025, for the health segment using current discount rates, the Company anticipates $12.6 billion of expected future gross premiums and $6.6 billion of expected future net premiums. As of June 30, 2024, using current discount rates, the Company anticipated $11.7 billion of expected future gross premiums and $6.0 billion in expected future net premiums. The determination of the liability for future policy benefits on the balance sheet does not include the difference between the expected future gross premiums and the expected future net premiums of $6.0 billion and $5.7 billion as of June 30, 2025 and 2024, respectively, and rather only includes the expected future net premiums.


38
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table summarizes the balances of, and changes in, policyholders’ account balances as of June 30, 2025 and 2024:

Policyholders' Account Balances
20252024
Interest Sensitive Life
Deferred Annuity(1)
Other Policy-holders' FundsInterest Sensitive LifeDeferred AnnuityOther Policy-holders' Funds
Balance at January 1,
$723,389 $656,573 $468,604 $732,948 $773,039 $236,958 
Issuances 347   358  
Premiums and deposits received10,400 6,953 148,520 11,110 6,409 168,470 
Policy charges(5,878)  (6,172)  
Surrenders and withdrawals(12,074)(32,065)(126,908)(11,476)(62,562)(7,351)
Benefit payments(16,332)(25,926) (16,740)(24,137) 
Interest credited13,758 10,561 10,903 13,968 12,213 9,104 
Other3,877 (546)(8,973)4,459 702 (6,556)
Balance at June 30,
$717,140 $615,897 $492,146 $728,097 $706,022 $400,625 
(1) At June 30, 2025, $427 million has been reinsured with third-party reinsurers under existing reinsurance agreements.


Policyholders' Account Balances
20252024
Interest Sensitive Life
Deferred Annuity(1)
Other Policy-holders' FundsInterest Sensitive LifeDeferred AnnuityOther Policy-holders' Funds
Balance at April 1,
$720,269 $636,219 $463,148 $729,721 $739,019 $401,269 
Issuances 176   160  
Premiums and deposits received
5,150 3,187 61,635 5,486 2,836 1,770 
Policy charges(2,892)  (3,061)  
Surrenders and withdrawals(6,108)(15,534)(33,780)(5,167)(30,999)(3,834)
Benefit payments(8,003)(13,095) (7,600)(11,366) 
Interest credited6,883 5,188 5,460 6,952 5,970 5,583 
Other1,841 (244)(4,317)1,766 402 (4,163)
Balance at June 30,
$717,140 $615,897 $492,146 $728,097 $706,022 $400,625 

Weighted-average credit rate3.89 %3.36 %4.65 %3.87 %3.35 %5.69 %
Net amount at risk$1,609,774 N/AN/A$1,714,347 N/AN/A
Cash surrender value$671,517 $615,897 $492,146 $680,564 $706,022 $400,625 
(1) At June 30, 2025, $427 million has been reinsured with third-party reinsurers under existing reinsurance agreements.

39
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables present the policyholders' account balances by range of guaranteed minimum crediting rates and the related range of difference, if any, in basis points between rates being credited to policyholders and the respective guaranteed minimums as of June 30, 2025 and 2024:
At June 30, 2025
Range of guaranteed minimum crediting ratesInterest Sensitive Life
Deferred Annuity(1)
Other Policyholders' Funds
At guaranteed minimum:
Less than 3.00%
$ $2,244 $398,451 
3.00%-3.99%
29,395 436,884 3,140 
4.00%-4.99%
598,244 176,769 55,368 
Greater than 5.00%
89,501  35,187 
Total
717,140 615,897 492,146 
51-150 basis points above:
Less than 3.00%
   
3.00%-3.99%
   
4.00%-4.99%
   
Greater than 5.00%
   
Total
   
Greater than 150 basis points above
Less than 3.00%
   
3.00%-3.99%
   
4.00%-4.99%
   
Greater than 5.00%
   
Total
   
Grand Total
$717,140 $615,897 $492,146 
(1) At June 30, 2025, $427 million has been reinsured with third-party reinsurers under existing reinsurance agreements.



40
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
At June 30, 2024
Range of guaranteed minimum crediting ratesInterest Sensitive LifeDeferred AnnuityOther Policyholders' Funds
At guaranteed minimum:
Less than 3.00%
$ $1,743 $304,454 
3.00%-3.99%
29,238 515,442 3,246 
4.00%-4.99%
608,867 187,985 6,539 
Greater than 5.00%
89,992  36,775 
Total
728,097 705,170 351,014 
51-150 basis points above:
Less than 3.00%
   
3.00%-3.99%
   
4.00%-4.99%
  49,611 
Greater than 5.00%
   
Total
  49,611 
Greater than 150 basis points above
Less than 3.00%
$ $ $ 
3.00%-3.99%
 852  
4.00%-4.99%
   
Greater than 5.00%
   
Total
 852  
Grand Total
$728,097 $706,022 $400,625 
41
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 7—Deferred Acquisition Costs

The following tables roll forward the deferred policy acquisition costs for the three and six month periods ended June 30, 2025 and 2024:
Life
American IncomeDTCLiberty NationalOtherTotal
Balance at January 1, 2024
$2,573,370 $1,737,117 $666,419 $294,869 $5,271,775 
Capitalizations259,856 78,976 58,100 6,280 403,212 
Amortization expense(87,377)(50,420)(27,614)(8,272)(173,683)
Foreign exchange adjustment(5,711)   (5,711)
Balance at June 30, 2024
$2,740,138 $1,765,673 $696,905 $292,877 $5,495,593 
Balance at January 1, 2025
$2,900,229 $1,781,230 $728,790 $290,506 $5,700,755 
Capitalizations268,475 73,401 59,258 6,172 407,306 
Amortization expense(100,155)(51,493)(30,352)(4,834)(186,834)
Foreign exchange adjustment9,821    9,821 
Balance at June 30, 2025
$3,078,370 $1,803,138 $757,696 $291,844 $5,931,048 
Life
American IncomeDTCLiberty NationalOtherTotal
Balance at April 1, 2024
$2,652,009 $1,754,184 $678,885 $293,747 $5,378,825 
Capitalizations132,413 36,851 32,035 3,267 204,566 
Amortization expense(44,401)(25,362)(14,015)(4,137)(87,915)
Foreign exchange adjustment117    117 
Balance at June 30, 2024
$2,740,138 $1,765,673 $696,905 $292,877 $5,495,593 
Balance at April 1, 2025
$2,986,007 $1,792,790 $743,388 $292,635 $5,814,820 
Capitalizations134,605 36,253 29,667 3,365 203,890 
Amortization expense(50,781)(25,905)(15,359)(4,156)(96,201)
Foreign exchange adjustment8,539    8,539 
Balance at June 30, 2025
$3,078,370 $1,803,138 $757,696 $291,844 $5,931,048 


42
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Health
United AmericanFamily HeritageLiberty NationalAmerican IncomeDTCTotal
Balance at January 1, 2024
$73,489 $452,843 $139,941 $66,783 $1,679 $734,735 
Capitalizations1,289 33,932 12,444 7,280 2 54,947 
Amortization expense(2,803)(14,521)(7,288)(2,237)(73)(26,922)
Foreign exchange adjustment   (237) (237)
Balance at June 30, 2024
$71,975 $472,254 $145,097 $71,589 $1,608 $762,523 
Balance at January 1, 2025
$70,530 $496,119 $148,920 $76,319 $1,533 $793,421 
Capitalizations1,352 38,104 11,721 7,403  58,580 
Amortization expense(2,809)(16,040)(7,819)(2,618)(74)(29,360)
Foreign exchange adjustment   441  441 
Balance at June 30, 2025
$69,073 $518,183 $152,822 $81,545 $1,459 $823,082 
Health
United AmericanFamily HeritageLiberty NationalAmerican IncomeDTCTotal
Balance at April 1, 2024
$72,604 $462,346 $144,313 $68,938 $1,643 $749,844 
Capitalizations793 17,242 4,465 3,750 1 26,251 
Amortization expense(1,422)(7,334)(3,681)(1,138)(36)(13,611)
Foreign exchange adjustment   39  39 
Balance at June 30, 2024
$71,975 $472,254 $145,097 $71,589 $1,608 $762,523 
Balance at April 1, 2025
$69,755 $506,712 $150,977 $78,833 $1,496 $807,773 
Capitalizations736 19,573 5,802 3,671  29,782 
Amortization expense(1,418)(8,102)(3,957)(1,327)(37)(14,841)
Foreign exchange adjustment   368  368 
Balance at June 30, 2025
$69,073 $518,183 $152,822 $81,545 $1,459 $823,082 
43
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents a reconciliation of deferred policy acquisition costs to the Condensed Consolidated Balance Sheets as of June 30, 2025 and 2024:
June 30,
20252024
Life
American Income$3,078,370 $2,740,138 
Direct to Consumer1,803,138 1,765,673 
Liberty National757,696 696,905 
Other291,844 292,877 
Total DAC—Life
5,931,048 5,495,593 
Health
United American 69,073 71,975 
Family Heritage518,183 472,254 
Liberty National152,822 145,097 
American Income81,545 71,589 
Direct to Consumer1,459 1,608 
Total DAC—Health
823,082 762,523 
Annuity
691 2,178 
Total
$6,754,821 $6,260,294 
44
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 8—Liability for Unpaid Claims

Activity in the liability for unpaid health claims is summarized as follows:
June 30,
2025
December 31,
2024
Balance at beginning of period
$210,994 $194,809 
Less reinsurance recoverables
(1,521)(2,157)
Net balance at beginning of period
209,473 192,652 
Incurred related to:
Current year422,468 767,076 
Prior years3,248 (10,460)
Total incurred425,716 756,616 
Paid related to:
Current year263,694 587,473 
Prior years151,463 152,322 
Total paid415,157 739,795 
Net balance at end of period
220,032 209,473 
Plus reinsurance recoverables
1,395 1,521 
Balance at end of period
$221,427 $210,994 

Below is the reconciliation of the liability of "Policy claims and other benefits payable" in the Condensed Consolidated Balance Sheets.
June 30,
2025
December 31,
2024
Policy claims and other benefits payable:
Life insurance$310,752 $321,838 
Health insurance221,427 210,994 
Total$532,179 $532,832 

45
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 9—Postretirement Benefits

Globe Life has qualified noncontributory defined benefit pension plans (Pension Plans) and contributory savings plans that cover substantially all employees. There is also a nonqualified noncontributory supplemental executive retirement plan (SERP) that covers a limited number of officers. The tables included herein will focus on the Pension Plans and SERP.

Pension Assets: The following table presents the assets of the Company's Pension Plans at June 30, 2025 and December 31, 2024.

Pension Assets by Component at June 30, 2025

 Fair Value Determined by:  
 
Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total
Amount
% of
Total
Exchange traded fund(4)
$36,015 $ $ $36,015 6 
Equity exchange traded fund(1)
328,993   328,993 53 
U.S. Government and Agency 180,413  180,413 29 
Other bonds 3  3  
Guaranteed annuity contract(2)
 44,139  44,139 7 
Short-term investments183   183  
Other2,697   2,697  
$367,888 $224,555 $ 592,443 95 
Other long-term investments(3)
33,962 5 
Total pension assets
$626,405 100 
(1)A fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of June 30, 2025, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds.
(4)A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years.


46
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Pension Assets by Component at December 31, 2024
 Fair Value Determined by:  

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)
Significant
Observable
Inputs (Level 2)
Significant
Unobservable
Inputs (Level 3)
Total
Amount
% of
Total
Exchange traded fund(4)
$35,483 $ $ $35,483 6 
Equity exchange traded fund(1)
322,846   322,846 53 
U.S. Government and Agency 179,418  179,418 29 
Other bonds 4  4  
Guaranteed annuity contract(2)
 43,893  43,893 7 
Short-term investments1,235   1,235  
Other1,420   1,420  
$360,984 $223,315 $ 584,299 95 
Other long-term investments(3)
30,546 5 
Total pension assets
$614,845 100 
(1)A fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of December 31, 2024, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds.
(4)A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years.

SERP: The following tables include premiums paid for COLI at June 30, 2025 and 2024 and investments of the Rabbi Trust at June 30, 2025 and December 31, 2024.
Six Months Ended
June 30,
20252024
Premiums paid for insurance coverage$ $443 
June 30,
2025
December 31,
2024
Total investments:
COLI
$58,126 $57,210 
Exchange traded funds100,721 98,314 
$158,847 $155,524 

Pension Plans and SERP Liabilities: The following table presents liabilities for the defined benefit pension plans and SERP at June 30, 2025 and December 31, 2024.
June 30,
2025
December 31,
2024
Pension Plans$577,844 $561,615 
SERP73,920 73,441 
Benefit obligation
$651,764 $635,056 

47
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Net Periodic Benefit Cost: The following table presents the net periodic benefit costs for the defined benefit pension plans and SERP by expense components for the three and six month periods ended June 30, 2025 and 2024.

Components of Net Periodic Benefit Cost
Three Months Ended
June 30,
Six Months Ended
June 30,
 2025202420252024
Service cost—benefits earned during the period$6,243 $6,228 $12,485 $12,449 
Interest cost on projected benefit obligation9,024 8,308 18,049 16,575 
Expected return on assets(11,563)(10,647)(23,126)(21,293)
Amortization:
Prior service cost292 269 584 538 
Actuarial (gain) loss 6  12 
Net periodic benefit cost
$3,996 $4,164 $7,992 $8,281 


Note 10—Earnings Per Share

Earnings per Share: A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Basic weighted average shares outstanding81,915,162 91,441,350 82,693,257 92,653,478 
Weighted average dilutive options outstanding877,499  937,793 333,855 
Diluted weighted average shares outstanding82,792,661 91,441,350 83,631,050 92,987,333 
Antidilutive shares867,652 4,958,491 755,708 2,063,624 

Antidilutive shares are excluded from the calculation of diluted earnings per share. All antidilutive shares noted above result from outstanding out-of-the-money employee and Director stock options.
48
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 11—Debt

The following table presents information about the terms and outstanding balances of Globe Life's debt.
 
Selected Information about Debt Issues
As of
June 30,
2025
December 31,
2024
InstrumentIssue DateMaturity Date Coupon Rate Par
Value
Unamortized Discount & Issuance CostsBook
Value
Fair
Value
Book
Value
Senior notes
09/27/201809/15/20284.550%$550,000 $(2,627)$547,373 $552,519 $546,999 
Senior notes
08/21/202008/15/20302.150%400,000 (2,632)397,368 353,416 397,132 
Senior notes
05/19/202206/15/20324.800%250,000 (3,518)246,482 245,922 246,272 
Senior notes
08/23/202409/15/20345.850%450,000 (4,984)445,016 465,089 444,814 
Junior subordinated debentures11/17/201711/17/20575.275%125,000 (1,548)123,452 97,500 123,443 
Junior subordinated debentures06/14/202106/15/20614.250%325,000 (7,570)317,430 209,300 317,387 
Term loan(2)
05/11/202308/15/20275.799%250,000 (1,479)248,521 248,521 248,204 
Total long-term debt
2,350,000 (24,358)2,325,642 2,172,267 2,324,251 
FHLB borrowings70,000  70,000 70,000  
Commercial paper397,000 (2,460)394,540 394,540 415,401 
Total short-term debt
467,000 (2,460)464,540 464,540 415,401 
Total debt
$2,817,000 $(26,818)$2,790,182 $2,636,807 $2,739,652 
(1)An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
(2)Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points.

The commercial paper has the highest priority of all unsecured debt, followed by senior notes then junior subordinated debentures. The senior notes are callable under a make-whole provision, and the junior subordinated debentures are subject to an optional redemption five years from issuance. Interest on the 4.25% junior subordinated debentures and the term loan are payable quarterly while all other long-term debt is payable semi-annually.

Credit facility: Globe Life has in place a credit facility which provides for a $1 billion revolving credit facility that may be increased to $1.25 billion. The credit facility matures March 29, 2029 and may be extended up to two one-year periods upon the Company's request. Pursuant to this agreement, the participating lenders have agreed to make revolving loans to Globe Life and to issue secured or unsecured letters of credit. The Company has not drawn on any of the credit to date.

The facility is further designated as a back-up credit line for a commercial paper program under which the Company may either borrow from the credit line or issue commercial paper at any time, with total commercial paper outstanding not to exceed the facility maximum of $1 billion, less any letters of credit issued. Interest is charged at variable rates. In accordance with the agreement, Globe Life is subject to certain covenants regarding capitalization.

As of June 30, 2025, the Company was in full compliance with these covenants.

49
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables present certain information about our commercial paper borrowings.

Credit Facility—Commercial Paper

As of
June 30,
2025
December 31, 2024June 30,
2024
Balance of commercial paper at end of period (par value)$397,000 $419,000 $313,225 
Annualized interest rate4.73 %5.22 %6.02 %
Letters of credit outstanding$115,000 $115,000 $115,000 
Remaining amount available under credit line488,000 466,000 571,775 



Credit Facility—Commercial Paper Activity

 Six Months Ended June 30,
 20252024
Average balance of commercial paper outstanding during period (par value)$456,181 $392,905 
Daily-weighted average interest rate (annualized)4.99 %5.76 %
Maximum daily amount outstanding during period (par value)$605,500 $633,425 
Commercial paper issued during period (par value)
1,158,250 997,492 
Commercial paper matured during period (par value)(1,180,250)(1,003,267)
Net commercial paper issued (matured) during period (par value)
(22,000)(5,775)

Federal Home Loan Bank: FHLB membership provides certain of our insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. The membership requires ownership of FHLB common stock, as well as the purchase of activity-based common stock equal to approximately 4.1% of outstanding borrowings.

Globe Life owned $33 million in FHLB common stock as of June 30, 2025 and $34 million as of December 31, 2024. The FHLB stock is restricted from redemption or repurchases for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments" in the Condensed Consolidated Balance Sheets. Borrowings with the FHLB are subject to the availability of pledged assets at the insurance subsidiaries of Globe Life. As of June 30, 2025, Globe Life's insurance subsidiaries' maximum borrowing capacity under the FHLB facility was approximately $649 million, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $1.3 billion. As of June 30, 2025, $397 million in funding agreements were outstanding with the FHLB, compared to $372 million as of December 31, 2024. This amount is included in "Other policyholders' funds" in the Condensed Consolidated Balance Sheets. The Company had $70 million and $180 million in short-term borrowings from the FHLB as of June 30, 2025 and 2024, respectively.


50
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Note 12—Business Segments

Globe Life is organized into three operating segments: life, health, and investments.

Globe Life's reportable insurance segments are based on the insurance product lines it markets and administers: life insurance and supplemental health insurance. There is also an investment segment that manages the investment portfolio and cash flow for the insurance segments. The Company's chief operating decision makers ("CODM"), our Co-CEOs, evaluate the overall performance of the operations of the Company in accordance with these segments.

During the fourth quarter of 2024 we entered into a coinsurance agreement to cede a majority of the annuity business to a third-party insurer. This impacted a significant portion of our annuities which had previously been classified as one of our reportable segments. The annuity segment has historically represented less than 1% of revenue and has not been core to the Company's business. We adjusted our segments from four down to three at December 31, 2024. All quarterly presentations of segment information related to prior year have been recast for the periods presented to reflect this change in segments.

Life insurance products marketed by Globe Life include traditional whole life and term life insurance. Health insurance products are generally guaranteed renewable and include Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products.

The Company adopted ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in 2024 which added disclosure requirements to segment expenses, improving the financial reporting of the entity’s overall performance and assessment of future cash flows. The disclosures required more detailed information related to the entity’s reportable segments and the new disclosures are also required prospectively on a quarterly basis. The prior-year presentation has been recast to reflect the new disclosures in accordance with this adopted accounting standard.

The following tables present segment premium revenue by each of Globe Life's distribution channels.


Premium Income by Distribution Channel
Three Months Ended June 30, 2025
 LifeHealthTotal
Distribution ChannelAmount% of
Total
Amount% of
Total
Amount% of
Total
American Income$445,511 53 $31,422 8 $476,933 39 
Direct to Consumer246,223 29 19,212 5 265,435 22 
Liberty National97,263 12 47,631 13 144,894 12 
United American1,570  163,978 43 165,548 13 
Family Heritage1,796  115,856 31 117,652 10 
Other47,181 6   47,181 4 
Total
$839,544 100 $378,099 100 $1,217,643 100 

51
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Premium Income by Distribution Channel
 Three Months Ended June 30, 2024
 LifeHealthTotal
Distribution ChannelAmount
% of
Total
Amount
% of
Total
Amount
% of
Total
American Income$423,534 52 $30,721 9 $454,255 39 
Direct to Consumer248,839 31 18,132 5 266,971 23 
Liberty National92,197 11 47,705 14 139,902 12 
United American1,558  149,230 42 150,788 13 
Family Heritage1,645  105,855 30 107,500 9 
Other47,709 6   47,709 4 
Total
$815,482 100 $351,643 100 $1,167,125 100 

Six Months Ended June 30, 2025
 LifeHealthTotal
Distribution ChannelAmount% of
Total
Amount% of
Total
Amount% of
Total
American Income$883,377 53 $62,113 8 $945,490 39 
Direct to Consumer491,823 29 38,188 5 530,011 22 
Liberty National193,445 12 95,553 13 288,998 12 
United American3,162  323,826 43 326,988 13 
Family Heritage3,522  228,210 31 231,732 10 
Other94,078 6   94,078 4 
Total
$1,669,407 100 $747,890 100 $2,417,297 100 
 Six Months Ended June 30, 2024
 LifeHealthTotal
Distribution ChannelAmount
% of
Total
Amount
% of
Total
Amount
% of
Total
American Income$837,578 52 $61,218 9 $898,796 39 
Direct to Consumer496,879 31 35,998 5 532,877 23 
Liberty National182,974 11 95,335 14 278,309 12 
United American3,401  290,865 42 294,266 13 
Family Heritage3,261  209,246 30 212,507 9 
Other95,654 6   95,654 4 
Total
$1,619,747 100 $692,662 100 $2,312,409 100 

Due to the nature of the life insurance industry, Globe Life has no individual or group that would be considered a major customer. Substantially all of Globe Life's business is conducted in the United States.
 
The measure of profitability established by the CODM for the insurance segments is underwriting margin before other income and administrative expenses, in accordance with the manner in which the segments are managed. It essentially represents gross profit margin on insurance products before insurance administrative expenses and consists primarily of premium less net policy benefits, acquisition expenses, and commissions. Required interest on policy liabilities is reflected as a component of the Investment segment (rather than as a component of underwriting margin in the insurance segment) in order to match this cost with the investment income earned on the assets supporting the policy liabilities.
52
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)

The measure of profitability for the Investment segment is excess investment income, representing the net income earned on the investment portfolio in excess of policy requirements. Other than the required interest on the insurance segments, no other intersegment revenues or expenses are recognized. Expenses directly attributable to corporate operations are included in the “Corporate & Other” category. Stock-based compensation expense is considered a corporate expense by Globe Life management and is included in this category. All other unallocated revenues and expenses on a pretax basis, including insurance administrative expense and interest on debt, are also included in the “Corporate & Other” segment category.
 
Globe Life holds a sizable investment portfolio to support its insurance liabilities, the yield from which is used to offset policy benefit, acquisition, administrative, and tax expenses. This yield or investment income is taken into account when establishing premium rates and profitability expectations for its insurance products. From time to time, investments are sold or called, or experience a credit loss event, each of which are reflected by the Company as realized gain (loss)—investments. These gains or losses generally occur as a result of disposition due to issuer calls, compliance with Company investment policies, or other reasons often beyond management’s control. Unlike investment income, realized gains and losses are incidental to insurance operations, and only overall yields are considered when setting premium rates or insurance product profitability expectations. While these gains and losses are not relevant to segment profitability or core operating results, they can have a material positive or negative result on net income. For these reasons, management removes realized investment gains and losses when it views its segment operations.

Management also removes non-operating items unrelated to the Company's core insurance activities when evaluating those results. Therefore, these items are excluded in its presentation of segment results because accounting guidance requires that operating segment results be presented as management views its business. All of these items are included in “Other operating expense” in the Condensed Consolidated Statements of Operations for the appropriate year. See additional detail below in the tables.

53
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note 1—Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income.
Three Months Ended June 30, 2025
LifeHealthInvestmentConsolidated
Revenue:
Premium$839,544 $378,099 $ $1,217,643 
Net investment income  282,169 282,169 
Segment revenue
839,544 378,099 282,169 1,499,812 
Realized gains (losses)(18,574)
Other income49 
Total consolidated revenue
$1,481,287 
Expenses:
Policy obligations(1)
519,355 229,924 5,410 754,689 
Required interest on reserves (211,160)(28,391)241,931 2,380 
Amortization of acquisition costs 96,201 14,841  111,042 
Commissions42,357 41,965  84,322 
Premium taxes16,682 7,649  24,331 
Non-deferred acquisition costs36,035 14,054  50,089 
Segment profit or (loss) $340,074 $98,057 $34,828 472,959 
Insurance administrative expenses:
Salaries34,677 
Other employee costs9,407 
Information technology costs19,555 
Legal costs5,827 
Other administrative costs16,581 
Parent expense3,555 
Stock-based compensation expense14,043 
Interest expense34,885 
Legal proceedings4,648 
Annuity(2,043)
 Total expenses1,167,988 
Income before income taxes per Condensed Consolidated Statements of Operations
$313,299 
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.





54
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Three Months Ended June 30, 2024
LifeHealthInvestmentConsolidated
Revenue:
Premium$815,482 $351,643 $ $1,167,125 
Net investment income  285,636 285,636 
Segment revenue815,482 351,643 285,636 1,452,761 
Realized gains (losses)(12,589)
Other income74 
Total consolidated revenue
1,440,246 
Expenses:
Policy obligations(1)
518,792 205,423 5,536 729,751 
Required interest on reserves (201,815)(27,410)237,309 8,084 
Amortization of acquisition costs 87,915 13,611  101,526 
Commissions39,698 41,661  81,359 
Premium taxes17,200 5,274  22,474 
Non-deferred acquisition costs33,369 12,596  45,965 
Segment profit or (loss) $320,323 $100,488 $42,791 463,602 
Insurance administrative expenses:
Salaries30,855 
Other employee costs8,063 
Information technology costs20,561 
Legal costs6,889 
Other administrative costs15,828 
Parent expense3,130 
Stock-based compensation expense10,090 
Interest expense31,404 
Legal proceedings2,435 
Non-operating expenses1,257 
Annuity(1,748)
 Total expenses1,117,923 
Income before income taxes per Condensed Consolidated Statements of Operations
$322,323 
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.



55
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Six Months Ended June 30, 2025
LifeHealthInvestmentConsolidated
Revenue:
Premium$1,669,407 $747,890 $ $2,417,297 
Net investment income  562,783 562,783 
Segment revenue1,669,407 747,890 562,783 2,980,080 
Realized gains (losses)(18,489)
Other income118 
Total consolidated revenue
$2,961,709 
Expenses:
Policy obligations(1)
1,029,111 463,853 10,804 1,503,768 
Required interest on reserves (419,696)(56,677)481,281 4,908 
Amortization of acquisition costs 186,834 29,360  216,194 
Commissions87,924 84,852  172,776 
Premium taxes34,693 15,142  49,835 
Non-deferred acquisition costs73,203 28,582  101,785 
Segment profit or (loss)
$677,338 $182,778 $70,698 930,814 
Insurance administrative expenses:
Salaries68,365 
Other employee costs19,708 
Information technology costs40,491 
Legal costs12,076 
Other administrative costs32,956 
Parent expense6,605 
Stock-based compensation expense26,062 
Interest expense69,877 
Legal proceedings10,776 
Annuity(3,853)
 Total expenses2,332,329 
Income before income taxes per Condensed Consolidated Statement of Operations
$629,380 
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.
56
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Six Months Ended June 30, 2024
LifeHealthInvestmentConsolidated
Revenue:
Premium$1,619,747 $692,662 $ $2,312,409 
Net investment income  568,214 568,214 
Segment revenue1,619,747 692,662 568,214 2,880,623 
Realized gains (losses)(24,388)
Other income150 
Total consolidated revenue $2,856,385 
Expenses:
Policy obligations(1)
1,038,663 407,750 9,004 $1,455,417 
Required interest on reserves (401,522)(54,583)472,634 16,529 
Amortization of acquisition costs 173,683 26,922  200,605 
  Commissions78,388 80,810  159,198 
  Premium taxes34,286 12,090  46,376 
  Non-deferred acquisition costs66,915 25,415  92,330 
Segment profit or (loss)
$629,334 $194,258 $86,576 910,168 
Insurance administrative expenses:
Salaries62,029 
Other employee costs18,076 
Information technology costs38,868 
Legal costs12,162 
Other administrative costs31,472 
Parent expense5,956 
Stock-based compensation expense19,357 
Interest expense60,025 
Legal proceedings2,435 
Non-operating expenses1,967 
Annuity
(3,663)
 Total expenses2,219,139 
Income before income taxes per Condensed Consolidated Statement of Operations
$637,246 
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.
57
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Assets for each segment are reported based on a specific identification basis. The insurance segments’ assets contain DAC. The investment segment includes the investment portfolio, cash, and accrued investment income. Goodwill is assigned to the insurance segments at the time of purchase. All other assets are included in the annuity and other corporate category. The tables below reconcile segment assets to total assets as reported on the Condensed Consolidated Balance Sheets.
 
Assets by Segment

 June 30, 2025
 LifeHealthInvestmentConsolidated
Cash and invested assets$ $ $20,164,212 $20,164,212 
Accrued investment income  271,670 271,670 
Deferred acquisition costs5,931,048 823,082  6,754,130 
Goodwill309,609 180,837  490,446 
Total segment assets
$6,240,657 $1,003,919 $20,435,882 27,680,458 
Annuity and other corporate
2,128,890 
Total assets
$29,809,348 

 December 31, 2024
 LifeHealthInvestmentConsolidated
Cash and invested assets$ $ $19,736,888 $19,736,888 
Accrued investment income  269,791 269,791 
Deferred acquisition costs5,700,755 793,421  6,494,176 
Goodwill309,609 180,837  490,446 
Total segment assets
$6,010,364 $974,258 $20,006,679 26,991,301 
Annuity and other corporate
2,084,880 
Total assets
$29,076,181 

Note 13—Subsequent Events

On July 1, 2025, Globe Life entered into a 30-year facility agreement (“Facility Agreement”) with a Delaware Trust (the “Trust”) to complete the issuance and sale of 500 thousand of Pre-Capitalized Trust Securities redeemable May 15, 2055 (the “P-Caps”) for an aggregate purchase price of $500 million in a private placement. On the Closing Date, the Company entered into a facility agreement with the Trust that grants the Company the right to require the Trust to purchase from the Company’s 6.580% Senior Notes due 2055 in an aggregate principal amount at any one time outstanding and held by the Trust, of up to $500 million. We agreed to pay a semi-annual facility fee of 1.789% per annum on the unexercised portion of the issuance right which will be expensed as incurred. The costs that are directly attributable to the debt issuance will be capitalized and amortized as interest expense over the term of the facility agreement. Approximately, $7 million of direct transaction costs associated with the P-Caps facility will be capitalized as part of the arrangement. P-Caps provide the Company with a source of liquidity, the proceeds of which, if drawn, would be used for general corporate purposes.

On July 3, 2025, Globe Life Inc. completed the acquisition of real estate located in McKinney, Texas for total consideration of $80 million. The acquisition was executed in order to support Company growth and efficiency through modern technological infrastructure and centralized operations. The acquisition includes land, a building structure and building improvements. The transaction was executed pursuant to a purchase agreement and will be accounted for as an asset acquisition. The building will be depreciated over its estimated useful life of 40 years on a straight-line basis. The Company expects to utilize the facility for its own operational needs.
58
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
As of the date of this filing, the current facility does not qualify for held for sale classification and no impairment indicators have been identified.

The Company has evaluated these subsequent events and determined no adjustments are required to the financial statements for the period ended June 30, 2025.

59
        GL Q2 2025 FORM 10-Q

Table of Contents
CAUTIONARY STATEMENTS
 
We caution readers regarding certain forward-looking statements contained in the foregoing discussion and elsewhere in this document, and in any other statements made by, or on behalf of Globe Life whether or not in future filings with the Securities and Exchange Commission. Any statement that is not a historical fact, or that might otherwise be considered an opinion or projection concerning the Company or its business, whether express or implied, is meant as and should be considered a forward-looking statement. Such statements represent management's opinions concerning future operations, strategies, financial results or other developments. We specifically disclaim any obligation to update or revise any forward-looking statement because of new information, future developments, or otherwise.
 
Forward-looking statements are based upon estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control. If these estimates or assumptions prove to be incorrect, the actual results of Globe Life may differ materially from the forward-looking statements made on the basis of such estimates or assumptions. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:
1.Economic and other conditions, including the impact of inflation, immigration, geopolitical events, escalating tariff and non-tariff trade measures imposed by the U.S. and other countries, and other governmental actions which affect the U.S. economy and/or U.S. consumer confidence, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and/or utilization of health care services that differ from Globe Life's assumptions;
2.Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that affect Medicare Supplement insurance sales, claims utilization or use);
3.Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that affect the sales of traditional Medicare Supplement insurance;
4.Interest rate changes that affect product sales, financing costs, and/or investment yields;
5.General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may comprise part of our investment portfolio) that affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;
6.Changes in the competitiveness of the Company's products and pricing;
7.Litigation or regulatory actions against the Company;
8.Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);
9.The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;
10.The customer response to new products and marketing initiatives;
11.Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12.Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;
13.The impact of reputational damage on the Company including the impact on the Company's ability to attract and retain agents;
14.The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity, level of claims, and demand for our products; and
15.Globe Life's ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.
Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission, including those described in the "Risk Factors" section of our most recent Annual Report on Form 10-K.
60
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 
The following discussion should be read in conjunction with Globe Life's Condensed Consolidated Financial Statements and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year.

"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.

Results of Operations

icons2.jpg
How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life and supplemental health, and the investment segment that supports the product lines.
icons.jpg
Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further subdivided by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below:

 Premium revenue
                                                           (Policy obligations)
                                                           (Policy acquisition costs and commissions)
                                                            Underwriting margin

icons3.jpg
Investment Segment. The investment segment involves the management of our capital resources, including investments and the management of liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below:
 Net investment income
(Required interest on policy liabilities)
                                                           Excess investment income


61
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Current Highlights.
Net income as a return on equity (ROE) for the six months ended June 30, 2025 was 18.8% and net operating income as an ROE, excluding accumulated other comprehensive income(1) was 14.4%.
Total premium increased 5% over the same period in the prior year. Life premium increased 3% for the period from $1.62 billion in 2024 to $1.67 billion in 2025.
Total net sales increased 6% over the same period in the prior year from $415 million in 2024 to $439 million in 2025. The average producing agent count across all of the exclusive agencies increased 4% over the prior year.
Book value per share increased 14% over the same period in the prior year from $58.06 to $66.07. Book value per share, excluding accumulated other comprehensive income(1), increased 10% over the prior year from $82.38 in 2024 to $90.26 in 2025.
For the six months ended June 30, 2025, the Company repurchased 3.3 million shares of Globe Life Inc. common stock at a total cost of $403 million for an average share price of $121.38.

The following graphs represent net income and net operating income for the six month periods ended June 30, 2025 and 2024.
965 967
(1)As shown in the charts above, net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses after tax and, as such, is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. It differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding accumulated other comprehensive income ("AOCI"), is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(2.0) billion and $(2.2) billion for the six months ended June 30, 2025 and 2024, respectively.
Book value per share, excluding AOCI, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(24.19) and $(24.32) for the six months ended June 30, 2025 and 2024, respectively.
Refer to Analysis of Profitability by Segment for non-GAAP reconciliation to GAAP.
62
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Summary of Operations.

Net income totaled $507 million during the six months ended June 30, 2025, compared with $513 million in the same period in 2024.
On a diluted per common share basis, net income per common share for the six months ended June 30, 2025 increased 10% from $5.51 to $6.07.
Net operating income was $530 million for the six months ended June 30, 2025, compared with $535 million for the same period in 2024.
On a diluted per common share basis, net operating income per common share for the six months ended June 30, 2025 increased from $5.76 to $6.34, a 10% increase.

Net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses, after tax and, as such, is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Additionally, net income was affected by certain non-operating items. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods.

As previously noted, a component of insurance underwriting margin is policy obligations, which includes for each reporting period the change in the liability for future policy benefits ("LFPB"). The LFPB is determined each reporting period based on the net level premium method. Net level premiums reflect a recomputed net premium ratio using actual experience since the issue date, and expected future experience based on future cash-flow assumptions See Note 6—Policy Liabilities for additional information.

Overall, the Company continues to see positive signs in its core operations, including sales and premium growth, and continues to achieve an operating ROE (excluding accumulated other comprehensive income) generally in the mid-teens.
63
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from GAAP net income primarily because it excludes certain non-operating items such as realized gains and losses and other significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

Analysis of Profitability by Segment
(Dollar amounts in thousands)
Six Months Ended June 30,
20252024Change%
Life insurance underwriting margin$677,338 $629,334 $48,004 
Health insurance underwriting margin182,778 194,258 (11,480)(6)
Excess investment income70,698 86,576 (15,878)(18)
Segment profit or (loss)930,814 910,168 20,646 
Annuity and other income3,971 3,813 158 
Administrative expense(173,596)(162,607)(10,989)
Other corporate expense(102,544)(85,338)(17,206)20 
Pre-tax total658,645 666,036 (7,391)(1)
Applicable taxes(128,213)(130,720)2,507 (2)
Net operating income
530,432 535,316 (4,884)(1)
Reconciling items, net of tax:
Realized gains (losses)(14,607)(19,266)4,659 
Non-operating expenses— (1,554)1,554 
Legal proceedings(8,513)(1,924)(6,589)
Net income
$507,312 $512,572 $(5,260)(1)

The life insurance segment is our primary segment and is the largest contributor to earnings in each period presented. The life insurance segment underwriting margin increased $48 million compared with the prior period, primarily a result of increased premiums and favorable policy obligations as a percent of premium. Excess investment income declined $16 million compared with the prior period, partly due to lower earned yields on commercial mortgage loans, limited partnerships and short term investments. The health segment experienced higher policy obligations and declined $11 million in the first six months of 2025 with $183 million of underwriting margin compared with $194 million in the first six months of 2024.
64
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
In 2025, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was the American Income Life Division (American Income). The following charts represent the breakdown of total underwriting margin by operating segment and distribution channel for the six months ended June 30, 2025.
325326

Total premium income rose 5% for the six months ended June 30, 2025 to $2.4 billion. Total net sales increased 6% to $439 million, when compared with 2024. Total first-year collected premium (defined in the following section) increased 3% to $343 million for 2025, compared to $333 million in 2024.

Life insurance premium income increased 3% to $1.67 billion over the prior-year total of $1.62 billion. Life net sales were relatively flat at $303 million for the first six months of 2025 as compared to the year ago period. First-year collected life premium increased 2% to $231 million. Life underwriting margin, as a percent of premium, increased to 41% for 2025 from 39% in 2024. Underwriting margin increased to $677 million in 2025, compared to $629 million in 2024.

Health insurance premium income increased 8% to $748 million over the prior-year total of $693 million. Health net sales rose 21% to $136 million for the first six months of 2025. First-year collected health premium rose 6% to $113 million. Health underwriting margin, as a percent of premium, was 24% for 2025 and 28% for 2024. Health underwriting margin declined to $183 million for the first six months of 2025, compared to $194 million in 2024.

Excess investment income, the measure of profitability of our investment segment, declined 18% during the first six months of 2025 to $71 million from $87 million in 2024. Excess investment income per common share, reflecting the impact of our share repurchase program, declined 9% to $0.85 from $0.93 when compared with the same period in 2024.

Insurance administrative expenses increased 7% in 2025 when compared with the prior-year period. These expenses were 7.2% as a percent of premium during 2025 compared to 7.0% in 2024.

For the six months ended June 30, 2025, the Company repurchased 3.3 million shares of Globe Life Inc. common stock at a total cost of $403 million for an average share price of $121.38.

65
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
The discussions of our segments are presented in the manner we view our operations, as described in Note 12—Business Segments.

We use three measures as indicators of premium growth and sales over the near term: “annualized premium in force,” “net sales,” and “first-year collected premium.”
Annualized premium in force is defined as the premium income that would be received over the following twelve months at any given date on all active policies if those policies remain in force throughout the 12-month period.
Net sales is calculated as annualized premium issued, net of cancellations generally in the first 30 days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically one month) has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued since annualized premium issued excludes cancellations, and cancellations do not contribute to premium income.
First-year collected premium is defined as the premium collected during the reporting period for all policies in their first policy year. First-year collected premium takes lapses into account in the first year when lapses are more likely to occur, and thus is a useful indicator of how much new premium is expected to be added to premium income in the future. First-year collected premiums are lower than net sales over the prior 12 months because premiums are not collected on lapsed policies after the date of lapse.

Cancellations are not included in lapses.

See further discussion of the distribution channels below for Life and Health.

66
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
LIFE INSURANCE

Life insurance is the Company's predominant segment. During 2025, life premium represented 69% of total premium and life underwriting margin represented 79% of the total underwriting margin. Additionally, investments supporting the reserves for life products produce the majority of income attributable to the investment segment.
 
The following table presents the summary of results of life insurance. Further discussion of the results by distribution channel is included below.

Life Insurance
Summary of Results
(Dollar amounts in thousands)
Six Months Ended June 30,Change
20252024
Amount% of PremiumAmount% of PremiumAmount%
Premium and policy charges$1,669,407 100 $1,619,747 100 $49,660 
Policy obligations1,029,111 62 1,038,663 64 (9,552)(1)
Required interest on reserves(419,696)(25)(401,522)(25)(18,174)
Net policy obligations609,415 37 637,141 39 (27,726)(4)
Amortization of acquisition costs186,834 11 173,683 11 13,151 
Commission expense87,924 78,388 9,536 12 
Premium taxes34,693 34,286 407 
Non-deferred acquisition costs73,203 66,915 6,288 
Total expense992,069 59 990,413 61 1,656 — 
Insurance underwriting margin
$677,338 41 $629,334 39 $48,004 

Net policy obligations amounted to 37% of premium for the six months ended June 30, 2025 compared to 39% in the year-ago period.

The table below summarizes life underwriting margin by distribution channel.
 
Life Insurance
Underwriting Margin by Distribution Channel
(Dollar amounts in thousands)
Six Months Ended June 30,
20252024
Change
Amount% of PremiumAmount% of PremiumAmount
%
American Income$400,702 45 $379,730 45 $20,972 
Direct to Consumer133,159 27 122,433 25 10,726 
Liberty National65,218 34 61,785 34 3,433 
Other(1)
78,259 78 65,386 64 12,873 20 
Total
$677,338 41 $629,334 39 $48,004 
(1) Includes a gain of $14 million related to the recapture of reinsurance for six months ended June 30, 2025 as disclosed in Note 1 - Significant Accounting Policies.
67
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table presents Globe Life's life insurance premium by distribution channel.

Life Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
Six Months Ended June 30,Change
20252024
Amount% of TotalAmount% of TotalAmount%
American Income$883,377 53 $837,578 52 $45,799 
Direct to Consumer491,823 29 496,879 31 (5,056)(1)
Liberty National193,445 12 182,974 11 10,471 
Other100,762 102,316 (1,554)(2)
Total
$1,669,407 100 $1,619,747 100 $49,660 

Annualized life premium in force was $3.38 billion at June 30, 2025, an increase of 4% over $3.27 billion a year earlier.

An analysis of life net sales, an indicator of new business production, by distribution channel is presented below. 

Life Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
Six Months Ended June 30,Change
20252024
Amount% of TotalAmount% of TotalAmount%
American Income$194,782 64 $191,863 63 $2,919 
Direct to Consumer56,271 19 59,177 20 (2,906)(5)
Liberty National47,084 15 47,494 16 (410)(1)
Other5,099 4,466 633 14 
Total
$303,236 100 $303,000 100 $236 — 


First-year collected life premium by distribution channel is presented in the table below. 

Life Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
Six Months Ended June 30,Change
20252024
Amount% of TotalAmount% of TotalAmount%
American Income$157,171 68 $150,362 66 $6,809 
Direct to Consumer30,676 13 35,716 16 (5,040)(14)
Liberty National38,799 17 36,764 16 2,035 
Other3,900 3,947 (47)(1)
Total
$230,546 100 $226,789 100 $3,757 
68
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

A discussion of life operations by distribution channel follows.

The American Income Life Division markets to members of labor unions and other affinity groups and continues to diversify its lead sources, utilizing internally generated leads, third-party internet vendor leads and referrals to facilitate sustainable growth. This Division is Globe Life's largest contributor of life premium of any distribution channel at 53% of the Company's June 30, 2025 total life premium. For the six months ended June 30, 2025, the average monthly life premium issued per policy was $59 as compared to $57 for the same period in the prior year. Net sales were $195 million for the six months ended June 30, 2025, up from $192 million in the year-ago period. The underwriting margin, as a percent of premium, was 45% for the six months ended June 30, 2025 and 2024.

The average producing agent count increased 3% over the year-ago period. The increase in average producing agent count was driven by an increase in new agent recruiting along with continued improvement in new agent retention. Sales growth in this Division, as well as within our other exclusive agencies, is generally dependent on growth in the size of the agency force.

Below is the average producing agent count as of the indicated periods for the American Income Life Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year.
At June 30,
Change
20252024Amount%
American Income
11,876 11,504 372 

American Income Life continues to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth and additional agency openings. In addition to offering financial incentives and training opportunities, the Division has made considerable investments in information technology, including a customer relationship management (CRM) tool for the agency force. This tool is designed to provide dashboards and drive productivity in lead distribution, conservation of business, and new agent recruiting. Additionally, this Division has invested in and successfully implemented technology that allows the agency force to engage in virtual recruiting, training, and sales activity. The agents have shifted to primarily a virtual experience with the customers and have generated a vast majority of sales through virtual presentations. We find this flexibility to be enticing for new recruits as well as a driver of retention in our agency force.

The Direct to Consumer Division (DTC) markets adult and juvenile life insurance through a variety of channels, including direct mail, insert media, and digital marketing. The different media channels support and complement one another in the Division's efforts to provide consumer outreach. All three channels work as part of an omnichannel approach. Sales from the internet and inbound phone calls continue to outpace the activity from direct mail. DTC's long-term growth has been fueled by consistent innovation and brand awareness. Additionally, the DTC Division provides valuable support to our agency business through brand impressions and inquiries that lead to sales in our exclusive agency channels. New initiatives are continuously introduced to help increase response rates, issue rates, and create a seamless customer experience. The juvenile insurance market is an important source of sales as well as a vehicle to reach the parents and grandparents of existing juvenile insureds, who are more likely to respond favorably to a direct to consumer solicitation for life coverage on themselves in comparison to the general adult population. Additionally, future offerings to parents and grandparents for adult and juvenile insurance are sources of lower acquisition-cost life insurance sales in the future.

DTC net sales declined 5% to $56 million for the six months ended June 30, 2025, compared to $59 million for the same period in the prior year. This decline is due primarily to an intentional reduction of direct mail and print insert marketing activity because of the impact of inflation on postage, paper and online advertising costs. We reported higher net sales in the second quarter of 2025, which were up 24% from the first quarter of the year, resulting from our initiatives noted above. While total year to date sales have declined compared to the prior year, the focus has been on improving profitability and improving underwriting margin. DTC’s underwriting margin was $133.2 million and 27% as a percent of premium for the six months ended June 30, 2025 compared to $122.4 million and 25% as a percent of premium for the same period in 2024. For the six months ended June 30, 2025, the average monthly life premium issued for DTC adults was $17 as compared to $15 for the same period in the prior year.

69
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The Liberty National Division markets individual life insurance to middle-income household and worksite customers. Recent investments in new sales technologies as well as recent growth in middle management within the Division are expected to support increased sales. Underwriting margin and premium were up 6% from the year ago period at $65 million and $193 million respectively. The underwriting margin as a percent of premium was flat for the six months ended June 30, 2025, at 34% compared to the year-ago period. For the six months ended June 30, 2025, the average monthly life premium per policy issued rose slightly compared to the prior year to $44 from $43.

Below is the average producing agent count for the six months ended June 30, 2025 and 2024 for the Liberty National Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year.
At June 30,
Change
20252024Amount%
Liberty National
3,785 3,560 225 

The Liberty National Division's average producing agent count increased when compared with the prior-year comparable period. This Division continues to execute a long-term plan to grow through expansion from small-town markets in the Southeast to more densely populated areas with larger pools of potential agent recruits and customers in the communities, regions, and cities the Liberty National Division serves. Expansion of this Division’s presence in larger geographic cities, with less penetrated areas will help create long-term sustainable agency growth. Additionally, the Division continues to help improve the ability of agents to develop new worksite marketing business. A CRM platform and enhanced analytical capabilities have helped the agents develop additional worksite marketing opportunities and improve the productivity of agents selling in the individual life market. As the Division gains momentum in its sales and recruiting initiatives, advances in technology and use of the CRM platform, it anticipates continued growth in recruiting activity, average producing agent count, and net sales.

The Other agency distribution channels primarily include non-exclusive independent agencies selling primarily life insurance. The Other distribution channels contributed $101 million of life premium income, or 6% of Globe Life's total life premium income in the six months ended June 30, 2025, and contributed 2% of net sales for the period.

HEALTH INSURANCE

Health insurance sold by the Company primarily includes Medicare Supplement insurance as well as retiree health insurance, accident coverage, and other limited-benefit supplemental health products such as cancer, critical illness, heart disease, intensive care, and other health products.

Health premium accounted for 31% of our total premium in 2025, while the health underwriting margin accounted for 21% of total underwriting margin. Health underwriting margin declined to $183 million compared to $194 million in the prior year. While the Company continues to emphasize life insurance sales relative to health, due to life’s superior long-term profitability and its greater contribution to excess investment income, the health business provides a significant contribution to return on equity as it does not require a substantial amount of up-front capital.

70
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table presents underwriting margin data for health insurance.

Health Insurance
Summary of Results
(Dollar amounts in thousands)
 Six Months Ended June 30,Change
 20252024
 Amount% of
Premium
Amount% of
Premium
Amount%
Premium$747,890 100 $692,662 100 $55,228 
Policy obligations463,853 62 407,750 59 56,103 14 
Required interest on reserves(56,677)(7)(54,583)(8)(2,094)
Net policy obligations407,176 55 353,167 51 54,009 15 
Amortization of acquisition costs29,360 26,922 2,438 
Commission expense84,852 11 80,810 11 4,042 
Premium taxes15,142 12,090 3,052 25 
Non-deferred acquisition costs28,582 25,415 3,167 12 
Total expense565,112 76 498,404 72 66,708 13 
Insurance underwriting margin
$182,778 24 $194,258 28 $(11,480)(6)

Net policy obligations amounted to 55% of premium for the six months ended June 30, 2025 compared to 51% in the year ago period.

The table below summarizes health underwriting margin by distribution channel.
 
Health Insurance
Underwriting Margin by Distribution Channel
(Dollar amounts in thousands)
Six Months Ended June 30,
20252024
Change
Amount% of PremiumAmount% of PremiumAmount
%
United American$14,019 $28,477 10 $(14,458)(51)
Family Heritage80,176 35 72,449 35 7,727 11 
Liberty National50,354 53 53,072 56 (2,718)(5)
American Income38,714 62 38,284 63 430 
Direct to Consumer(485)(1)1,976 (2,461)(125)
Total
$182,778 24 $194,258 28 $(11,480)(6)

71
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Globe Life markets supplemental health insurance products through a number of distribution channels. The following table is an analysis of our health premium by distribution channel.

Health Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
 Six Months Ended June 30,Increase
(Decrease)
 20252024
Amount% of TotalAmount% of TotalAmount%
United American$323,826 43 $290,865 42 $32,961 11 
Family Heritage228,210 31 209,246 30 18,964 
Liberty National95,553 13 95,335 14 218 — 
American Income62,113 61,218 895 
Direct to Consumer38,188 35,998 2,190 
Total
$747,890 100 $692,662 100 $55,228 

Premiums related to limited-benefit supplemental health products comprise $417 million, or 56%, of the total health premiums for the six months ended June 30, 2025, compared with $388 million, or 56%, in the same period in the prior year. Premium from Medicare Supplement products comprises the remaining $331 million, or 44%, for the six months ended June 30, 2025, compared to $305 million, or 44%, in the same period in the prior year.

Annualized health premium in force was $1.54 billion at June 30, 2025, an increase of 7% over $1.44 billion a year earlier.

Presented below is a table of health net sales by distribution channel.
 
Health Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
 Six Months Ended June 30,Increase
(Decrease)
 20252024
Amount% of TotalAmount% of TotalAmount%
United American$53,162 39 $34,651 31 $18,511 53 
Family Heritage56,377 42 49,536 44 6,841 14 
Liberty National15,380 11 15,969 14 (589)(4)
American Income9,619 10,386 (767)(7)
Direct to Consumer1,431 1,643 (212)(13)
Total
$135,969 100 $112,185 100 $23,784 21 

Health net sales related to limited-benefit supplemental health products comprise $101 million, or 74%, of the total health net sales for the six months ended June 30, 2025, compared with $84 million, or 75%, in the same period in the prior year. Medicare Supplement sales make up the remaining $35 million, or 26%, for 2025 compared to $28 million, or 25%, in the same period in the prior year.

72
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The following table presents health insurance first-year collected premium by distribution channel.

 Health Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
 Six Months Ended June 30,Increase
(Decrease)
 20252024
Amount% of TotalAmount% of TotalAmount%
United American$42,723 38 $42,434 40 $289 
Family Heritage43,921 39 38,666 36 5,255 14 
Liberty National13,982 12 14,102 13 (120)(1)
American Income9,623 9,568 55 
Direct to Consumer2,319 1,885 434 23 
Total
$112,568 100 $106,655 100 $5,913 
 
First-year collected premium related to limited-benefit supplemental health products is $77.2 million, or 69%, of total first-year collected premium for the six months ended June 30, 2025 compared with $76.9 million, or 72%, in the same period in the prior year. First-year collected premium from Medicare Supplement policies make up the remaining $35.3 million, or 31%, for the six months ended June 30, 2025 compared to $29.8 million, or 28%, in the same period in the prior year.

A discussion of health operations by distribution channel follows.
The United American Division consists of non-exclusive independent agencies who may also sell for other companies. The United American Division was Globe Life's largest health agency in terms of health premium income, with net sales up 53% from the same period in the prior year.
This Division includes different units:

UA General Agency, which primarily sells individual Medicare Supplement insurance through independent agents;
Special Markets, which markets retiree health insurance to employer and union groups through brokers; and
Globe Life Group Benefits, which offers group worksite supplemental health insurance through brokers.

The majority of the premium revenue comes from Medicare Supplement. Underwriting margin as a percent of premium for the Division was 4% for the six months ended June 30, 2025 and 10% for the same period in 2024. The decline in underwriting margin as a percent of premium when compared to prior year is primarily attributable to increased claims utilization during the current year from Medicare Supplement. We adjust premium rates based upon an annual review of utilization and claim cost trends and submit revisions for approval to the insurance department regulators, and if approved, the new premium rates generally become effective in the following year.

The Family Heritage Division primarily markets limited-benefit supplemental health insurance to small- to medium- sized businesses. Most of its policies include a return of premium feature, where premium paid is returned less any claims paid to the policyholder at the end of a specified period stated within the insurance policy. Underwriting margin as a percent of premium was 35% for the six months ended June 30, 2025 and 2024.
The Division experienced a 14% rise in health net sales as compared with the same six-month period a year ago, primarily due to increased agent count and increased agent productivity. The Division will continue to implement incentive and retention programs to further these increases in the number of producing agents.
73
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Below is the average producing agent count at the end of the period for the Family Heritage Division. The average producing agent count is based on the actual count at the beginning and end of each week during the year. The average producing agent count increased 10% compared with the same period a year ago. Along with the Division's increased efforts to grow agent count, it is also focused on the further training and development of its middle management. While growth in net sales and earned premium is impacted by agent productivity, growth in the number of producing agents will be the primary driver of future growth in sales, similar to our other exclusive agencies.
At June 30,
Change
20252024Amount%
Family Heritage
1,458 1,328 130 10 

The Liberty National Division represented 13% of all Globe Life health premium income for the six months ended June 30, 2025. The Liberty National Division markets limited-benefit supplemental health products, consisting primarily of cancer, critical illness, and accident insurance. Much of Liberty National's health business is generated through worksite marketing targeting small businesses. Health premium at the Liberty National Division was $95.6 million for the six months ended June 30, 2025 up from $95.3 million for the same period in 2024. Liberty National's first-year collected premium fell 1% to $14.0 million in the six months ended June 30, 2025 compared with $14.1 million for the same period in 2024. Health net sales for the six months ended June 30, 2025 fell 4% from the comparable period in 2024. For the six months ended June 30, 2025, underwriting margin as a percent of premium was 53%, compared with 56% in the same period in the prior year primarily due to an increase in policy obligations in the current period.

While both the American Income Life Division and the Direct to Consumer Division sell life insurance, they also market health products. The American Income Life Division primarily markets accident plans. The Direct to Consumer Division primarily markets Medicare Supplement insurance to employer or union-sponsored groups. On a combined basis, these other channels accounted for 13% of health premium for the six months ended June 30, 2025 and 14% for the same period in 2024.


INVESTMENTS

We manage our capital resources, including investments and cash flow, through the investment segment. Excess investment income represents the profit margin attributable to investment operations and is the measure that we use to evaluate the performance of the investment segment as described in Note 12—Business Segments. It is defined as net investment income less the required interest attributable to policy liabilities.

Management views excess investment income per diluted common share as an important and useful measure to evaluate the performance of the investment segment. It is defined as excess investment income divided by the total diluted weighted-average shares outstanding, representing the contribution by the investment segment to the consolidated earnings per share of the Company.

74
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Excess Investment Income. The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.

Analysis of Excess Investment Income
(Dollar amounts in thousands, except for per share data) 
Six Months Ended
June 30,
Change
20252024Amount%
Net investment income$562,783 $568,214 $(5,431)(1)
Interest on policy liabilities(1)
(492,085)(481,638)(10,447)
Excess investment income
$70,698 $86,576 $(15,878)(18)
Excess investment income per diluted share
$0.85 $0.93 $(0.08)(9)
Mean invested assets (at amortized cost)$21,494,647 $21,307,683 $186,964 
Average insurance policy liabilities17,727,143 17,395,345 331,798 
(1)Interest on policy liabilities, at original rates, is a component of total policyholder benefits, a GAAP measure.

Excess investment income declined $16 million, or 18%, compared with the year-ago period. Excess investment income per diluted common share was $0.85 for the six months ended June 30, 2025, a decrease of 9% from the prior-year period. Excess investment income per diluted common share generally increases or decreases at a different pace than excess investment income because the number of diluted shares outstanding generally decreases from year to year as a result of our share repurchase program.

Net investment income for the six months ended June 30, 2025 was $563 million, or 1% less than the year-ago period. Mean invested assets increased 1% during the first six months of 2025 over the same period last year. Net investment income declined in the current period primarily due to lower earned yields on short-term investments, commercial mortgage loans and limited partnerships compared to the prior year. The effective annual yield rate earned on the fixed maturity portfolio was 5.27% in the first six months of 2025, compared to 5.26% a year earlier. In addition to fixed maturities, the Company has also invested in commercial mortgage loans and limited partnerships with debt-like characteristics that diversify risk and enhance risk-adjusted, capital-adjusted returns on the portfolio. The earned yield on the Company's commercial mortgage loans for the six months ended June 30, 2025 was 5.62% compared with 8.47% in the prior year period. The lower earned yield on commercial mortgage loans is partly due to lower floating rates in addition to loans in non-accrual status. The earned yield on limited partnership investments for the six months ended June 30, 2025 was 7.60% and 8.90% in the comparable prior year period. See additional information in Note 4—Investments.

Globe Life's net investment income benefits from higher interest rates on new investments. While increasing interest rates have resulted in a net unrealized loss from our available-for-sale debt securities included in accumulated other comprehensive income (loss) as of June 30, 2025, we are not concerned because we do not generally intend to sell, nor is it likely that we will be required to sell, the fixed maturities prior to their anticipated recovery.

Required interest on insurance policy liabilities reduces excess investment income, as it is the amount of net investment income necessary to cover the interest-related growth on insurance policy liabilities. As such, it is reclassified from the insurance segment to the investment segment. As discussed in Note 12—Business Segments, management regards this as a more meaningful analysis of the investment and insurance segments. Required interest is based on the original discount rate assumptions for our insurance policies in force.

The vast majority of our life and health insurance policies are fixed interest rate protection policies, not investment products, and are accounted for under current GAAP accounting guidance for long-duration insurance products which mandates that interest rate assumptions for a particular block of business be “locked in” for the life of that block of business. Each calendar year, we set the original discount rate to be used to calculate the benefit reserve liability for all insurance policies issued that year. The liability reported on the balance sheet is updated in subsequent periods using current discount rates as of the end of the relevant reporting period with a corresponding adjustment to other comprehensive income.
75
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

The discount rate used for policies issued in the current year has no impact on the in force policies issued in prior years, as the rates of all prior issue years are also locked in for purposes of recognizing income. As such, the overall original discount rate for the entire in force block of 5.6% is a weighted average of the discount rates being used from all issue years. Changes in the overall weighted-average discount rate over time are caused by changes in the mix of the reserves on the entire block of in force business. Business issued in the current year has little impact on the overall weighted-average original discount rate due to the size of our in force business.

In comparison to the year-ago period, required interest on insurance policy liabilities increased $10 million, or 2%, to $492 million, consistent with the 2% growth in average interest-bearing insurance policy liabilities.

Realized Gains and Losses. Our life and health insurance companies collect premium income from policyholders for the eventual payment of policyholder benefits, sometimes paid for many years or even decades in the future. Since benefits are expected to be paid in future periods, premium receipts in excess of current expenses are invested to provide for these obligations. For this reason, we hold a significant investment portfolio as a part of our core insurance operations. This portfolio consists primarily of high-quality fixed maturities containing an adequate yield to provide for the cost of carrying these long-term insurance product obligations. As a result, fixed maturities are generally held for long periods to support these obligations. Expected yields on these investments are taken into account when setting insurance premium rates and product profitability expectations.

Despite our intent to hold fixed maturity investments for a long period of time, investments are occasionally sold, exchanged, called, or experience a credit loss event, resulting in a realized gain or loss. Gains or losses are only secondary to our core insurance operations of providing insurance coverage to policyholders. The Company also has investments in certain limited partnerships, held under the fair value option, with fair value changes recognized in Realized gains (losses) in the Condensed Consolidated Statements of Operations.

Realized gains and losses can be significant in relation to the earnings from core insurance operations, and as a result, can have a material positive or negative impact on net income. The significant fluctuations caused by gains and losses can cause period-to-period trends of net income that are not indicative of historical core operating results or predictive of the future trends of core operations. Accordingly, they have no bearing on core insurance operations or segment results as we view operations. For these reasons, and in line with industry practice, we remove the effects of realized gains and losses when evaluating overall insurance operating results.

The following table summarizes our tax-effected realized gains (losses) by component.

Analysis of Realized Gains (Losses), Net of Tax
(Dollar amounts in thousands, except for per share data)
 Six Months Ended June 30,
 20252024
 AmountPer ShareAmountPer Share
Fixed maturities:
Sales$(4,262)$(0.05)$(7,840)$(0.09)
Matured or other redemptions(1)
(5,257)(0.06)(39)— 
Provision for credit losses32 — (13)— 
Fair value option—change in fair value(4,823)(0.06)(15,084)(0.16)
Mortgages
242 — (1,701)(0.02)
Other investments
(1,060)(0.01)910 0.01 
Total realized gains (losses)—investments
(15,128)(0.18)(23,767)(0.26)
Other gains (losses)(2)
521 0.01 4,501 0.05 
Total realized gains (losses)
$(14,607)$(0.17)$(19,266)$(0.21)
(1)During the six months ended June 30, 2025 and 2024, the Company recorded $128.3 million and $78.9 million, respectively, of exchanges of fixed maturity securities (noncash transactions) that resulted in a realized losses of $(2.5) million and $0 net of tax, respectively.
(2)Other realized gains (losses) are primarily a result of changes in the fair value for assets held in rabbi trust.



76
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Investment Acquisitions. Globe Life's investment policy calls for investing primarily in investment grade fixed maturities that meet our quality and yield objectives. We generally invest in securities with longer-term maturities because they more closely match the long-term nature of our life and health policy liabilities. We believe this strategy is appropriate since our expected future cash flows are generally stable and predictable and the likelihood that we will need to sell invested assets to raise cash is low.

The following table summarizes selected information for fixed maturity investments. The effective annual yield shown is based on the acquisition price and call features, if any, of the securities. For non-callable bonds, the yield is calculated to maturity date. For callable bonds acquired at a premium, the yield is calculated to the earliest known call date and call price after acquisition ("first call date"). For all other callable bonds, the yield is calculated to maturity date.

Fixed Maturity Acquisitions Selected Information
(Dollar amounts in thousands)
Six Months Ended
June 30,
 20252024
Cost of acquisitions:
Investment-grade corporate securities$479,578 $898,390 
Investment-grade municipal securities18,228 6,520 
Other securities
10,292 18,186 
Total fixed maturity acquisitions(1)
$508,098 $923,096 
Effective annual yield (one year compounded)(2)
6.43 %5.94 %
Average life (in years, to next call)35.8 30.9 
Average life (in years, to maturity)38.3 33.0 
Average ratingA-A-
(1)Fixed maturity acquisitions included unsettled trades of $0 in 2025 and $0 in 2024.
(2)Tax-equivalent basis, where the yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.

For investments in callable bonds, the actual life of the investment will depend on whether the issuer calls the investment prior to the maturity date. Given our investments in callable bonds, the actual average life of our investments cannot be known at the time of the investment. Absent sales and "make-whole calls," however, the average life will not be less than the average life to next call and will not exceed the average life to maturity. Data for both of these average life measures is provided in the above chart.

Acquisitions in 2025 and 2024 consisted primarily of corporate and municipal bonds with securities spanning a diversified range of issuers, industry sectors, and geographical regions. In the first six months of 2025, we invested primarily in the industrial, financial, and utility sectors. For the entire portfolio, the taxable equivalent effective yield earned was 5.27%, up approximately 1 basis point from the yield in the first six months of 2024. The increase in taxable equivalent effective yield was primarily due to new purchases at yields exceeding the yield on dispositions and the average portfolio yield. For the remainder of 2025, the Company will continue to execute on its existing strategy by seeking to invest in assets that satisfy our quality and other objectives, while maximizing the highest risk-adjusted, capital-adjusted return.

77
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

In addition to the fixed maturity acquisitions, Globe Life invested in commercial mortgage loans and in other long-term investments. Other long-term investments primarily consist of investment funds. See Note—4 Investments for further discussion.

The following table summarizes Globe Life's other investment acquisitions of the following assets.

Other Investment Acquisitions
(Dollar amounts in thousands)
Six Months Ended
June 30,
20252024
Limited partnerships
$52,816 $149,223 
Commercial mortgage loans
66,836 92,483 
Common stock
1,844 14,013 
Convertible notes
— 2,850 
Total
$121,496 $258,569 

Since fixed maturities represent such a significant portion of our investment portfolio, 88% of total amortized cost net of allowance for credit losses at June 30, 2025, the remainder of the discussion of portfolio composition will focus on fixed maturities. Selected information concerning the fixed maturity portfolio is as follows:

Fixed Maturity Portfolio Selected Information
At
June 30,
2025
December 31, 2024June 30,
2024
Average annual effective yield(1)
5.26%5.25%5.24%
Average life, in years, to:
Next call(2)
15.315.115.1
Maturity(2)
19.519.319.1
Effective duration to:
Next call(2,3)
8.88.88.9
Maturity(2,3)
10.510.610.7
(1)Tax-equivalent basis. The yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.
(2)Globe Life calculates the average life and duration of the fixed maturity portfolio two ways:
(a) based on the next call date which is the next call date for callable bonds and the maturity date for non-callable bonds; and
(b) based on the maturity date of all bonds, whether callable or not.
(3)Effective duration is a measure of the price sensitivity of a fixed-income security to a 1% change in interest rates.
78
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Credit Risk Sensitivity. The following tables summarize certain information about the major corporate sectors and security types held in our fixed maturity portfolio at June 30, 2025 and December 31, 2024.

Fixed Maturities by Sector
June 30, 2025
(Dollar amounts in thousands)
Below Investment GradeTotal Fixed Maturities
% of Total
Fixed Maturities
 Amortized
Cost, net
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Amortized
Cost, net
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
At Amortized Cost, netAt Fair Value
Corporates:
Financial
Insurance - life, health, P&C$7,999 $115 $— $8,114 $2,878,552 $66,927 $(195,213)$2,750,266 15 16 
Banks60,345 372 (3,707)57,010 939,288 23,379 (51,085)911,582 
Other financial74,974 — (13,034)61,940 1,187,107 16,979 (140,315)1,063,771 
Total financial143,318 487 (16,741)127,064 5,004,947 107,285 (386,613)4,725,619 26 27 
Industrial
Energy44,541 — (4,807)39,734 1,320,121 40,323 (77,110)1,283,334 
Basic materials— — — — 1,133,943 25,235 (91,895)1,067,283 
Consumer, non-cyclical— — — — 2,160,520 17,332 (229,860)1,947,992 11 11 
Other industrials25,000 — (5,126)19,874 1,118,016 20,190 (93,617)1,044,589 
Communications2,760 288 — 3,048 804,332 16,123 (81,118)739,337 
Transportation— — — — 629,724 13,442 (40,937)602,229 
Consumer, cyclical
167,086 — (25,379)141,707 491,721 3,836 (60,404)435,153 
Technology50,274 1,256 — 51,530 342,051 2,026 (62,532)281,545 
Total industrial289,661 1,544 (35,312)255,893 8,000,428 138,507 (737,473)7,401,462 42 43 
Utilities58,195 — (6,571)51,624 2,113,952 55,957 (109,524)2,060,385 12 12 
Total corporates
491,174 2,031 (58,624)434,581 15,119,327 301,749 (1,233,610)14,187,466 80 82 
States, municipalities, and political divisions:
General obligations— — — — 909,974 4,564 (216,859)697,679 
Revenues— — — — 2,393,177 18,986 (417,065)1,995,098 13 12 
Total states, municipalities, and political divisions
— — — — 3,303,151 23,550 (633,924)2,692,777 18 16 
Other fixed maturities:
Government (U.S. and foreign)— — — — 450,798 152 (41,309)409,641 
Collateralized debt obligations— — — — — — — — — — 
Other asset-backed securities11,648 35 — 11,683 76,166 114 (810)75,470 — — 
Total fixed maturities
$502,822 $2,066 $(58,624)$446,264 $18,949,442 $325,565 $(1,909,653)$17,365,354 100100



79
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Fixed Maturities by Sector
December 31, 2024
(Dollar amounts in thousands)
Below Investment GradeTotal Fixed Maturities
% of Total
Fixed Maturities
 Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
At Amortized Cost, netAt Fair Value
Corporates:
Financial
Insurance - life, health, P&C$38,584 $32 $(7,801)$30,815 $2,817,161 $49,928 $(206,943)$2,660,146 15 15 
Banks65,718 254 (3,506)62,466 1,026,367 17,023 (59,795)983,595 
Other financial74,973 — (14,917)60,056 1,162,847 15,647 (146,305)1,032,189 
Total financial179,275 286 (26,224)153,337 5,006,375 82,598 (413,043)4,675,930 27 27 
Industrial
Energy44,580 — (5,410)39,170 1,318,501 33,825 (77,700)1,274,626 
Basic materials— — — — 1,147,932 20,121 (91,699)1,076,354 
Consumer, non-cyclical640 — (3)637 2,087,181 11,222 (255,241)1,843,162 11 11 
Other industrials25,000 — (4,796)20,204 1,089,118 14,847 (108,283)995,682 
Communications— — — — 832,355 12,085 (90,817)753,623 
Transportation— — — — 572,829 9,800 (38,953)543,676 
Consumer, cyclical
128,674 331 (28,378)100,627 492,653 3,113 (75,592)420,174 
Technology50,278 — (2,419)47,859 341,407 597 (67,045)274,959 
Total industrial249,172 331 (41,006)208,497 7,881,976 105,610 (805,330)7,182,256 42 42 
Utilities58,996 22 (6,797)52,221 2,081,366 39,716 (118,007)2,003,075 11 12 
Total corporates487,443 639 (74,027)414,055 14,969,717 227,924 (1,336,380)13,861,261 80 81 
States, municipalities, and political divisions:
General obligations— — — — 909,765 3,695 (177,021)736,439 
Revenues— — — — 2,391,136 16,967 (357,738)2,050,365 13 12 
Total states, municipalities, and political divisions
— — — — 3,300,901 20,662 (534,759)2,786,804 18 16 
Other fixed maturities:
Government (U.S., municipal, and foreign)— — — — 438,636 19 (51,664)386,991 
Collateralized debt obligations36,923 5,943 — 42,866 36,923 5,943 — 42,866 — — 
Other asset-backed securities4,754 10 — 4,764 79,237 39 (2,186)77,090 — 
Total fixed maturities$529,120 $6,592 $(74,027)$461,685 $18,825,414 $254,587 $(1,924,989)$17,155,012 100100



80
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Corporate securities, which consist of bonds and redeemable preferred stocks, were the largest component of the fixed-maturity portfolio as of June 30, 2025, representing 80% of amortized cost, net, and 82% of fair value. The remainder of the portfolio is invested primarily in securities issued by the U.S. government and U.S. municipalities. The Company holds insignificant amounts in foreign government bonds, collateralized debt obligations, asset-backed securities, and mortgage-backed securities. Corporate securities are diversified over a variety of industry sectors and issuers. At June 30, 2025, the total fixed maturity portfolio consisted of 1,016 issuers.

Fixed maturities had a fair value of $17.4 billion at June 30, 2025, compared to $17.2 billion at December 31, 2024. The net unrealized loss position in the fixed-maturity portfolio decreased from $1.7 billion at December 31, 2024 to $1.6 billion at June 30, 2025 due to a change in market rates during the period.

For more information about our fixed-maturity portfolio by component at June 30, 2025 and December 31, 2024, including a discussion of allowance for credit losses, an analysis of unrealized investment losses, and a schedule of maturities, see Note 4—Investments.

An analysis of the fixed-maturity portfolio by composite quality rating at June 30, 2025 and December 31, 2024, is shown in the following tables. The company uses the NAIC designation for credit quality ratings. The NAIC designation is generally determined using the second lowest rating available from nationally recognized statistical rating organizations (“NRSRO”) when three or more ratings are available and the lowest rating when two or fewer rating are available. When NRSRO ratings are unavailable the rating may be assigned by the Securities Valuation Office (“SVO”) of the NAIC.

Fixed Maturities by Rating
At June 30, 2025
(Dollar amounts in thousands)
Amortized Cost, net % of TotalFair
Value
% of TotalAverage Composite Quality Rating on Amortized Cost, net
Investment grade:
AAA$942,695 $837,905 
AA3,351,694 17 2,746,832 16 
A5,816,062 31 5,500,548 31 
BBB+3,230,903 17 3,039,564 18 
BBB3,954,154 21 3,711,886 21 
BBB-1,151,112 1,082,355 
Total investment grade
18,446,620 97 16,919,090 97 A-
Below investment grade:
BB375,502 334,428 
B125,122 109,638 
Below B2,198 — 2,198 — 
Total below investment grade
502,822 446,264 BB-
$18,949,442 100 $17,365,354 100 
Weighted average composite quality rating
A-


81
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Fixed Maturities by Rating
At December 31, 2024
(Dollar amounts in thousands)
Amortized
Cost, net
% of Total
Fair
Value
% of TotalAverage Composite Quality Rating on Amortized Cost
Investment grade:
AAA$968,220 $855,165 
AA3,225,044 17 2,691,908 15 
A5,508,446 29 5,147,203 30 
BBB+3,267,101 17 3,040,313 18 
BBB4,087,323 22 3,799,696 22 
BBB-1,240,160 1,159,042 
Total investment grade
18,296,294 97 16,693,327 97 A-
Below investment grade:
BB397,823 349,028 
B92,176 67,593 
Below B39,121 — 45,064 — 
Total below investment grade
529,120 461,685 BB-
$18,825,414 100 $17,155,012 100 
Weighted average composite quality rating
A-

The overall quality rating of the portfolio is A-, the same as of year-end 2024. Fixed maturities rated BBB are 44% of the total portfolio at June 30, 2025, down from 46% at December 31, 2024. While this ratio is high relative to our peers, it is at its lowest level since 2006 and we have limited exposure to higher-risk assets such as derivatives, equities, and asset-backed securities. Additionally, the Company does not participate in securities lending and has no off-balance sheet investments as of June 30, 2025. Of our fixed maturity purchases, BBB securities generally provide the Company with the best risk-adjusted, capital-adjusted returns largely due to our ability to hold securities to maturity regardless of fluctuations in interest rates or equity markets.

An analysis of changes in our portfolio of below-investment grade fixed maturities at amortized cost, net of allowance for credit losses is as follows:

Below-Investment Grade Fixed Maturities
(Dollar amounts in thousands)
Six Months Ended
June 30,
20252024
Balance at beginning of period
$529,120 $529,511 
Downgrades by rating agencies65,627 29,006 
Upgrades by rating agencies(30,565)— 
Dispositions
(65,513)(12,549)
Acquisitions
6,893 17,737 
Provision for credit losses40 (17)
Amortization and other(2,780)414 
Balance at end of period
$502,822 $564,102 


82
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Our investment policy calls for investing primarily in fixed maturities that are investment grade and meet our quality and yield objectives. Thus, the balance of below-investment grade issues is primarily the result of ratings downgrades of existing holdings. Below-investment grade bonds at amortized cost, net of allowance for credit losses, were 3% of total fixed maturities at amortized cost as of June 30, 2025.

OPERATING EXPENSES

Operating expenses are classified into two categories: insurance administrative expenses and expenses of the Parent Company. Insurance administrative expenses generally include expenses incurred after a policy has been issued. As these expenses relate to premium for a given period, management measures the expenses as a percentage of premium income. The Company also views stock-based compensation expense as a Parent Company expense. Expenses associated with the issuance of our insurance policies are reflected as acquisition expenses and included in the determination of underwriting margin.

An analysis of operating expenses is shown below.

Operating Expenses Selected Information
(Dollar amounts in thousands)
 Six Months Ended June 30,Increase
 20252024(Decrease)
Amount% of
Premium
Amount% of
Premium
Amount%
Insurance administrative expenses:
Salaries$68,365 2.8 $62,029 2.7 $6,336 10 
Other employee costs19,708 0.8 18,076 0.8 1,632 
Information technology costs40,491 1.7 38,868 1.7 1,623 
Legal costs12,076 0.5 12,162 0.5 (86)(1)
Other administrative costs32,956 1.4 31,472 1.3 1,484 
Total insurance administrative expenses173,596 7.2 162,607 7.0 10,989 
Parent company expense6,605 5,956 649 
Stock compensation expense26,062 19,357 6,705 
Legal proceedings10,776 2,435 8,341 
Non-operating expenses— 1,967 (1,967)
$217,039 $192,322 $24,717 13 

Total operating expenses for June 30, 2025 increased in comparison with the prior year primarily due to increases in insurance administrative expenses as well as stock compensation and legal proceedings. Insurance administrative expenses increased $11 million primarily due to higher employee costs, which include salaries and other costs. Insurance administrative expenses as a percent of premium were 7.2% for the six months ended June 30, 2025 compared to 7.0% for the same period in 2024. Stock compensation expense increased primarily due to changes in the mix of awards and increase in award values.

83
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

SHARE REPURCHASES

Globe Life has an ongoing share repurchase program that began in 1986. The share repurchase program is reviewed with the Board of Directors quarterly, and continues indefinitely unless and until the Board of Directors decides to suspend, terminate or modify the program. On November 18, 2024, the Board of Directors authorized the repurchase of up to $1.8 billion under the Company's existing share repurchase program. Management generally determines the amount of repurchases based on the amount of excess cash flows and other available sources after the payment of dividends to the Parent Company shareholders, general market conditions, and other alternative uses. Since implementing our share repurchase program in 1986, we have used $10.7 billion to repurchase Globe Life Inc. common shares, after determining that the repurchases provide a greater risk-adjusted after-tax return than other investment alternatives.

Excess cash flow at the Parent Company is primarily comprised of dividends received from the insurance subsidiaries less interest expense paid on its debt and other limited operating activities. Additionally, when stock options are exercised, proceeds from these exercises and the resulting tax benefit are used to repurchase additional shares on the open market to minimize dilution as a result of the option exercises.

The following table summarizes share repurchases for the six month periods ended June 30, 2025 and 2024.

Analysis of Share Repurchases
(Amounts in thousands, except per share data) 
 Six Months Ended June 30,
 20252024
 Purchases with:
SharesAmountAverage
Price
SharesAmountAverage
Price
Excess cash flow at the Parent Company(1)
3,317 $402,603 $121.38 3,964 $329,737 $83.17 
Option exercise proceeds881 108,598 123.27 300 26,404 88.09 
Total4,198 $511,201 $121.78 4,264 $356,141 $83.52 
(1)Excludes excise tax on the repurchase of treasury stock of $3.7 million and $3.2 million for the six months ended June 30, 2025 and 2024, respectively.
The amount of share repurchases in the first six months were higher due to higher excess cash flow. The amount of excess cash flow was higher than in the prior year primarily due to higher statutory earnings and the inclusion of extraordinary dividends approved in late 2024. Throughout the remainder of this discussion, share repurchases will only refer to those made from excess cash flow at the Parent Company.

FINANCIAL CONDITION
 
Liquidity. Liquidity provides Globe Life with the ability to meet on demand the cash commitments required to support our business operations and meet our financial obligations. Our liquidity is primarily derived from multiple sources: positive cash flow from operations, a portfolio of marketable securities, a revolving credit facility, commercial paper, and advances from the Federal Home Loan Bank.

Insurance Subsidiary Liquidity. The operations of our insurance subsidiaries have historically generated substantial cash inflows in excess of immediate cash needs. Cash inflows for the insurance subsidiaries primarily include premium and investment income. In addition to investment income, maturities and scheduled repayments in the investment portfolio are cash inflows. Cash outflows from operations include policy benefit payments, commissions, administrative expenses, and taxes. A portion of cash inflows in the current year will provide for the payment of future policy benefits and are invested primarily in long-term fixed maturities as they better match the long-term nature of these obligations. Excess cash available from the insurance subsidiaries’ operations is generally distributed as a dividend to the Parent Company, subject to regulatory restrictions. The dividends are generally paid in amounts equal to the subsidiaries’ prior year statutory net income excluding realized capital gains. While the insurance subsidiaries annually generate more operating cash inflows than cash outflows, the companies also have the entire available-for-sale fixed-maturity investment portfolio available to create additional cash flows if required.
84
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Four of our insurance subsidiaries are members of the FHLB of Dallas. FHLB membership provides the insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. While not the only source of liquidity, the FHLB could provide the insurance subsidiaries with an additional source of liquidity, if needed. Refer to Note 11—Debt for further details.

Parent Company Liquidity. An important source of Parent Company liquidity is the dividends from its insurance subsidiaries. These dividends are received throughout the year and are used by the Parent Company to pay dividends on common and preferred stock, interest and principal repayment requirements on Parent Company debt, and operating expenses of the Parent Company.
Six Months Ended
June 30,
Twelve Months Ended
December 31,
20252024Projected 20252024
Liquidity Sources:
Dividends from Subsidiaries$351,394 $358,255 
$700,000—$750,000
$692,690 
Excess Cash Flows(1)
$474,953 $327,283 
$780,000—$830,000
$455,013 
(1)Excess cash flows are reported gross of shareholder dividends. For the six months ended June 30, 2025 and 2024, shareholder dividends were $43 million and $44 million, respectively. For the twelve months ended December 31, 2025, we project approximately $84 million in shareholder dividends, compared to the $85 million paid in 2024.

Dividends from subsidiaries and excess cash flows are projected to be higher in 2025 than in 2024 primarily due to improved earnings from favorable mortality trends and growth in business, as well as positive impacts from lower reserve increases under statutory accounting impacting the 2024 statutory earnings that derive the 2025 dividends. The excess cash flows in 2025 include the extraordinary dividends approved in the latter part of 2024 of $192 million. Additional sources of liquidity for the Parent Company are cash, intercompany receivables, intercompany borrowings, debt markets, term loans, and a revolving credit facility.

On July 1, 2025, we entered into a 30-year facility agreement (“Facility Agreement”) with a Delaware Trust (the “Trust”) formed by us in connection with the sale by the trust of $500 million pre-capitalized trust securities redeemable May 15, 2055 in a Rule 144A private placement. The Trust invested the proceeds from the sale of its securities in a portfolio of principal and interest strips of U.S. Treasury securities (the “Strips”).

The Facility Agreement provides us with the right to sell at any time to the Trust up to $500 million of our 6.580% Senior Notes due 2055 (the “6.580% Senior Notes”) in exchange for a corresponding amount of the Strips held by the Trust (the “Issuance Right”). We agreed to pay a semi-annual facility fee of 1.789% per annum on the unexercised portion of the Issuance

The Issuance Right will be exercised automatically in full upon (i) our failure to pay the facility fee or to purchase any Strips required to be purchased under the Facility, if the failure to pay is not cured within 30 days, or (ii) certain bankruptcy events involving the Company. We are also required to exercise the Issuance Right in full if our consolidated stockholders’ equity (excluding AOCI) falls below $1.55 billion, subject to certain adjustments.

The Company can redeem the 6.580% Senior Notes at any time, in whole or in part, at a price equal to the greater of par or a make-whole redemption price. At June 30, 2025, the Company had no senior note issuances under the Facility Agreement.

Short-Term Borrowings. An additional source of Parent Company liquidity is a credit facility with a group of lenders. The facility was amended on March 29, 2024, resulting in an increased capacity of $250 million. The facility allows for unsecured borrowings and stand-by letters of credit up to $1 billion, which could be increased up to $1.25 billion. While the Parent Company may request the increase, it is not guaranteed. The updated five-year credit agreement will mature on March 29, 2029. Up to $250 million in letters of credit can be issued against the facility. The facility serves as a backup line of credit for a commercial paper program under which commercial paper may be issued at any time, with total commercial paper outstanding not to exceed the facility maximum less any letters of credit issued. Interest charged on the commercial paper program resembles variable rate debt due to its short term nature. As of June 30, 2025, we had available $488 million of additional borrowing capacity under this facility,
85
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

compared to $572 million a year earlier. As of June 30, 2025, the Parent Company was in full compliance with all covenants related to the aforementioned debt.

As a part of the credit facility, Globe Life has stand-by letters of credits. These letters of credit are issued on behalf of our insurance subsidiaries.

The following tables present certain information about our commercial paper borrowings.

Credit Facility—Commercial Paper
(Dollar amounts in thousands)
At
June 30,
2025
December 31, 2024June 30,
2024
Balance of commercial paper at end of period (par value)$397,000 $419,000 $313,225 
Annualized interest rate4.73 %5.22 %6.02 %
Letters of credit outstanding$115,000 $115,000 $115,000 
Remaining amount available under credit line488,000 466,000 571,775 

Credit Facility—Commercial Paper Activity
(Dollar amounts in thousands)
 Six Months Ended June 30,
 20252024
Average balance of commercial paper outstanding during period (par value)$456,181 $392,905 
Daily-weighted average interest rate (annualized)4.99 %5.76 %
Maximum daily amount outstanding during period (par value)$605,500 $633,425 

The Company reduced commercial paper borrowings by $22 million since year end. The Company was able to issue commercial paper as needed under this facility during the six months ended June 30, 2025 and 2024.

Globe Life expects to have readily available funds for 2025 and the foreseeable future to conduct its operations and to maintain target capital ratios in the insurance subsidiaries through liquid assets currently available, internally-generated cash flow and the credit facility. In the event more liquidity is needed, the Parent Company could generate additional funds through multiple sources including, but not limited to, the issuance of debt, an additional short-term credit facility or term loan, and intercompany borrowing.

Consolidated Liquidity. Consolidated net cash inflows from operations were $740 million in the first six months of 2025, compared with $725 million in the same period of 2024. The increase is attributable to routine fluctuations in the settlement of operating activities. In addition to cash inflows from operations, our insurance companies received proceeds from dispositions of fixed maturities available for sale, mortgage loans, and other long-term investments in the amount of $434 million during the first six months of 2025. As previously noted under the caption Short-Term Borrowings, the Parent Company has in place a revolving credit facility. The insurance companies have no additional outstanding credit facilities.

Cash and short-term investments were $356 million at June 30, 2025, compared with $250 million at December 31, 2024. In addition to these liquid assets, $17 billion (fair value at June 30, 2025) of fixed income securities are available for sale in the event of an unexpected need. Approximately $1.3 billion, at fair value, are pledged for outstanding FHLB advances and reinsurance. Further, approximately 98% of our fixed income securities are publicly traded, freely tradable under SEC Rule 144, or qualified for resale under SEC Rule 144A. While our fixed income securities are classified as available for sale, we have the ability and general intent to hold any securities to recovery or maturity. Our strong cash flows from operations, on-going investment maturities, and available liquidity under our credit facility make any need to sell securities for liquidity highly unlikely.

86
        GL Q2 2025 FORM 10-Q

Table of Contents
Globe Life Inc.
Management's Discussion & Analysis

Capital Resources. The Parent Company's capital structure consists of short-term debt (the commercial paper facility and current maturities of long-term debt), long-term debt, and shareholders’ equity. It does not include short-term FHLB borrowings, which are obligations of the insurance subsidiaries and typically repaid over the course of the year.

Long-Term Borrowings. At June 30, 2025, the outstanding long-term debt at book value was $2.3 billion unchanged from December 31, 2024.

Selected Information about Debt Issues
As of June 30, 2025
(Dollar amounts in thousands)
InstrumentIssue DateMaturity DateCoupon Rate Interest Payment DatesPar
Value
Book
Value
Fair
Value
Senior notes09/27/201809/15/20284.550%semiannual$550,000 $547,373 $552,519 
Senior notes08/21/202008/15/20302.150%semiannual400,000 397,368 353,416 
Senior notes(1)
05/19/202206/15/20324.800%semiannual250,000 246,482 245,922 
Senior notes
08/23/202409/15/20345.850%semiannual450,000 445,016 465,089 
Junior subordinated debentures11/17/201711/17/20575.275%semiannual125,000 123,452 97,500 
Junior subordinated debentures06/14/202106/15/20614.250%quarterly325,000 317,430 209,300 
Term loan(2)
05/11/202308/15/20275.799%quarterly250,000 248,521 248,521 
Total long-term debt
2,350,000 2,325,642 2,172,267 
FHLB borrowings70,000 70,000 70,000 
Commercial paper397,000 394,540 394,540 
Total short-term debt
467,000 464,540 464,540 
Total debt
$2,817,000 $2,790,182 $2,636,807 
(1)An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
(2)Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points. The term loan was amended on August 15, 2024 extending the maturity date from November 11, 2024 to August 15, 2027 and increasing the principal amount from $170 million to $250 million.

Financing costs consist primarily of interest on our various debt instruments. The table below presents the components of financing costs and reconciles interest expense per the Condensed Consolidated Statements of Operations.

Analysis of Financing Costs
(Dollar amounts in thousands)
Six Months Ended
June 30,
Increase
(Decrease)
20252024Amount%
Interest on funded debt$47,179 $33,853 $13,326 39 
Interest on term loans7,674 5,956 1,718 29 
Interest on short-term debt15,011 20,203 (5,192)(26)
Other13 13 — — 
Financing costs
$69,877 $60,025 $9,852 16 

During the first six months of 2025, financing costs increased 16% compared to the prior year. The increase in financing costs is primarily due to higher average balances in the current year compared to the prior year due to the issuance of debt in the third quarter of 2024. More information on our debt transactions is disclosed in the Financial Condition section of this report.
87
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis

Subsidiary Capital: The National Association of Insurance Commissioners (NAIC) has established a risk-based factor approach for determining threshold risk-based capital levels for all insurance companies. This approach was designed to assist the regulatory bodies in identifying companies that may require regulatory attention. A Risk-Based Capital (RBC) ratio is typically determined by dividing adjusted total statutory capital by the amount of RBC determined using the NAIC’s factors. If a company’s RBC ratio approaches two times the RBC amount, the company must file a plan with the NAIC for improving its capital levels (this level is commonly referred to as “Company Action Level” RBC). Companies typically hold a multiple of the Company Action Level RBC depending on their particular business needs and risk profile.

Our goal is to maintain statutory capital within our insurance subsidiaries at levels necessary to support our current ratings. For 2025, Globe Life has targeted a consolidated Company Action Level RBC ratio of 300% to 320%. The Company has concluded that this capital level is more than adequate and sufficient to support its current ratings, given the nature of its business and its risk profile. For 2024, our consolidated Company Action Level RBC ratio was 316%. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.

Shareholders' Equity: Shareholders’ equity was $5.4 billion at June 30, 2025. This compares with $5.3 billion at December 31, 2024 and $5.2 billion at June 30, 2024. During the six months since December 31, 2024, shareholders’ equity increased as a result of net income of $507 million during the first six months of 2025, but was offset by share repurchases of $403 million and an additional $109 million in share repurchases to offset the dilution from stock option exercises. Additionally, the change in the balance of AOCI increased shareholders' equity $46 million primarily due to changes in interest rates and discount rates over the period.

On April 25, 2025, the Parent Company announced that it had declared a quarterly dividend of $0.27 per share. This dividend was paid on August 1, 2025.

We plan to use excess cash available at the Parent Company as efficiently as possible in the future. Excess cash flow, as we define it, results primarily from the dividends received by the Parent Company from its insurance subsidiaries less the interest paid on debt. The cash received by the Parent Company from our insurance subsidiaries is after they have made substantial investments during the year to grow the business. Possible uses of excess cash flow include, but are not limited to, share repurchases, acquisitions, shareholder dividend payments, investments in securities, or repayment of short-term debt. We will determine the best use of excess cash after ensuring that targeted capital levels are maintained in our insurance subsidiaries. If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds.

Future policy benefits are computed using current discount rates with the impact of changes in discount rates included in accumulated other comprehensive income. Additionally, the liability for future policy benefits is calculated using net premiums rather than gross premiums. Given that gross premiums are considerably higher than net premiums for our business, as seen in Note 6—Policy Liabilities, the measurement of the liability is higher than what it would be had it been computed using gross premiums. This is an important consideration when analyzing shareholders' equity.

We maintain a significant available-for-sale fixed maturity portfolio to support our insurance policy liabilities. Current accounting guidance requires that we revalue our portfolio to fair market value at the end of each accounting period. The period-to-period changes in fair value, net of their associated impact on income tax, are reflected directly in shareholders’ equity. Changes in the fair value of the portfolio can result from changes in market rates.

While a majority of invested assets are revalued, accounting rules do not permit interest-bearing insurance policy liabilities to be valued at fair value in a consistent manner as that of assets, with changes in value applied directly to shareholders’ equity. Due to the size of our policy liabilities in relation to our shareholders’ equity, an inconsistency exists in measurement, which may have a material impact on the reported value of shareholders’ equity. Fluctuations in interest rates cause undue volatility in the period-to-period presentation of our shareholders’ equity, capital structure, and financial ratios. Due to the long-term nature of our fixed-maturity investments and liabilities and the strong cash flows consistently generated by our insurance subsidiaries, we have the ability to hold our securities to maturity. As such, we do not expect to incur losses due to fluctuations in market value of fixed maturities caused by market rate changes and temporarily illiquid markets. Accordingly, our management, credit
88
        GL Q2 2025 FORM 10-Q

Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis

rating agencies, lenders, many industry analysts, and certain other financial statement users prefer to remove the effect of this accounting rule when analyzing our balance sheet, capital structure, and financial ratios.
89
        GL Q2 2025 FORM 10-Q

Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
 
There have been no quantitative or qualitative changes with respect to market risk exposure during the six months ended June 30, 2025.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures: Globe Life Inc., under the direction of the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, has established disclosure controls and procedures that are designed to ensure that information required to be disclosed by Globe Life in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The disclosure controls and procedures are also intended to ensure that such information is accumulated and communicated to Globe Life's management, including the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
 
As of the end of the fiscal period completed June 30, 2025, an evaluation was performed under the supervision and with the participation of Globe Life management, including the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer, of the disclosure controls and procedures (as those terms are defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon their evaluation, the Co-Chairmen and Chief Executive Officers and the Executive Vice President and Chief Financial Officer have concluded that disclosure controls and procedures are effective as of the date of this Form 10-Q. In compliance with Section 302 of the Sarbanes Oxley Act of 2002 (18 U.S.C. § 1350), each of these officers executed a Certification included as an exhibit to this Form 10-Q.

Changes in Internal Control over Financial Reporting: During the period ended June 30, 2025, there were no changes to Globe Life Inc.'s internal control over financial reporting or in other factors that could significantly affect the internal control over financial reporting subsequent to the date of their evaluation which have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.  


Part II—Other Information

Item 1. Legal Proceedings

Discussion regarding litigation is provided in Note 5—Commitments and Contingencies.


Item 1A. Risk Factors
 
The Company had no material changes to its risk factors.



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Certain Equity Securities by the Issuer and Others for the Second Quarter of 2025
Period
(a) Total Number
of Shares
Purchased
(b) Average
Price Paid
Per Share
(c) Total Number of
Shares Purchased as 
Part of Publicly Announced
Plans or Programs
(d) Maximum Number
of Shares (or
Approximate Dollar
Amount) that May
Yet Be Purchased
Under the Plans or
Programs
April 1-30, 2025427,129 $121.76 427,129 — 
May 1-31, 20251,168,418 121.02 1,168,418 — 
June 1-30, 2025451,775 120.90 451,775 — 

90
        GL Q2 2025 FORM 10-Q

Table of Contents
Item 5. Other Information

(c) Trading arrangements

During the six months ended June 30, 2025, none of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a Non-Rule 10b5-1 trading arrangement, as each term is defined under Item 408(a) of Regulation S-K.
91
        GL Q2 2025 FORM 10-Q

Table of Contents
Item 6. Exhibits
 
Exhibit No.Description
4.1
10.1
10.2
31.1
31.2
31.3
32.1
101.INSXBRL Instance Document- the instance document does not appear in the Interactive Data file because the XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
104Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).


92
        GL Q2 2025 FORM 10-Q

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
GLOBE LIFE INC.
Date: August 6, 2025/s/ J. Matthew Darden
J. Matthew Darden
Co-Chairman and Chief Executive Officer
Date: August 6, 2025/s/ Frank M. Svoboda
Frank M. Svoboda
Co-Chairman and Chief Executive Officer
Date: August 6, 2025/s/ Thomas P. Kalmbach
Thomas P. Kalmbach
Executive Vice President and Chief Financial Officer

93
        GL Q2 2025 FORM 10-Q